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Summary of Thesis 
 
Hydroxyapatite (HA) coating of hard tissue implants is widely employed for its 
biocompatible and osteoconductive properties as well as its improved mechanical 
properties (Borsari et al., 2005; Stoch et al., 2005; Lu et al., 2004). The provision of 
this bioactive surface (modified surface) onto which the bone can strongly bond will 
in turn limit micromotions at the implant-host interface (Borsari et al., 2005; Stoch et 
al., 2005). Plasma technology is the principal deposition process for coating HA on 
bioactive metals for this application (Campbell et al., 2003). However, thermal 
decomposition of HA can occur during the plasma deposition process, resulting in 
coating variability in terms of purity, uniformity and crystallinity, which can lead to 
implant failure caused by aseptic loosening (Mohammadi et al., 2008; Gross et al., 
2004; Chang and Khor., 1996; Søballe and Overgaard, 1996). An alternative coating 
technology, CoBlastTM, based on grit blasting technology, has been used to deposit 
HA onto titanium (Ti) metal using a dopant/abrasive regime. This is an ambient 
temperature and low cost deposition process which retains the chemical composition 
of the starting materials thereby offering better control of the coating properties. 
However, one of the major drawbacks in the use of biomedical materials is the 
occurrence of biomaterials associated infections (BAI) (Schmidmaier et al., 2006). 
These infections are the result of colonisation of bacterial microbes leading to the 
inevitable biofilm formation on the surface of the implant. Biomaterial-associated 
infections pose great surgical problems, as revision surgery is not always easy and 
patients suffer severe discomfort (Van Howelingen, 2012; Schmidmaier et al., 
2006). Traditional therapeutic approaches are complicated with a number of 
drawbacks including poor delivery and impact of antibiotics at the localised site or 
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development of antibiotic resistance microbes (Jiranek et al., 2006; Amyes and 
Gemmell, 1997; Gold and Moellering, 1996). Prophylactic treatment involving large 
doses of antibiotics administered before and after surgery increases the risks of 
systemic toxicity and organ failure (Ruszczak and Fress, 2003; Price et al., 1996). 
Recently, there has been an emergence of resistant bacterial strains, which are 
proven difficult to eradicate using conventional antibiotics (Parvizi et al., 2009). 
Therefore, there is a need for a bioceramic coating on hard tissue implants that not 
only promotes bone-implant integration but also inhibits bacterial colonisation.  
 
The thesis is structured over a number of chapters as follows: 
In Chapter 1, a literature review has been prepared which covers the main topics 
focused in this study. Typical biomaterials used for hard tissue implants are outlined. 
Moreover, HA and its importance as a bioceramic coating on hard tissue implants is 
discussed. The bone fixation process at the implantation site involving the biological 
and chemical interactions at the implant-bone interface is covered. In addition, the 
surface properties of the implant which influences cellular response of the osteoblasts 
(bone forming cells) are summarised. Problems associated with hard tissue implants 
and possible solutions that have been extensively studied are included. The process 
involved in biofilm formation is detailed. An overview of the deposition processes 
used to deposit HA as well as the CoBlast technology are presented. 
 
Similar materials and methods were used to characterise the modified surfaces in the 
various studies (Chapters 3-7) as a result, a general overview of these materials and 
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methods are outlined in Chapter 2. The materials and modified surfaces were 
characterised where appropriate, using various analytical techniques to understand 
the elemental and chemical composition (EDX, XPS, XRD, FT-IR), physical 
properties (SEM, surface roughness, coating mass and thickness) and cell culture 
analysis (cell proliferation and cytotoxicity). Details of the microbiology 
assessments executed (antimicrobial and anticolonising studies) are outlined. The 
antimicrobial studies consisted of evaluating the impact of the leached ion released 
from the surface and the effect of the immobilised ion on the surface (permanent, 
non leaching surface effect) using Staphylococcus aureus (S. aureus) and clinical 
strains (methicillin resistant Staphylococcus aureus (MRSA), methicillin sensitive 
Staphylococcus aureus (MSSA) and Staphylococcus epidermis (S. epidermis). In 
addition, anticolonising assessments were performed to investigate the potential 
biofilm formation of bacterial microbes onto the surfaces. An in vivo study was also 
performed to assess the efficacy of the implants’ surfaces against S. aureus in an 
infection model using nude mice. In Chapter 7, the methods used to characterise the 
implants surfaces for microbial attachment (% kill, SEM), and subsequent 
inflammatory and systemic responses are summarised. 
 
In Chapter 3, CoBlast has been used to successfully modify a Ti substrate with a 
HA treatment. A series of apatitic abrasives under the trade name MCD, was 
investigated to determine the effect of abrasive particle size on the surface properties 
of both microblast (abrasive only) and CoBlast (HA/abrasive) treatments. The 
CoBlast HA substrates were compared to the microblast substrates and an untreated 
Ti. The various powders (HA powder, apatitic abrasives) and the treated substrates 
were characterised for chemical composition, coating coverage, crystallinity and 
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topography including surface roughness. The results revealed that the surface 
roughness of the HA blasted modification was affected by the particle size of the 
apatitic abrasives used. More importantly, the CoBlast process did not alter the 
chemistry of the crystalline HA during deposition. Enhanced viability of osteoblastic 
cells was observed on the CoBlast HA surfaces compared to the microblast and 
untreated Ti.  
 
Chapter 4, compares in an in vitro study, the HA coating deposited using CoBlast 
and also using the standard plasma spraying process. Ion release from the HA 
surfaces over 3 days are assessed and the bioactivity of these surfaces in stimulating 
body fluid (SBF) were evaluated. The HA surface induced the formation of a 
carbonated apatite (CHA) on its surfaces following incubation in SBF. Possible 
mechanisms for this formation are outlined however further analysis is required for 
confirmation. Both surfaces are characterised before and after the bioactivity study 
for chemical and physical properties. The HA surfaces were analysed for osteoblast 
cell viability using MG-63 osteoblasts. The mechanical properties of the adhesion 
bond strength between the HA coating and the Ti substrate was assessed before and 
after the formation of the carbonated apatite. The data revealed that the deposition of 
the HA coating using plasma technology resulted in a rougher and thicker coating 
however, the quality of the coating was inferior to the CoBlast surface. The CoBlast 
HA coating was more crystalline, uniform, exhibited higher levels of osteoblast 
proliferation in vitro and produced higher levels of mechanical stability despite its 
lower rate of dissolution.  
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In Chapter 5, CoBlast technology was used to successfully deposit a series of 
substituted apatites onto Ti. The 5% wt substituted apatite powders (AgA, SrA and 
ZnA) were deposited due to their potential use as antimicrobial materials and 
coatings to combat BAI. The modified surfaces were assessed for their chemical and 
physical properties as well as cell viability of osteoblasts. Surfaces demonstrated 
good cell proliferation without any cytotoxicity observed. The antimicrobial and 
non-colonising behaviour of the surfaces were assessed using S. aureus as the 
bacterial challenge. Promising levels of initial microbial inhibition were observed 
from all of the substituted surfaces. The anticolonising behaviour was attributed to 
the surface impact of the immobilised ions in conjunction with the low levels of ions 
released from the surface. The Ag substituted apatite was observed to outperform 
both the SrA and ZnA in terms of biofilm inhibition. However, better surface impact 
was observed for the SrA with enhanced osteoblast proliferation compared to the 
ZnA surface. Promising results of the anticolonising and preliminary 
osteoconductive potential of 5% wt substituted apatites were revealed in Chapter 5. 
 
Chapter 6 evaluates the use of substituted apatites with an increased loading of 12% 
wt (AgA, SrA) in a similar study to Chapter 5. In addition, a co-substituted silver-
strontium (AgSr) apatite was evaluated due to the enhanced cell proliferation 
behaviour of SrA and anticolonising behaviour of AgA in the previous study. 12% 
AgA was seen to again outperform the other surfaces in terms of its anticolonising 
behaviour and as a result was subjected to further antimicrobial and anticolonising 
studies using clinical strains (MRSA, MSSA and S. epidermis). The results revealed 
that the AgA surface demonstrated good antibacterial activity (eluted and 
immobilised ion) against MRSA followed by MSSA. Good anticolonising activity 
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was only observed at day 1 against MRSA. Poor impact against S. epidermis was 
observed compared to the other clinical isolates assessed. AgA demonstrates 
promising potential as a coating to combat BAI.  
 
AgA of two different loadings (5% wt and 12% wt) were deposited onto a Ti K-wire 
implants using CoBlast technology and the anticolonising behaviour of these 
implants were assessed in an in vivo model in Chapter 7. EDX and SEM were used 
to determine the chemical composition and morphology of the surfaces. The 
implants were subcutaneously implanted into nude mice and inoculated with S. 
aureus as the bacteria challenge, which delivered a localised infection. Following 
two days, the explanted 12% wt AgA coated K-wire was seen to outperform the 5% 
wt AgA. Lower inflammatory responses were activated with the insertion of the Ag 
loaded K-wires in an infection model. These results indicate that the AgA coating on 
the surface of orthopeadic implants inhibits adhesion preventing colonising 
behaviour with good biocompatibility potential. 
 
Finally, in Chapter 8 a general discussion on the findings of the studies performed 
in Chapters 3-7 is given. This discussion is divided into four sections, in order to 
address the main objectives of the thesis and the research questions probed:  
(i) Ultimate aim: Added value and key benefits of CoBlast technology. CoBlast, a 
room temperature process, has the ability to deposit the ‘as-received’ powders 
and tailor the surface composition and properties. Surfaces with enhanced 
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osteoblast cell viability, osteoconductive potential and promising 
anticolonising activity can be deposited. 
(ii) Objective 1: Evaluations of HA coatings deposited using CoBlast technology 
in in vitro studies. CoBlast HA coatings could positively influence the long-
term success of hard tissue implants and offers an attractive alternative to the 
industry standard plasma process.  
(iii) Objective 2: Evaluation of substituted apatites with antimicrobial metals as an 
infection preventing strategy in in vitro studies. Substituted apatite coatings 
were shown to inhibit bacterial colonisation without compromising osteoblast 
cell viability.  
(iv) Objective 3: Evaluation of AgA as an infection preventing surface in an in vivo 
model. AgA at a silver loading of 12% wt was shown to be effective in 
inhibiting S. aureus colonisation compared to 5% wt AgA with a lower 
inflammatory response activated in a subcutaneous model in nude mice. 
Conclusions, limitations of this work and future work are also included. 
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    Chapter 1 
1.0 Introduction and Literature Review 
Hydroxyapatite (HA) and doped apatites were deposited onto titanium (Ti) (V) metal 
using a grit blasting CoBlast technology. The HA surface was deposited as a 
bioactive surface to induce chemical and biological responses whereas the 
substituted apatites, which comprised of antimicrobial metals, offer the dual purpose 
of being osteoconductive in addition to its anticolonising activity. The coatings are 
characterised to investigate the effectiveness of the CoBlast technology to deposit 
the bioceramics onto Ti metal and also to assess the quality of the coatings 
deposited, which will affect the stablity and degradation. The literature review 
focuses on these keys areas so as to understand the important factors which must be 
studied so as to critically evaluate CoBlast coatings. The keys areas comprises of 
understanding the following: properties of biomaterials; implant fixation process; 
problems that undermine long-term fixation focusing on biofilm formation as a main 
reason; biofilm formation process and preventative measures and competing 
technologies. A summary of the literature review is as follows: 
Bioceramics and metals are commonly used biomaterials for hard tissue implants. 
(Dorozhkin, 2010). Hard tissue implants find applications in both the dental and 
orthopaedic areas where the implants must form a secure bond with the bone in order 
to promote stability to the load bearing implants (Borsari et al., 2005; Stoch et al., 
2005; Lu et al., 2004). These biomaterials evoke specific biological responses which 
are responsible for successfully integrating and securing the implant to living tissue 
ensuring longevity of the implant in order to enhance everyday functionality 
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(Arinzeh et al., 2005; Xue et al., 2004; Overgaard, et al., 1999). HA is a bioceramic 
applied as a coating onto metallic implants to induce good quality bone formation at 
the implants surface and to minimise micromotions which could undermine the 
implants stability (Borsari et al., 2005; Lu et al., 2004). In this literature review, the 
different types of biomaterials used are discussed as well as the important properties 
they must posess to ensure successful integration with host tissue. Once the implant 
is inserted into the body, there is a casade of chemical and biological reactions which 
occur at the surface-bone interface responsible for fixating the implant to bone. 
Fixation is a complex process involving a variety of biological cells. This review 
describes this complex fixation process (chemical and biological interactions, bone 
formation, remodelling). The attachment and proliferation of osteoblasts, bone 
forming cells to the implants surface is considered an important step in this fixation 
process. Constructing surfaces with the surface properties that enhance these 
interactions will ensure successful implantation. In addition the surface properties 
that influence osteoblast adhesion is discussed. 
 
The review outlines the two main problems which compromise the long-term 
success of hard tissue implants: aseptic loosening and biomaterial associated 
infections (BAI). Aseptic loosening may be caused by an unstable mechanical bond 
between the implant and bone due to poor initial fixation, incompatible mechanical 
properties or poor coating properties such as cracking or delamination (Abu-Amer et 
al., 2007; Huiskes et al., 1993). Other sources include corrosion or degradation of 
the biomaterial surface resulting in inflammation. On the other hand, BAI are 
predominatly caused by the introduction of bacteria during surgery (Schmidmaier et 
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al., 2006, Van de Belt et al., 2001). These microbes attach onto the implant surface 
and subsequently proliferate into a resiliant biofilm which can be difficult to 
eradicate. The steps involved in biofilm formation are outlined and the prevention 
strategies that are established to combat such infections are presented. These namely 
include biocide release, which involves the release of antibiotics or antimicrobial 
ions from the implants surface to kill bacterial microbes (Liu and Chang, 2009; Chai 
et al., 2007). Surfaces that have been designed to repell microbes from the surface 
through charge and surface chemistry interactions (Russell, 2009; Berry et al., 2000; 
Gottenbos et al., 2000). Finally, the utilisation of non-leaching surfaces capable of 
killing microbes on contact is discussed (Antoci et al., 2008; Hu et al., 2007; Gabriel 
et al., 2006). These surfaces include immobilising or tethering antimicrobial 
materials through covalently bonding onto the implants surface. Research performed 
in these areas is discussed. 
 
Conventional methods used to deposit biocermics onto metals are discussed. There 
are advantages and disadvantages associated with these processes which are 
summarised. Problems include non-uniformity, reproducibility, delamination and 
degradation leading to aseptic loosening (Mohammadi et al., 2007; Gross et al., 
2004; Chang and Khor., 1996; Søballe and Overgaard, 1996). Coating adhesion, 
chemical composition and purity are problematic and results in pre- and post- 
treatment steps so as to overcome these failings. CoBlast offers an attractive 
alternative to conventional methods as this low temperature deposition process 
deposits a higher quality coating compared to plasma.  
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1.1 Hard Tissue Implants 
With an ageing human population who participate regularly in physical activites, 
there has been an increase in degenerative diseases such as osteoporosis (weaken of 
bones), osteoarthritis (inflammation in bone joints) and bone infections 
(osteomyelitis and peridontitis), also bone fractures (open and closed traumatic 
fractures) which result in pain or loss in function. It has been estimated that one out 
of two Americans will require medical care for a bone or joint issue in their lifetime 
and the cost of dealing with denegerative diseases is approximately $849 billion 
dollars a year in the USA (Gunnigle, 2011). It is also estimated that 15% of the 
world’s population experiences pain and joint degeneration due to the presence of 
osteoarthritis (Vallejo et al., 2004).  Bone-related disesases and bone fractures 
account for the need for hard tissue implants whose function is to provide and 
enhance a bodily function thus, improving the quality and longevity of human life 
(Dorozhkin, 2010).  
 
Hard tissue implants are widely used in repair, replacement or augumetation of 
diseased or damaged parts of the body system such as bones, joints and teeth. Hard 
tissue implants are prostheses that will bond with bone and needs to be successfully 
integrated with the living tissue for long-term stability. These types of medical 
implants are predominantly composed of metals and are often coated with a 
bioactive coating, which are surgically implanted. Through the bone fixation process 
in the body, a structural and functional connection between the living bone and the 
implant is made. Hard tissue implants find application in two main areas; dental and 
orthopaedic settings.  
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A dental implant is an artificial tooth root replacement used in prosthetic dentistry and 
can have a number of manifestations including screws, cylinders or blades which are 
surgically placed into the jawbone and can hold one or more prosthetic teeth. There 
are many types of orthopaedic implants such as joint arthroplasties, spinal fixation 
devices, fracture plates, wires, pins, screws, artificial ligament attachment implants, 
craniofacial implants and maxillofacial implants (Ryan et al., 2006). Joint 
arthroplasties are used to relieve pain or restore range of motion by reconstructing 
lower limb joints such as the hip, knee and ankle. Total hip replacement (THR) 
involves using components such as acetabular cups and femoral heads. Whereas knee 
implants consist of two types 1) unilateral replacement, patella femoral joint 
replacement or 2) total knee replacement. Even though the focus of this research is 
based on orthopaedic implants, in particular those associated with THR, it may also 
be applied to dental implants. Hard tissue implants are engineered from a wide range 
of biomaterials and should posses fundamental properties such as good mechanical 
and biological compatibility, enhanced wear and corrosion resistance and superior 
bioactivity to improve the mechanical interlocking between the implants surface and 
living tissue.  
 
1.1.1 Biomaterials for Hard Tissue Implants 
A biomaterial is defined as ‘a substance that has been engineered to take a form 
which, alone or as part of a complex system, is used to direct, by control of 
interactions with components of living systems’ (Williams, 2009). They play a vital 
role in ‘ensuring the success of a medical device and are intended to interface with 
biological systems to evaluate, treat, augment or replace any tissue, organ or function 
of the body’ (Williams, 1999). Biomaterials can be described as being bioactive, 
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bioinert and biocompatible. A bioactive material is one that elicits a specific 
response at the interface of the material which results in the formation of a bond 
between tissues and the material (Williams, 1999) including bonding directly to bone 
(Ducheyne and Qiu, 1999). For the purposes of biomedical implants, the term 
bioinert can be defined as ‘a minimal level of response from the host tissue in which 
the implant becomes covered in a thin fibrous layer which is non-adherent’ (Best et 
al., 2008). Finally in the context of the development of novel biomaterials, 
biocompatibility is an important property and represents ‘a material that does not 
elicit an unresolved inflammatory response or demonstrate immunogenicity or 
cytotoxicity’ (Rezwan et al., 2006).  
 
The evolution of biomaterials according to Hench and Polak, encompasses three 
generations: bioinert materials such as the use of biomedical metals (first 
generation); bioactive and biodegradable materials e.g. calcium phosphate coatings 
and drug delivery systems (second generation) and materials designed to stimulate 
specific cellular responses at the molecular level are classed as third generation 
biomaterials (third generation) (Hench and Polak, 2002). Most of the research to date 
on hard tissue implants has been specifically focused on first and second generation 
materials whereas approaches in tissue engineering has been related to the design 
and evolution of third generation biomaterials which are engineered to release 
growth factors and osteoprogenitor cell populations (Hench and Polak, 2002). Table 
1.1 shows the types of materials that can be chosen for specific applications. 
Common biomaterials used in hard tissue implants include metals, ceramics, 
polymers or composites (e.g. mixtures of ceramics and polymers).  
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Table 1.1: Implant materials used in the body (Navarro et al., 2008; Park and 
Bronino, 2003). 
Material Category Material for Implant Use Examples 
 
Metals  Titamium and its alloys, cobalt-chromium 
alloys, stainless steels, gold, silver, 
plantium 
 
Joint replacements, bone plate, 
screws 
Ceramics Aluminum oxide, calcium phosphates, 
bioactive glasses 
Dental abutments, orthopaedic 
femoral heads, bone grafts, bone 
cements 
 
Polymers Nylon, silicon, rubber, 
polyester,polyethylene, poly(methacrylic 
acid)  
Hip sockets, soft tissues, liner of 
acetabular cups, spacers 
 
 
The design and selection of a biomaterial for hard tissue implant is an important 
consideration and Geetha et al., reported that these implants must possess the 
following properties (Geetha et al., 2009): 
 Biocompatibility: The success of the implant is mainly dependent on the 
reaction of the human body to the implant. The two main factors that affect the 
biocompatibility are the host’s response which is induced by the material and 
the material’s degradation within the host. The biomaterial itself and the 
degradation products must be highly non-toxic and should not cause any 
inflammatory response or allergic reaction. 
 Suitable mechanical properties: Implants are used for high load bearing 
applications which are subjected to repeated cyclic loads and strains. It is 
important for the implant to have high mechanical strength (tensile strength) 
and low Young’s modulus (stiffness) comparable to that of bone in order to 
prevent implant loosening and ensure lifetime functionality. Table 1.2 
summarises the mechanical properties of typical biomaterials used for hard 
tissue implants. 
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 High corrosion and wear resistance: Low resistance to corrosion and wear 
results in the release of ions or wear debris into the body, which will elicit 
allergic or toxic reactions.  
 Osteointegration: If the implant surface fails to integrate with the adjacent 
bone micromotions can result, which will subsequently lead to failure due to 
implant loosening (Geetha et al., 2009).   
 
Table 1.2: Comparison of mechanical properties between implant material and 
bone (Bonfield, 1998; Thompson and Hench, 1998). 
Material Young’s Modulus (GPa)  Tesile Strength  
(MPa) 
 
Alumina 365 
 
6-55 
Sintered HA 70-90 
 
50-110 
HA coating 0.5-5.32 
 
>51 1,3 
Stainless steel 316L 193 
 
540 
Cobalt-chromium alloys 230 
 
900-1540 
Titanium (Grade V) 106 
 
900 
Poly(methyl methacrylate)  
bone cement 
 
3.5 
 
70 
High density polyethyene 1 
 
30 
Cortical bone 7-30 
 
50-150 
 (1ISO Standard, 2008; 2Tsui et al, 1998; 3 FDA, 1992) 
 
1.1.1.1 Metals 
Bioinert metals are excellent biomaterials for load-bearing orthopaedic applications, 
some of which include 316L stainless steel (SS), cobalt-chromium alloy (CoCr), and 
titanium based alloys including shape memory nitinol (NiTi). A major problem with 
the use of alloys such as SS and CoCr is the release of elements such as nickel, 
chromium and cobalt due to the corrosion in the body’s environment (Okazaki and 
Gotoh, 2005). Other drawbacks include the ‘stress shielding effect’ arising from the 
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mismatch of Young’s modulus properties between metal and bone (higher stiffness 
than bone (>30 GPa)), which leads to insufficient stress transfer to bone and results 
in bone cell death around the implant (Sumner et al., 1998) or the formation of 
fibrous membrane. This ‘stress shielding effect’ will lead to implant failure due to 
implant loosening (Geetha et al., 2009; Sun et al., 2001; Sumner et al., 1998). NiTi 
is commonly used as the biomaterial in stents due to its unique property of ‘shape 
memory’, which is the ability of the material to recover its shape after applied stress 
is favoured (Navarro et al., 2008; Eggeler et al., 2004). This is attractive in the 
context of hard tissue metal implants which undergo excessive cyclic loading. 
However, its use for hard tissue implants of large surface area is still being 
investigated due to concerns relating to the release of toxic nickel, a potential 
carcinogen (Kapanen et al., 2001). Ti (V) is the most commonly used metal for 
implantation, due to its excellent mechanical properties (high strength and low 
modulus relative to bone), high corrosion resistance, biocompatibility, light weight 
and excellent osteointegration properties (Niinomi, 2002). A new generation of 
metals for orthopaedic implants include porous Ti metals, which are sintered metals 
with increased surface roughness as a result of their three dimensional (3D) 
structures. The attractiveness of these materials is due to their ability to reduce 
modulus mismatch at the bone-implant interface and enhance long-term fixation 
(Levine, 2008). 
 
1.1.1.2 Ceramics 
Ceramics are defined as ‘non metallic, inorganic and which can be shaped and 
consolidated at high temperatures’ (Ravaglioli and Krajewski, 1992). Hench and 
Wilson defined bioceramics as ‘biomaterials designed and fabricated from ceramic 
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origins used for repair and reconstruction of diseased, damaged or worn-out’ parts of 
the body (Hench and Wilson, 1993). Bioceramics are categorised as either ‘bioinert’ 
or ‘bioactive’, examples of the former include alumina (Al2O3) and zirconia (Zr2O). 
Alumina is the most commonly used inert bioceramic due to its excellent mechanical 
properties. Due to their similarity in chemical composition to that of bone and teeth, 
calcium phosphates (CaP) have emerged as an important family of bioceramics. CaP 
coatings are bioactive as they can form interfacial bonding system with living tissue. 
Different types of CaP with varying degrees of calcium to phosphate (Ca/P) molar 
ratios are available including hydroxyapatite (HA), tricalcium phosphate (TCP), 
biphasic calcium phosphate (BCP), amorphous calcium phosphate (ACP), or calcium 
deficient HA (CDHA). BCP is a mixture of HA with either α-TCP or β-TCP 
(Dorozhkin, 2010). The chemical composition and the calcium to phosphate molar 
ratio of these CaP compounds and a number of other CaP compounds are outlined in 
Table 1.3.   
 
CaP have been extensively used for clinical applications relating to bone cements, 
bone filling, bone substituting and bone tissue engineering materials, due mainly to 
their bioactivity, biocompatibility and osteoconductive properties (Tan et al., 2011; 
Best et al. 2008; Saikia et al., 2008; Habraken et al., 2007; Jiranek et al., 2006; 
Knaack et al., 1998). Despite their poor mechanical properties in a bulk form (brittle 
and low tensile strength), these bioceramics are employed as coatings on metallic 
implants (Borsari et al., 2005; Oh et al., 2005; Stoch et al., 2005; Lu et al., 2004). 
Thus, CaP coatings on metallic implant devices offers the possibility of combining 
the strength of the metals and the bioactivity of the ceramics. The biodegradation 
properties of ceramics such as thermodynamic solubility, crystallinity feature 
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(crystalline/amorphous), presence of impurities and additives, and structural 
properties (dense/porous) are considered important parameters for their success in 
bone repair and regeneration. 
 
Table 1.3: CaP compounds commonly used as biomaterials (Dorozhkin, 2010). 
Abbreviation Compound Formula Ca/P molar 
ratio 
DCPD Dicalcium phosphate dehydrate, 
mineral brushite 
 
CaHPO4·2H2O 1.0 
DCP Dicalcium phosphate anhydrous, 
mineral monetite 
 
CaHPO4 1.0 
OCP Octacalcium phosphate 
 
Ca8(HPO4)2(PO4)4·5H2O 1.33 
α-TCP α-Tricalcium phosphate 
 
α-Ca3(PO4)2 1.5 
β-TCP β-Tricalcium phosphate 
 
β-Ca3(PO4)2 1.5 
ACP Amorphous calcium phosphate CaxHy(PO4)z·nH2O, n = 3–4.5; 
15–20% H2O 
 
1.0–2.2 
CDHA Calcium-deficient hydroxyapatite Ca10-x(HPO4)x(PO4)6-x(OH)2-x[f] 
(0 < x < 1) 
 
1.5–1.67 
HA Hydroxyapatite Ca10(PO4)6(OH)2 
 
1.67 
OA Oxyapatite Ca10(PO4)6O 
 
1.67 
TTCP Tetracalcium phosphate, mineral 
hilgenstockite 
Ca4(PO4)2O 2.0 
 
 
 
Bioactive bioceramics maybe resorbable or non-resorbable. CaP, such as TCP are 
classed as resorbable ceramics as they degrade and are completely resorbed in vivo 
(Ginebra et al., 2006). Whereas other CaP compounds such as HA have low 
solubility, are more stable under physiological conditions and therefore are classed 
as non-resorbable although there is the potential for dissolution of the CaP system 
through slow ion release. HA are attractive as coatings as they have demonstrated 
enhanced bone apposition and maintain integration with the regenerated bone tissues 
after implantation compared to the resorbable TCP (Ginebra et al., 2006).  
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Bioglasses are also resorbable bioceramics and were first developed by Hench in the 
1970’s. Bioglasses have excellent biocompatibility as well as bone bonding ability. 
Typical bioglass formulations consist of the following: sodium oxide, calcium oxide, 
phosphorus pentoxide and silicon oxide and these formulation induce bone growth 
three times faster than HA (Cao and Hench, 1996). However, bioglasses have poor 
mechanical properties which limits their use to non-loading applications such as 
bone fillers in the orthopaedic and dental arenas (Jones et al., 2006; Rezwan et al., 
2006). Commerically available bioglasses include Perioglas® for the treatment of 
periodontitis and Novabone® used a bone filler. Release of silicon, calcium, oxygen 
and sodium ions contribute to intracellular and extracellular responses in addition to 
their chemical bonding to host bone (Xynos et al., 2001). Studies have shown that 
bioactive glasses enhance the wound healing of soft tissues due to its anti-
inflammatory response (Verrier et al., 2004; Bendall et al., 1998). Bioglass performs 
at a higher level being osteostimulative (bone healing properties), due to its ability to 
stimulate growth factor production in addition to its osteoconductivity (enhanced 
recruitment, proliferation and differentiation properties) (Tan et al., 2011; Hu and 
Zhong, 2009). Through chemical formulation, properties can be varied resulting in 
control of the resorption rate, however, increase in crystallinity reduces the level of 
bioactivity (Peitl Filho et al., 1996; Pereira et al., 1994).   
Current investigations involve the use of composites, which are composed of 
biodegradable polymers reinforced with ceramic particles. The aim is to replicate the 
natural micro-environment and encourage the development of tissue with good 
mechanical properties. The composite matrix functions purely as a scaffold since the 
the composite degrades as regeneration proceeds (Navarro et al., 2005 and Navarro 
et al., 2004). Scaffolds can be either porous or dense composed of bioglasses, HA, 
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ACP and BCP as the ceramic component in a poly(lactic-co-glycolic acid) derived 
co-polymers (PLGA) or polycaprolactone matrix. Stem cells, growth factors and 
peptide sequences have been incorporated into the composites for tissue engineering 
purposes such as tissue repair and regeneration (Hardouin et al., 2000). 
 
1.2 Hydroxyapatite 
The bioceramic, hydroxyapatite (HA), Ca10(PO4)6(OH)2, constitutes 65% of the 
mineral fraction of human bone and stoichiometric HA has a Ca/P molar ratio of 
1.67 (Kim et al., 1998). HA is crystalline and therefore, offers higher stability in 
aqueous media compared to other CaP compounds. However, biological apatites 
differ chemically to HA, in that carbonate is a major substitute in biological bone (5-
8%) (Kumta et al., 2005) and they contain trace elements such as fluorine, chlorine, 
magnesium, sodium and potassium (Bertinetti et al., 2006). Consequently, biological 
bone is deficient in calcium ions (Ca+2) with respect to HA and has an average Ca/P 
molar ratio of 1.5. The deviation from a Ca/P molar ratio of 1.67, lowers the 
crystallinity and increases the solubility of the CaP compound (Tampieri et al., 2005; 
Landi et al., 2003), whereas highly crystalline stoichiometric HA exhibits a lower 
solubility in vitro and in vivo (Mavropoulos et al., 2003).  
The thermodynamic instability of HA results in the decomposition of this crystalline 
material into various CaP phases when processed at high temperatures (>1300 ºC) 
(Muralithran and Ramesh, 2000; Gross and Berndt, 1998; Gross et al., 1998; Zhou et 
al.,, 1993). This can lead to the formation of intermediates such as calcium oxide 
(CaO), octa-hydroxyapatite (OHA), α-TCP, β-TCP and tetra-calcium phosphate 
(TTCP) (Gross and Berndt, 1998; Gross et al., 1998). The presence of these 
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impurities in a HA material can decrease the crystallinity and subsequently, make it 
more prone to dissolution. Thermal degradation products including α-TCP, β-TCP, 
TTCP and OHA are resorbable and biodegrade more rapidly in an aqueous 
environment compared to pure HA (Ginebra et al., 2006; Ducheyne et al., 1990). 
The dissolution rate decreases in the following order: ACP>DCP>TTCP>α-TCP>β-
TCP>>HA. It was demonstrated in an animal study that 99% of ACP was degraded 
in twenty-six weeks after implantation (Knaack et al., 1998). The accelerated 
resorption of TCP before bone ingrowth is a major problem as it undermines the 
stability of the implant leading to failure (Heimann and Wirth, 2006). Alternatively, 
it was determined that a more crystalline HA surface (75-95%) demonstrated higher 
stability in vivo with slower dissolution and better mechanical fixation after 12 
weeks, suggesting a better choice for long-term mechanical and biological fixation of 
implants compared to a lower crystalline surface (50-55%) (Xue et al., 2004; 
Overgaard et al., 1999). Dekker et al., (2005) reported better osteointegration as a 
result of a higher quality and quantity of lamellar bone formed on a crystalline CaP 
surface compared to an amorphous carbonated apatite surface in vivo. The authors 
hypothesised that osteoblasts were unable to maintain adhesion on the implant 
surface due to the resorbability of the lower crystalline surface (Dekker et al., 2005). 
Peraire et al., (2006) reported that following 6 months implantation, a thin crytalline 
HA coating had remained intact with no signs of dissolution or degradation. 
However, these studies were in agreement, that the highly crystalline HA coating is 
suitable for long-term implantation and the low crystalline coating has superiority in 
promoting faster initial bone fixation (Peraire et al., 2006, Xue et al, 2005; 
Overgaard et al, 1999). 
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One of the main reasons supporting the use of HA as a bone substitute material is its 
versatility. Along with the other documented bioactive characteristics, it can undergo 
thermal treatments in order to increase (or decrease) phase purity, cystallinity, HA 
particle size and change chemical composition (dehydration and functional group 
alteration) (LeGeros, 2001; LeGeros and Craig, 1993). This type of processing is 
usually required to varying degrees to confer HA material with desired chemical, 
structural and dissolution properties, to enhance its capability in an in vivo setting 
(Yang et al., 2007; Yang et al, 2005). There has been much interest in BCP for this 
reason. The biodegradation of the BCP can be tailored by altering the HA and TCP 
ratio to achieve rapid fixation and long-term stability of the implant (Steward et al., 
2004; Overgaard et al., 1999).  
 
For many years, HA has been used for the coating of orthopaedic implants due to its 
biocompatible properties. Commerically available orthopaedic hip protheses coated 
with HA includes: S-ROM® sleeve (Depuy, US); McMin® acetabular component 
(Corin Medical Ltd, UK); ABG® femoral stem (Howmedica, US); Omifit® 
acetabular shell (Osteonics, US) (Gross et al., 2004). To date, much investigation has 
been carried out regarding the use of hydroxyapatite as an osteoinductive material, 
with uses as both bone graft implants in the bulk form and also as a coating on metal 
implants. HA has shown ability to bind chemically to bone with enhanced bone 
apposition to implants without the formation of fibrous tissues. As a bone graft 
substitute, porous forms of bulk HA have been shown to induce bony apposition at 
the cell-biomaterial interface and to also encourage the mineralisation (Hile et al., 
2005; Hing et al., 2004). There have been short- and long- term studies performed to 
evaluate HA as an implant material. In one study by Marcacci et al. they showed that 
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when HA was used as a bone defect filler, complete fusion between the implant and 
the host bone occurred five to seven months after surgery (Marcacci et al., 2007). In 
all patients, a good integration of the implant with the host tissue was maintained at 
the end of the investigation (six to seven years post surgery). No late fractures in the 
implant zone were observed. This study demonstrated the long-term durability of 
bone regeneration achieved by the use of HA. They concluded that the use of 
osteoprogenitor cells in conjunction with porous bioceramics such as HA were a 
viable alternative to the use of autologous bone for the repair of critical-sized long 
bone defects (Marcacci et al., 2007). Extensive clinical research has demonstrated 
the continued fixation of HA coated orthopaedic implants over test periods (two-ten 
years), illustrating the beneficial properties of HA as a successful osteoconductive 
coating (D’Lima et al., 1999; Røkkum et al., 1999; Dorr et al., 1998; Donnelly et al., 
1997). D’Lima et al., (1999) followed up on Omifit-HA titanium stem in 56 patients 
for 2-5 years with excellent clinical and radiographic results. Subsidence was non-
progressive after 1 year. Stable bone ingrowth fixation was evident at the 
hydroxyapatite coated part of the implant (D’Lima et al, 1999). 
 
1.3 Implant Fixation  
When an implant is inserted into the body, there are a number of key interactions 
both biological and chemical which govern events leading to the formation of bonds 
between the biomaterial and bone, and the ultimate integration of the implant with 
the host tissue. Integral to this area, a number of cellular components are involved in 
the formation and regulation of bone development. The interactions of osteoblasts, 
the bone forming cells, with the implant surface is of great importance and the 
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surface properties of the implant will influence this interaction process. 
Concurrently, there is also a series of chemical reactions that occur between the 
bioceramic and the physicological environment that involves dissolution and 
modification of the bioceramic. A number of terms commonly used to describe the 
fixation of the implant to bone, in addition to the different events that occur at the 
implant-bone interface, are summarised in the next section.  
 
1.3.1 Fixation Terms 
The process of osteoinduction refers to the recruitment and differentiation of 
specialised cells, osteoconduction is the bone forming process seen on the surface of 
hard tissue implants and finally osteointegration is the fixation or anchorage of the 
implant to the living tissues. The osteoconduction phase is dependent on osteoblasts 
formation during the osteoinduction stage and the osteointegration is dependent on 
the activity of these osteoblasts for the stability of the implant. Albrektsson and 
Johansson, offered a more comprehensive definition of these terms: 
 Osteoinduction: Involves the recruitment of immature cells, osteoprogenitor 
cells and the stimulation (induction agents, hormones and inflammation 
response) of these cells to develop into pre-osteoblasts which then mature into 
osteoblasts (bone forming cells). In trauma events, such as fractures, induction 
agents are released to initiate the healing process (induction period) 
(Albrektsson and Johansson, 2001).  
 Osteoconduction: Process by which bone grows on the surface with a provision 
of a scaffold, such as the case with an implant. Osteoblasts are the cells that are 
responsible for the synthesis, deposition and mineralisation of the extracellular 
matrix of the bone, described in the next section (1.3.2). Adhesion of 
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osteoblasts is considered an important step in osteoconduction (Albrektsson and 
Johansson, 2001). 
 Osteointegration: Is the stable anchorage of an implant achieved by direct bone-
to-implant contact. Successful integration involves the process where the 
implant is connected to the living tissues by the formation of bony tissue around 
the implant without the growth of fibrous tissue at the bone implant interface. 
Osteoblastic and osteoclastic activities are mainly responsible for the 
osteointegration of implants (Albrektsson and Johansson, 2001).  
Histological sections reveal bone to implant contact of the order of 10-20 microns 
(µm) is only needed for osteointegration and also interfacial implant movement of 
more than 150 µm will inevitably lead to soft tissue formation instead of bone 
(Brunski, 1999). 
 
1.3.2 Bone Formation and Remodelling 
Bone is an extremely dense form of connective tissues (osseous tissues), which in its 
various shapes makes up the human skeleton frame. Bone has three main functions. 
The first is the mechanical role in the support of surrounding tissues and organs 
whilst providing sites for attachment for ligaments, tendons and muscles which are 
involved in the bodily movements. The second is its function in calcium homeostasis. 
Bone is a calcium reservoir which exchanges bone minerals with the fluids of the 
body. Finally, its role in haematopoiesis (blood cell renewal), where the bone marrow 
is the only source that supplies the body with the nutrient-carrying blood cells and 
infection fighting white blood cells (Martini, 2005). Osseous tissues contain 
specialised cells and a matrix consisting of 65% mineral (inorganic) and 35% organic 
materials. The mineral phase is largely made up of HA (crystalline calcium 
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phosphate). The HA provides rigidity to the organic matrix which is composed of 
90% collagen and 10% non-collagenous proteins. The collagen fibers provide an 
organic framework on which HA is inserted. The non-collagenous proteins include 
osteocalcin, osteonectin and osteopontin (Martini, 2005). There are two types of bone 
a) the structural protective layer called compact or cortical bone and b) spongy 
cancelleous bone (Puckett et al., 2008). 
 
The bone is regulated by four different types of specialised cells, these include 
osteoprogenitor, osteoblasts, osteocytes and osteoclasts. The activities of these cells 
are responsible for growth and development and remodelling of bone (Figure 1.1).  
 
Figure 1.1: Bone remodelling process illustrating the resorption and formation of 
bone (Roche, 2012). 
 
Osteoblasts are the main cells responsible for bone formation. Osteoprogenitor cells 
are derived from stem cells originating in the mesenchyme (tissue from which all the 
connective tissues are formed) (Albrektsson and Johansson, 2001). Osteoprogenitor 
cells lack many of the known osteoblast markers such as ALP or osteocalcin (Jäger et 
al., 2007; Boyan et al., 1996). External stimuli including induction agents (hormones 
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and growth factors) and also an inflammation response are responsible for the 
differentiation of the osteoprogenitor cells into pre-osteoblast and then to osteoblast 
cells (Jäger et al., 2007; Boyan et al., 1996). Bone morphogentic proteins (BMP) are 
responsible for the stimulation of stem cells into the active osteoblast. 
 
Osteoblast cells play a vital role in the bone repair and also in success of 
implantation. They are responsible for synthesising bone through the production of 
new bone matrix in a process called osteogenesis. Osteoblasts synthesise and release 
organic bone matrix (osteoid), certain hormones (cytokines) and growth factors 
(Raggart and Partridge, 2010; Jäger et al., 2007). This is followed by mineralisation 
around the osteoid where the osteoblasts are responsible for elevating the local 
concentrations of CaP and promoting the deposition of the calcium salts in the 
organic matrix (Raggart and Partridge, 2010; Jäger et al., 2007; Martini, 2005). 
Alkaline phosphatase (ALP) is an important enzyme responsible for the 
crystallisation of the calcium salts (HA form) which leads to the subsequent 
hardening and calcification of the matrix (Jäger et al., 2007; Barrère et al., 2006; 
Martini, 2005). The osteoblasts themselves become embedded into the mineralised 
matrix and these mature osteoblasts are termed osteocytes. Osteocyctes are 
responsible for maintaining the protein and mineral content of the matrix and also 
participate in the repair process of damaged bone (Barrère et al., 2006; Martini, 
2005). 
 
Osteoclasts are cells produced by hematopoietic stem cells that remove and recycle 
bone matrix (Lu et al., 2002). They do this by secreting acids and proteolyic 
enzymes that dissolve bone. This erosion process is important in the regulation of 
Chapter 1: Introduction and Literature Review 
         
Page | 21  
 
calcium and phosphate concentrations in body fluid. In living bone, the osteoclasts 
are constantly removing matrix and the osteoblasts are constantly adding to it, a 
process called “remodelling” (Martini, 2005). This antagonistic behaviour is 
extremely important process in order to repair bone micro-damage that occurs during 
normal daily activity and also to replace bone during the growth process and 
following fracture injuries (Aubin, 2001). When the osteoclasts remove calcium salts 
faster than the osteoblasts deposit it, then the bone becomes weak leading to 
osteoporosis. However, dense and stronger bone results from muscular stress as a 
result of exercise due to enhanced osteoblast activity (Martini, 2005). Macrophages, 
also from the same lineage as osteoclasts, are crucial in early inflammatory phases of 
bone healing removing debris as a result of bone fracture and surgical implantations 
(McKee et al., 2011). Recently, specialised macrophages termed osteomacs, have 
been suggested to play important roles in bone remodelling such as regulating 
osteoblast mineralisation, stimulating osteoblast differentiation and regulating 
osteoclast recruitment, formation and function (Raggatt et al., 2008; Chang et al., 
2008; Pettit et al., 2008). 
 
1.3.3 Osteoblastic Adhesion to Implants 
The success of the implantation is governed by how well the first phase of osteoblast 
attachment and adhesion occur. This will then lead to the subsequent osteoblast 
proliferation and differentiation on contact with the implant surface resulting in 
deposition of the bone matrix and ALP (osteogenesis process). When an implant 
comes in contact with a biological environment, the implant surface becomes 
conditioned with a layer of adsorbed protein. Osteoblasts attach themselves to the 
conditioned layer on the implant surface through electrostatic interactions and van der 
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Waals forces. Several extracellular matrix and plasma proteins, such as fibronectin 
and vibronectin, have been shown to mediate cell-substrate attachment (Garcia et al., 
1999). Cell attachment to these proteins is the result of their chemotactic behaviour 
(adhesive properties) due to their Arg-Gly-Asp (RGD) sequence which is specific to 
the fixation of cell membrane receptors like integrin (Grzesik and Robey, 1994). 
Integrins plays an important role not only in cell-substrate adhesion but also in 
proliferation, cell migration and consequently cell growth and differentiation. Cell-
implant adhesion activation is essential for signal transduction and regulation of gene 
expression for collagen and other bone proteins. The process of Ca ion influx is also 
activated by the cell adhesion (Anselme, 2000).  
 
Attachment and adhesion will be indicated by morphology changes of the osteoblast 
cultured on the surface. Evidence of cytoskeleton organisation (lamellipodia and 
filopodia) will indicate the cell’s ability to adhere to the surface. Extension of the 
plasma membrane combined with the larger surface area of a flattened cell on the 
surface will signify adhesion as cell spreading is an essential step in cell adhesion 
(Zhu et al., 2004). This morphology of flattened shaped and filopodia and 
lamellipodia formation promotes cell migration.   
 
1.3.4 Surface Properties that Alter Cell-Implant Interactions 
The cell-substrate interaction is a critical factor in the success of the osteoblast 
adhesion and the subsequent osteoconduction process, and consequently the 
physicochemical and biological properties of the biomaterial play an important role. 
The specific properties of the implant’s surface such as the chemistry, topography, 
wettability and biocompatibility can all be augmented to induce a desired cellular 
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response. As previously mentioned, cells do not interact directly with the naked 
implant’s surface however, they do bind to a conditioned protein layer which is 
deposited after implantation. It is well established that the surface characteristics of 
the naked implant’s surface will determine which biomolecules will be adsorbed. 
The composition, type, amount and conformation of this protein coated surface will 
consquently influence osteoblast attachment, proliferation and osteogenic 
differentiation (Baujard-Lamotte et al., 2008; Yang et al., 2003). Water molecules 
reach the implant surface first, hence, it has been hypothesised that increased 
wettabilty enhances interactions between the implant surface and the biological 
environment (Rupp et al., 2004). The surface chemistry of a material is influenced 
by the outer functional groups present and dictates which biological molecules 
adsorb on the surface (Keselowsky et al., 2004). In addition it affects the orientation 
and adhesion of the cells and how they form the first monolayer of tissue (Rouahi et 
al., 2006; Webb et al., 2000; Schwartz and Boyan, 1994). It is generally thought that 
hydrophilic surfaces will adsorb lower levels of a more active conformation of the 
bulky proteins in the conditioned layer (Baujard-Lamotte et al., 2008). However, it 
has been reported that fibronectin absorbs on both hydrophilic and hydrophobic 
surfaces but has a higher affinity for hydrophobic surfaces whereas albumin 
preferentially absorbs onto hydrophobic substrates (Roach et al., 2005). An increase 
in fibronectin was observed on Ti compared to the larger protein, albumin. The 
conformation of fibronectin governed the osteoblast attachment through the arginine-
glycine-aspartic acid (RGD) receptor site sequence (Yang et al., 2003). In general, 
RGD-functionalised surfaces have been shown to significantly increase 
osteointegration (in vivo) compared to unmodified Ti substrates (Elmengarrd et al., 
2005; Kroese-Deutman et al, 2005).  
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It is generally accepted that the three dimensional (3D) surface topography (shape, 
size and surface texture) of the implant is one of the most important parameters that 
influences cellular reactions (Puckett et al., 2008; Bigerelle and Anselme, 2005; 
Anselme et al., 2000). There is much research evaluating the osteoblast behaviour 
(attachment, proliferation and osteogenic differentiation) on the micro (1-10 µm) and 
nano (<1µm) structure of substrates (Puckett et al., 2008; Schuh et al., 2004; Cho 
and Park, 2003; Wennenberg et al., 1997). The micron range of roughness 
maximises the interlocking between the mineralised bone and the surface of the 
implant. Smoother implant surfaces induced fibrous tissue growth and implant 
loosening in vivo compared to significant osteoconductive properties of roughened 
implants (Schwartz et al., 2008; Grizon et al., 2002; Wennenberg et al., 1997). 
Different techniques are used to promote osteointegration such as chemical etching 
and sand-blasting as a means to alter the surface roughness (Schuh et al., 2004; Cho 
and Park, 2003; Wennenberg et al., 1997). Even though roughened surfaces were 
found to reduce osteoblast proliferation, increased roughness was found to promote 
osteogenic differentiation (expressed ALP and collagen) (Boyan, 2003; Martin, 
1995). In recent studies, it has been demonstrated that cells use of the nano-
topography of the surface for adhesion and that the osteoblasts aligned themselves 
along defined substrate morphology (Pukett et al., 2008). Enhanced protein and cell 
binding interactions by larger surface areas/increased roughness was also confirmed 
using porous HA (Rouahi et al., 2006). Lin et al., (2008) demonstrated that porous 
HA can interact with the stem cells and generate potent inductive substances other 
than BMPs, that are responsible for stimulating differentiation into osteoblasts, 
thereby, highlighting the osteoinductive properties of the HA material.  
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Cell adhesion is generally better on hydrophilic surfaces compared to hydrophobic 
surfaces (Zhao et al., 2005; Massaro et al., 2001; Redey et al., 2000). These studies 
suggested that a high surface energy surface (high polar content) was favorable for 
osteoblast adhesion as a result of better wetting characteristics (Maxian et al., 1993) 
As previsously mentioned, CaP and HA are known for their excellent 
osteoconductivity due to their bioactive properties. The release of calcium and 
phosphate ions has been linked to early bone formation in vivo (Arinzeh et al., 2005; 
Gosain et al., 2002) as well as the differentiation of osteoprogenitor cells determined 
by the expression of a number of different differentiation markers in vitro (Arinzeh 
et al., 2005 Siebers et al., 2004). However, it was reported that crystalline HA and a 
BCP mixture containing a 70/30 ratio of HA/TCP demonstrated significantly 
increased expression of messenger ribonucleic acid (mRNA) for ALP from 
osteoblasts at day six compared to the other surfaces containing BCP mixtures of 
lower HA content (Wang et al., 2004). It was suggested that the difference of mRNA 
expression for ALP maybe related to the differences in chemistry, surface energy 
and/or topography of CaP surfaces, however, no conclusive evidence was given 
(Wang et al., 2004).  
 
1.3.5 Bone-Biomaterial Interface 
When an implant is inserted into the body, a dynamic complex process between the 
implant and surrounding tissues is initiated. Interactions involving water, dissolved 
ions, biomolecules (proteins) and cells surround the implant following implantation. 
Bioactive materials such as HA and bioglasses can stimulate a direct bond to form 
between the implant and the surrounding bone, and thus enhance osteointegration. 
Gross and Berndt defined that bioactivity is determined by the ability of material to 
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invoke a crystallised carbonate apatite layer from physiological fluid (Gross and 
Brendt, 1998). Hench was the first to propose a bonding mechanism for bioglass and 
also introduced the concept that all bioactive ceramics form a ‘bone like apatite layer 
on their surfaces in the living body and bond to bone through this apatite layer’ 
(Hench, 1998; Cao and Hench, 1996). This is brought about through the partial 
dissolution of the HA coating which will increase the calcium and phosphate 
concentration at the local environment followed by precipitation of CaP crystals with 
the incorporation of the collagenous matrix and bone growth toward the implant 
(Sun et al., 2001). It has even been postulated that growth factors such as BMPs 
could be co-precipitated with the HA crystals onto the surface which in turn recruit 
cells and induce differentiation (Yuan et al., 1998). Later Ducheyne and Qui 
proposed a similar bonding mechanism for bioceramics, however they postulated the 
theory of ion exchange and structural rearrangement at the bioceramic-tissue 
interface, which leads to interdiffusion from the surface boundary layer into the 
bioceramic (Ducheyne and Qui, 1999). Xin et al., (2005) reported differences with 
respect to apatite formation on various porous bioceramic solids such that formation 
was less likely to occur on HA (low dissolution) and α-TCP (rapid dissolution) 
surfaces compared to other bioceramics (bioglass, glass-ceramics and β-TCP). 
Differences in precipitation between the in vivo and in vitro samples were also 
observed (Xin et al., 2005).  
 
According to Dorozhkin, HA dissolution occurs through five steps which show that 
throughout the process of HA dissolution, the surface changes in composition 
forming Ca3(PO4)2 (TCP) and CaHPO4 (DCP) (Dorozhkin, 1999; Dorozhkin 1997). 
These two different chemical components of the surfaces take part in a dissolution 
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reaction (Eq 1.1-1.5). The dissolution of HA coatings increase as the porosity and 
surface area increase and the particle size and crystallinity decrease.  
Ca5(PO4)3OH(s) + H+(aq)  ↔Ca5(PO4)3(H2O)+(s)   (Eq 1.1) 
2Ca5(PO4)3(H2O)+(s)  ↔3Ca3(PO4)2(s) +Ca2+ (aq) + 2H2O(aq)  (Eq 1.2) 
Ca3(PO4)2(s) +2H+(aq) ↔ Ca2+ (aq) + 2CaHPO4(s)   (Eq 1.3) 
CaHPO4(s) +H+ ↔ Ca2+ (aq) + H2PO4−(aq)     (Eq 1.4) 
CaHPO4(s) + ↔ Ca2+ (aq) + HPO42− (aq)     (Eq 1.5) 
However, recently a mechanism to explain the bioactivity of HA was described by 
Bertazzo et al., (2005) and is based on a combination of those proposed by the 
Hench and Dulcheyne and Qui models. The steps involved in bone formation are 
presented in Figure 1.2. HA surface is solubilised (surface transformation Eq 1.1-1.5) 
when dissolution of the HA layer is initiated (Step 1); continuation of the 
solubilisation of the HA surface (Step 2) and finally equilibrium between 
physiological solutions and the modified surface of HA is achieved (Step 3). Step 4 
involves adsorption of proteins and/or other biological moieties. Steps 5 and 6, cell 
adhesion and cell proliferation, followed by the osteogenic differentiation (Step 7), 
are the subsequent stages which lead to new bone formation (Step 8). 
 
 
Figure 1.2: Diagram representing the phenomena that occur on the surface of HA 
after implantation (Bertazzo et al., 2010). 
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The bone-implant surface is subjected to further bone ingrowth and remodelling and a 
biological fixation can be achieved as described earlier in Section 1.3.2. However, the 
stability associated with crysalline HA surfaces inhibits their transformation. The acid 
environment produced at the implantation site as result of cellular actitivity and 
enzymes produced can initiate the dissolution of the HA surface (Baron et al., 1985). 
LeGeros et al., (2001). described the dissolution initiated by host enzymes leads to 
the release of calcium ions with supersaturation of ions at the interfacial region 
between surface and physiological solution. Subsequent precipitation of carbonated 
apatites can occur through seeded growth on the HA crystalline surface (LeGeros et 
al., 2001). On the otherhand, Cao and Hench postulated that a highly crystalline HA 
surface with low dissolution will not experience dramatic morphological change and 
that bone tissue will bond directly to the HA crystal through epitaxial growth (Cao 
and Hench, 1996).  
The successful incorporation of an orthopaedic implant into the body relies heavily on 
the ability of the surface to conduct bone growth and bond to bone directly. This in 
turn allows mechanical stability of the implant and aids in its functioning by 
becoming an active part of the system. 
 
1.4 Problems Associated with Hard Tissue Implants 
Biomaterial selection for coating hard tissue implants poses a number of challenges, 
these include aseptic loosening and biofilm formation.  
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1.4.1 Aseptic Loosening 
Aseptic loosening describes implant failure that is the direct result of loosening of 
the implant without the presence of infection. Aseptic loosening is a disabling 
condition that can affect patients 10 to 20 years following total hip arthroplasties 
(THA) and clinical symptoms of inflammation, impaired function and excessive pain 
are generally not apparent until late stages of failure (Abu-Amer et al., 2007; 
Huiskes, 1993). Revision surgergy is often neccessary to overcome this problem. 
According to Abu-Amer et al., aseptic loosening can be the result of poor initial 
fixation (bone-implant bonding), mechanical loss of fixation over time or biological 
loss of fixaton caused by particulate debris (metallic, polymeric and ceramic) 
inducing osteolysis around the implant (Abu-Amer et al., 2007). Huiskes proposed 
the following concept of failure scenarios for aseptic loosening of cemented and 
cementless implants (Huiskes et al., 1993): 
 Damage accumulation failure: Is the gradual cracking of cement or coating 
over time as a consequence of load bearing activities and/or cyclic loading. 
This results in interfacial de-bonding called delamination. These will influence 
the long-term mechanical integrity of the implant resulting in implant failure.  
 Wear debris inflammation: This describes particulates breaking off from the 
implant surface either from the coating/metal interface or metal/metal interface 
of the implant. The debris can migrate to the implant/bone interface and result 
in tissue inflammation causing bone cell death, a condition known as 
osteolysis.   
 Stress shielding failure: As mentioned previously, for increased longevity of 
the implant the biomaterial must possess similar mechanical properties to that 
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of bone, if mismatches exist, alteration of the transfer of stress to the 
underlying tissue will result, leading to bone cell death.  
 Stress bypass failure: Sometimes fixations in the body can be heterogeneous 
leading to stress transfer over the localised spots. Bone ingrowth can be patchy 
at the implant-bone interface and stability of the implant is weakened. 
 Growth failure: A high frequency of micromotion of the implant relative to the 
bone can inhibit osseous growth giving rise to inadequate bonding as a result 
of gaps between the implant and bone (>3 mm). If bonding does not occur a 
fibrous membrane will form on the implant surface, the strength of the bonding 
between the implant-bone is compromised.  
 Destructive wear failure: The dis-integration of the joint replacement 
prosthesis as a result of load bearing activities. The modular components of the 
implant gradually wear out and the mechanical integrity can no longer be 
maintained. 
It has been reported that aseptic loosening which is a major complication and causes 
more that 52% of the revisions of hip arthroplasty continues to be major 
complication in the USA (Ulrich et al., 2008). The provision of a bioactive surface 
onto which the bone can strongly bond will successfully limit micromotions at the 
implant-host interface. Also the biological, chemical and mechanical attachment 
between an implant surface and osseous tissue has been reported to limit aseptic 
loosening (Dumbleton and Manley, 2004). Attachment can be achieved by positively 
enhancing the interactions that occur at the implant-bone interface through the 
deposition of bioactive coatings onto the implant surface.   
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1.4.2 Biomaterial Associated Infections 
One of the main problems that occurs with hard tissue implant surgery is biomaterial 
associated infections (BAI). It has been reported that on average about 5% of 
initially inserted internal fixation devices become infected (Darouiche, 2004). The 
prevalence of infection two years after surgery was 1.63% for hips and 1.86% for 
knees (Huo et al., 2010). These infections are the result of bacterial adhesion and 
subsequent colonisation, leading to the biofilm formation at the implantation site 
(Van de Belt et al., 2001; Dougherty, 1998; Van Loosdrecht et al., 1990). The 
formation of the biofilm on the implant surface leads to reduced stability and 
ultimately its failure. The most common bacteria responsible for such infections are 
Staphylococcus species in particular Staphylococcus aureus (S. aureus) and 
Staphylococcus epidermidis (S. epidermidis). Common sources of BAI include 
contaminated implant/device surfaces, exogeneous pathogens from skin, surgical 
instrumentation, local environment, distant local infections in the patient (An and 
Friedman, 1996).  
 
Irradicating such infections remains a challenge and BAI remains one of the most 
common reasons leading to revision surgery (Van Houwelingen et al., 2012; Huo et 
al., 2010; Hendriks et al., 2004). Treatment of infections at the implant site can be 
complicated and the approaches routinely employed have major drawbacks. 
Systemic delivery of antibiotics can result in poor delivery of the therapeutic to the 
implantation site. The high doses required may result in systemic toxicity with 
associated renal and liver complications (Ruszczak and Friess, 2003; Price et al., 
1996). Another approach is to use antibiotic-loaded biomaterials, however, this is not 
always the most effective treatment, as prolonged elution of low levels of the 
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therapeutic agents below the minimum inhibitory concentration (MIC) increases the 
risk of the development of antibiotic resistance (Jiranek et al., 2006; Amyes and 
Gemmell, 1997; Gold and Moellering, 1996). Resistant strains of bacteria have 
become more prevalent. Methicillin-resistant organisms, most prominently 
methicillin-resistant S. aureus (MRSA) infections were noted to increase from 16% in 
1999 to 37% in 2006 and methicillin-resistant S. epidermis (MRSE) infections 
showed a similar increase from 11% to 15% in the same time period (Parvizi et al., 
2009). Regarding these methicillin resistant infections as well as chronic BAI, two 
stage reconstruction surgery is the standard treatment consisting of the removal of 
the prosthesis, surgical debridement and insertion of an antibiotic loaded cement 
spacer (first stage). Following antibiotic therapy for a minimium of 6 weeks, the 
artifical prosthesis is implanted (second stage) (Van Houwelingen et al., 2012). 
Comparing single stage and two stage treatment of methicillin resistant 
staphlyococcus species, debridement and antibiotic therapy (single stage treatment) 
was successful in 37% whereas two stage procedure had success rate of 60% for total 
knee replacement and 75% for THR (Parvizi et al., 2009). While single-stage 
revision has had good results, two-stage re-implantation remains the gold standard 
for the treatment of chronically infected THA where non methicillin strains were 
identified as the cause (90% success rate). Inhibiting bacterial adhesion is often 
regarded as an alternative approach in preventing implant associated infections 
(Zibermann and Elsner, 2008). Therefore, there is a need for a bioceramic coating 
that will not only have osteointegrative properties but can also effectively resist 
bacterial colonisation. 
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1.4.2.1 Biofilm Formation 
Bacterial adherence is a complex multi-step process that is influenced by the host, 
the device and the microbe. This complex phenomena has been simplified into the 
following phases: attachment, adhesion and aggregation (Gristina, 1987). However, 
prior to the attachment stage there is the formation of a ‘conditioning film’ 
(biomolecules) within seconds on exposure of the implant to the biological 
environment which suggests that the microbes adhere to the formed conditioning 
film and not to the bare implant surface. The initial adhesion (attachment stage) of 
the microbes depends on the physicochemical characteristics of the biomaterial 
surface, microbe cell surface and the biological fluid in the environment (Van 
Loosdrecth et al., 1990). Hetrick and Schoenfisch, summarised the process involved 
in biofilm formation (Hetrick and Schoenfisch, 2006). The attachment can be 
divided into two time dependent stages (Figure 1.3).  
 
Phase I involves reversible cellular association with the biomaterial surface through 
long and short range chemical interactions, which occurs in the first 1-2 hours of 
implantation (Vacheethasanee and Marchant, 2000). Phase II (2-3 hours post 
implantation) involves a stronger adhesion mechanism through molecular bridges 
between the organism and the implant surface formed through specific cell surface 
chemical reactions (Vacheethasanee and Marchant, 2000). At this stage (24 hour 
post implantation), the attached microorganisms secrete an exopolysaccharide layer 
which anchors the biofilm and forms an outer lining of the biomaterial called 
‘glycocalyx’ (Gristina and Costerton, 1985). The glycocalyx, in addition to 
anchoring the biofilm, also protects against environmental attacks and treatment with 
antibiotics (Isiklar et al., 1996; Gristina, 1987). The aggregation step involves the 
Chapter 1: Introduction and Literature Review 
         
Page | 34  
 
colonisation of the bacteria subsequently leading to the formation of a thick film of 
‘slime’. Organisms on the outside of the slime may detach and give rise to septic 
infection (Van de Belt et al., 2001). 
 
Figure. 1.3: Representation of bacterial adhesion to a biomaterial substrate (Hetrick 
and Schoenfisch, 2006). 
 
1.5 Biofilm Preventative Strategies  
Many different strategies have been developed to combat the incidence of BAI. 
Three main approaches have been developed to construct anticolonising coatings for 
biomedical applications: biocide releasing, microbe-repelling and contact-active 
anticolonising coatings. The former approach is well established and has received 
much research attention compared to the other strategies. However, microbe 
repelling and contact-active coatings are relatively new approaches and these novel 
methods offer potential in the treatment of infection in the orthopaedic setting. 
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1.5.1 Biocide Release 
This involves the release of antimicrobial agents, namely antibiotics and 
antimicrobial metals from a matrix impregnated coating on hard tissue implants, 
which kills microbes at the localised site. Biocide release can be tailored to have 
burst and controlled release components in order to combat infection in the 
perioperative and post-surgical phase (Liu and Chang, 2009; Chai et al., 2007; Teller 
et al., 2007; Rossi et al., 2004; Lucke et al., 2003). Release proceeds through 
diffusion from the coating matrix or coincides with erosion of the coating matrix 
(Liu and Chang, 2009; Chai et al., 2007; Teller et al., 2007). Alternatively, bioglass 
was shown to posses antimicrobial properties as a result of the dissolution of the 
bioglass matrix elevating the pH at the localised site (Hu et al., 2009).  
 
1.5.1.1 Antibiotic Loaded Bone Cements 
The development of antibiotic loaded bone cements (ALBC) have been extensively 
studied since their discovery in the 1960’s. These frontier materials consisting of 
drug loaded poly(methyl methacrylate) (PMMA) bone cements (BC) are 
commercially available today e.g. Simplex P (Stryker, United Kingdom (UK)) and 
Palacos G (Biomet, Warsaw). Alternatively, cements are also available which are 
vacuum-mixed with antibiotics such as ampicillin, erythromycin, colistin, cefazolin, 
gentamicin, vancomycin and tobramycin by surgeons and then moulded with the 
implant like a putty (Zilberman and Elsner, 2008). The antibiotic dosage in ALBC’s 
for treatment of musculosketal infection can be as high as 6-8 g per 40 g BC 
(Springer et al., 2004). The release of antibiotics from BC follows a biphasic 
mechanism. Initial release, during the first hours after exposure of antibiotic loaded 
cement to a fluid, is mainly a surface phenomenon (first phase) while prolonged 
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release over several days is a bulk diffusion process (second phase) (Van de belt et 
al., 2000). The second phase relies on the availability of pores and connecting 
capillaries in the cements through which the fluids can penetrate and dissolve the 
antibiotics that slowly diffuse through the matrix. Factors that affect antibiotic 
release include antibiotic type, BC type and mixing conditions (Jiranek et al., 2006). 
The main advantage of BC usage is that it works in the treatment of deep infections 
with much clinical data to support its success (Jiranek et al., 2006). The 
disadvantages of using these materials includes (i) the presence of unreacted 
monomer which may cause cyctotoxic effects leading to chemical necrosis of the 
bone; (ii) some are non-degradable e.g. PMMA; (iii) 80% of the antibiotic has been 
reported to be effectively locked in the BC for many years resulting in sub-inhibitory 
exposure and induction of resistance in subjected strains and (iv) the mechanical 
strength of the BC can be compromised due to the addition of the drug and the 
subsequent drug release (Hendriks et al., 2004; Powles et al., 1998). Some of these 
problems can be overcome with resorbable bone cements such as those composed of 
CaP and brushite cements. The resorbable bone cement can lead to faster and more 
prolonged drug release, at higher concentration, with efficacy against militant 
bacteria strains without toxicity (Habraken et al., 2007; Jiranek et al., 2006). 
 
1.5.1.2 Antibiotic Loaded Implant Coatings-Cementless Implants 
The use of bioactive materials such as CaO, HA, TCP as drug eluting orthopaedic 
coatings pose a simple cementless solution for the treatment of BAI. Extensive 
research has been carried out to develop a simple means of impregnating the drug 
into the HA pores (Chai et al., 2007; Pham et al., 2002) or into the HA matrix (Teller 
et al., 2007; Stigter et al., 2002). In vitro release of antibiotics from these materials 
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has been reported for vancomycin, gentamicin and ciprofloxacin with no 
antibacterial impact beyond three days for materials loaded using a soakage method 
(Chai et al., 2007). The antibacterial assessments demonstrated inhibition of S. 
auerus after 24 hours with short loading times of 15 mins however, the authors 
hypothesised that efficiacy of only up to 2 days could be achieved (Brohede et al., 
2009). The downfall associated with using these materials loaded with antibiotics 
through a soakage method is that a short elution profile results (1-3 days). Recent 
research has shown a simple ‘fast-loading slow-release’ mechanism of incorporating 
antibiotics through loading HA coated Ti surfaces in antibiotic solutions where the 
antibiotics (tobramycin, cephalothin, amoxicillin) chemically bind to the CaP 
(Brohede et al., 2009, Stigter et al., 2004). 
 
In order to further extend the period of drug liberation, the addition of different 
biodegradable polymers has been employed. Biopolymers are also attractive 
alternatives to PMMA with the key benefit of being completely bioresorable, which 
eliminates the need for surgical removal. These drug delivery systems allow for 
increased antibiotic loading and more controllable release kinetics that can be 
modified by the polymer’s degradation profile. Biodegradable, Food and Drug 
Administration (FDA) approved polyesters such as poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA) and poly(ethlene glycol) (PEG), and their co-polymers 
have been manufactured into different forms (microspheres, films, beads) and are 
successfully used on orthopaedic devices (Habraken et al., 2007). These combination 
coatings demonstrate low burst release and a linear drug release up to 24 weeks 
(Zilberman et al., 2008), with clinical data reported in the prevention of infections on 
intra-medullary implants up to 6 weeks after implantation (Schmidmaier et al., 2006; 
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Lucke et al., 2003). Poly(hydroxy alkanoates) (PHA) have demonstrated excellent 
control over gentamicin release over a period of 6 weeks with bacterial eradication 
within 24-48 hours (Rossi et al., 2004). Other novel approaches use polymerisation 
techniques to produce drug loaded PLGA/HA microspheres (Shi et al., 2009) and 
novel polymer-drug microspheres developed with a HA shell (Xu and Czernuszka, 
2008). Toxicological studies with PLGA devices suggest that local tissue reactions at 
the site of application may occur (Dailey et al., 2006; Sundback et al., 2005) with 
strong inflammatory responses after 24 months in vivo when composites of PLA and 
TCP were implanted. The degradation of the PLA was linked to the inflammatory 
response (Ignatius et al., 2001). Despite concerns that the acidic by-products of the 
biocompatable PLGA may denature proteins (Nair and Laurencin, 2007), it has been 
recently shown to release BMP-2 from PLGA based microspheres (Kirby et al., 
2011).    
 
1.5.1.3 Substituted Apatites 
Alternatives to antibiotics have also been researched, and the use of substituted or 
doped apatites which can deliver the added functionality of antimicrobial surfaces to 
the HA bioactive surfaces. Substituted apatites are CaP materials where the Ca ion 
has been replaced by other cations. Investigations into the use of ions such as silver 
(Ag), zinc (Zn) and copper (Cu) which were incorporated into HA have shown to 
have a positive antimicrobial effect (Zhou et al., 2008; Ahmed 2006; Chen et al., 
2006; Chung et al., 2006; Kim et al., 1998). Strontium ions, an element present in 
trace quantities in the mineral phase of bone has also been reported to have an 
antimicrobial effect in vitro (Lin et al., 2008; Guida et al., 2003). Of these 
antimicrobial ions investigated, Ag doped apatites have been the most extensively 
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studied. Silver has strong inhibitory and bactericidal effects aswell as a broad 
spectrum of activity against a wide range of pathogens (Feng et al., 2000b). 
Concerns relating to the toxicological issues surrounding systemic or local 
accumulation of metals have been raised (Campoccia et al., 2006). Several proposed 
mechanisms have been reported to explain the antimicrobial mode of action of the 
metal ions. These mechanisms include disruption of the electron transport chain, 
inhibition of deoxyribonucleic acid (DNA) replication, DNA cleavage, membranous 
disruptions, formation of reactive oxygen species and enzyme inhibition (Applerot et 
al., 2009; Zhou et al., 2008; Park et al., 2009; Feng et al., 2000b; Fagian et al., 1986; 
Richards, 1984; Yakabe et al., 1980; Bragg and Rainnie, 1975; Kasahara and 
Anraku, 1974). 
 
Recently, it has been reported that Ag containing HA coatings demonstrated good 
antibacterial and osteogenic properties with low toxicity in vitro (Roy et al., 2012, 
Ruan et al., 2009). Good osteoblast adhesion and proliferation was observed on Ag 
loaded HA surfaces however it was noted that the Ag content should be limited to 
between 1-3% wt in vitro (Sandukas et al., 2011). The osteoconductivty of Ag 
containing HA coatings on Ti was evaluated in rat tibiae confirming that there was 
good bone formation for a 3% wt loading. However, inhibition of bone formation 
was observed at higher Ag loadings of 50% wt (Yonekura et al., 2011). Ag loaded 
CaP coatings have also demonstrated antibacterial activity against MRSA in vitro 
(Ando et al., 2010) and in vivo (Shimazaki et al., 2010) without cytotoxic effects.   
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1.5.2 Microbe Repelling Strategies  
Microbe repelling coatings are still under development and find applications in many 
medical areas but to date are rarely found in the orthopaedic setting. These materials 
include tailoring coating properties such as surface charge and hydrophobicity by 
altering the surface chemistry in order to reduce bacterial attachment, thus 
preventing microbial colonisiation (Russell, 2009; Berry et al., 2000; Gottenbos et 
al., 2000).  
 
The infection risk associated with each biomaterial varies according to the material 
and is determined by the interplay between adhesion and surface growth of the 
infecting organism. Hydrophobic polymers such as fluoroplastic coated implants for 
otolaryngology applications have proven to inhibit biofilm formation using S. aureus 
as the challenge organism (Berry et al., 2000). Research including clinical trials on a 
lipophilic coating, phosphorylcholine (PC), demonstrated that biofilm formation was 
reduced on PC coated materials compared to the uncoated material for biomedical 
applications (Russell, 2009; Shigeta et al., 2006). Other approaches used protein 
coatings of heparin and albumin to inhibit bacterial adhesion (Kinnari et al., 2005; 
Galliani et al., 1994; Nagaoka and Kawakami, 1995). Even though these 
biomaterials reduce the adhesion of the bacteria cells they do not exhibit bactericidal 
effects (Gottenbos et al., 2000).   
 
Studies have concluded that the surface growth of initially adhering bacteria is 
influenced by the surface charge of the biomaterials (Gottenbos et al. 2000; Harkes 
Chapter 1: Introduction and Literature Review 
         
Page | 41  
 
et al., 1992). A wide range of postive and negative charged polymeric surfaces were 
investigated (poly(dimethyl siloxane), teflon, polyethylene, polypropylene, 
polyurethane, poly(ethylene terephthalate) (PET) and PMMA as well as postively 
and negatively charged co-polymers of methacrylic acid) (Gottenbos et al. 2000; 
Harkes et al., 1992). The surface growth of Escherichia coli (E. coli) was slow or 
absent on positively charged surfaces due to the resultant tight binding between the 
bacteria and the charged surface as compared to negatively charged surfaces (Harkes 
et al., 1992). The growth of P. aeruginosa on biomaterial surfaces also decreased 
with an increasing binding strength to the surface (Gottenbos et al., 2000). It has 
been shown that when a biomaterial surface is more negatively charged, the chance 
of coagulase negative bacteria adhering is reduced thereby delaying the formation of 
the biofilm as a result of electostatic repulsion. Alternatively, positively charged 
surfaces are more adhesive but the strong electrostatic attraction of the organisms 
impedes surface growth of Gram negative bacteria (Gottenbos et al., 2000).  
 
1.5.3 Contact Active Anticolonising Coatings 
This novel and less established approach uses non leaching biocidal agents, which 
kill microbes on contact with the coating surface, without the need for release of the 
antimicrobial agent. ‘Self sterilising’ surfaces containing quaternary ammonium 
compounds (QAC) polycaionic materials, anchored to the implant surface through 
covalent bonds, exert their effects by damaging cell membranes (Murata et al., 2007; 
Milović et al., 2005). The permanent attachment of drugs to surfaces through the 
different functional groups of antibiotics (amine, carboxyl or aldehyde) which form 
covalent bonds or electrostatic interactions with the specific groups on the coating 
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has been investigated (Ginalska et al., 2005). In the study by Ginalska et al., 
gentamicin sulphate was covalently immobilised on a PET prosthesis and sealed 
with gelatin. Ninety-seven percent of the antibiotic remained bound on the 
biomaterial for at least 30 days. A bacteriostatic effect against S. aureus, E. coli and 
P. aeruginosa was exerted with no biofilm formation (Ginalska et al., 2005). 
 
Functionality can also be introduced to the surface through the use of linkers which 
can then tether antibiotics to the surface through weak electrostatic or covalent 
interactions. Research has shown the effective use of silanes as linkers to bind drugs 
to Ti surfaces (Antoci et al., 2008; Jose et al., 2005). Vancomycin was coupled to a 
Ti surface using two linkers, 3-aminopropyltriethoxysilane and 8-amino-2,6-
dioxoctanoic acid and demonstrated 88% reduction in S. aureus attachment 
compared to uncoated Ti over 2 hours (Jose et al, 2005). Colonisation of S. 
epidermis for 30 hours was also inhibited and the anticolonising activity was 
maintained following 7 repeated cycles of 24 hour incubation with the strain (Antoci 
et al., 2008). Other research has used glycol spacers in addition to silanes to link 
vancomycin to Ti (V) in order to functionalise the Ti surface. Anticolonising effects 
of up to 44 days against S. aureus were observed in vitro (Edupuganti et al., 2007). 
Natural polycations such as chitosan have been immobilised onto Ti to confer 
antimicrobial activity on the surface through disruption of cell membrane of 
microbes. Coatings prepared through coupling chitosan to silanised Ti using a 
glutaraldehyde linker demonstrated enhanced osteoblast proliferation and 
antimicrobial effect against a wide range of strains for 55 hours compared to Ti 
(Carlson et al., 2008). The use of antimicrobial peptides (AmP) (Faber et al., 2003) 
as a non-leaching material for medical devices has been developed (Ferreira et al., 
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2008). The mode of action of AmP includes the formation of pores in the cell 
membrane leading to cell lysis (Tzoris et al., 2003) and demonstrated antibacterial, 
antiviral and antifungal activity (Zasloff et al., 2002). AmP, tethered using PEG 
spacer to a silanised Ti surface, was responsible for killing E.coli on contact (Gabriel 
et al., 2006).  
 
Another alternative includes immobilising antimicrobial metals in CaP coatings on 
implant substrates. Recent studies have shown that the catalytic action of metals in 
coatings has the capacity to produce reactive oxygen species which induce apoptosis 
(Hu et al., 2007). There has been some formulation development of doped apatites to 
reduce the elution of microbial ions (Ag+) through the addition of other metals (Zn, 
Cu) to modify the TCP network thus reducing the rate of the material’s breakdown 
(Matsumoto et al., 2009). Even though there is some elution of ions, a synergistic 
effect has been reported whereby the antimicrobial effect was attributed not only to 
the low concentrations of ions released but also to the free radical species formed by 
the immoblised antimicrobial metals (Matsumoto et al., 2009; Hu et al., 2007). 
 
The advantage of using contact active anticolonising coatings includes the reduced 
toxicity as a result of the antimicrobial agent not being released. However, antibiotic 
coupled surfaces may give rise to the development of resistant pathogens (Ferreira 
and Zumbuehl, 2009). The synthetic preparation of polycations is cheap, they are not 
susceptible to degradation and do not give rise to bacterial resistance (Milović et al., 
2005). Unfortunately, not much is known about their cytotoxicity and 
biocompatability in vivo (Milović et al., 2005). Synthetic polycationic compounds 
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with antimicrobial activity have not yet been approved by the FDA and European 
Medicines Agency for applications on medical device coatings whereas 
immobolisation of FDA approved antibiotics may have less regulatory hurdles to 
overcome (Ferreira and Zumbuehl., 2009). AmP are reported to be less likely to 
induce bacterial resistance than traditional antibiotics because they kill quickly and 
specificantly target the microbial membranes. However, it was also observed that the 
activity of the tethered AmP does not directly correspond to that of their analogs in 
free solution (Hilpert et al., 2009).  
 
1.6 Deposition Techniques 
A number of HA coating deposition techniques have been employed to confer a 
bioactive layer onto metallic substrates. Plasma spraying is a form of thermal 
spraying and is the most extensively used to generate HA coating of various 
thicknesses (Lombardi et al., 2006; Talib and Toff, 2004; Xue et al., 2004; Khor et 
al., 2003; Ong and Chan, 2000). It is the most common method utilised in the 
medical device industry, to apply HA surface coatings. These do not always lead to 
the ideal surface being engineered as the coating is deposited at temperatures ranging 
between 10,000-12,000 oC which subsequently leads to the formation of undesirable 
phases of CaP (Narayanan et al., 2008, Campbell et al., 2003). This results in 
problems with respect to coating uniformity, reproducibility and adhesion of the 
coating onto the substrate. (Heimann and Wirth, 2006; Gross and Berndt, 1998; 
Gross et al., 1998; Chen et al., 1994; LeGeros et al., 1991). As a result, research has 
been directed towards finding similar deposition processes that can achieve 
improved coating performance. These include pulsed laser deposition (PLD) (Koch 
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et al., 2007; Katto et al., 2005), radio frequency (RF) magnetron sputtering (Nelea et 
al., 2003; Long et al., 2002), sol-gel immersion techniques (Stoch et al., 2005; Weng 
et al., 2003) and electrophoretic deposition (Wang et al., 2002; Stoch et al., 2001; 
Ducheyne et al., 1990). Table 1.4 outlines the advantages and disadvantages of 
various techniques used to deposit a HA layer onto metals. Unfortunately, none of 
these techniques can provide the perfect coating due to the formation of cracks, 
residual stresses and secondary phases (impurities) as a result of the process 
conditions, which reduce the long-term coating durability leading to implant failure 
(Geesink et al., 2002).  
 
The increased solubility associated with the formation of undesirable CaP phases 
produced during plasma spray processes can eventually lead to the poor direct 
apposition of bone and compromise the mechanical stability of the implant 
(Heimann and Wirth, 2006; LeGeros et al., 1991). Poor integration with the host 
tissue occurs when the coating itself delaminates over time due to the poor bonding 
strength of the HA onto the underlying surface or as the coating itself resorbs into 
the surrounding environment (Mohammadi et al., 2007), leading to implant failure 
and the requirement for revision surgery (Gross et al., 1998).  
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Table 1.4: Various techniques to deposit CaP on metal implants (Narayanan et al, 2008; Yang et al, 2005). 
Category Technique  Summary Thick-
ness  
Advantages  Disadvantages  
 
Thermal  Thermal 
Spraying 
including 
plasma 
spraying 
 
High temperature process  
10,000 -12,000ºC producing thick 
homogenous HA coatings. 
30–200 
μm  
High deposition rates; low cost.  High temperatures induce decomposition; rapid cooling 
produces amorphous coatings.  
 
 
 Sputter 
coating  
Radio frequency (RF)-magnetron 
sputtering from CaP glass targets. 
Thin but dense HA coatings with strong 
adhesion and compact microstructure. 
 
0.5–3 μm  Uniform coating thickness on flat 
substrates; dense coating.  
Expensive; time consuming; produces amorphous coatings. 
 Pulsed laser 
deposition  
Inside a vacuum chamber, a pulsed laser 
beam is focused on a rotating HA target. 
Thin coatings with high fatigue resistance. 
0.05–5 μm Coating by crystalline and 
amorphous phases; dense and 
porous coating.  
 
Expensive. 
 Hot isostatic 
pressing  
Hot pressing of HA granules onto titanium 
surface. Uniform coating. 
 
0.2–2.0 
nm  
Produces dense coatings. Cannot coat complex substrates; high temperature required; 
thermal expansion mismatch; elastic property differences; 
expensive; removal/interaction of encapsulation material.  
 
Wet 
Methods 
Sol-gel 
technique  
Prepared by soaking in Ca and P gel 
following by a sintering process. 
<1 μm  Can coat complex shapes; low 
processing temperatures; 
relatively cheap as coatings are 
thin.  
 
Some processes require controlled atmosphere processing; 
expensive raw materials; time consuming process; post sintering 
process. 
 Biomimetic 
coating  
Immersion in simulating biological fluid 
(SBF). 
<30 μm  Low processing temperatures; can 
form bonelike apatite; can coat 
complex shapes.  
 
Time consuming; requires replenishment and a pH constancy of 
simulated body fluid.  
 
Electo- 
chemical 
Electro- 
phoresis 
Cathodic deposition of CaP from 
electrolyte.  
0.1–2.0 
mm  
Uniform coating thickness; rapid 
deposition rates. 
Difficult to produce crack-free coatings; requires high sintering 
temperatures.  
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From a commercial standpoint, plasma spraying offers a rapid deposition approach 
with coatings produced at a sufficiently low cost (Ong and Chan, 2000). Controlling 
the deposition parameters of high temperature methods can be hard to achieve 
especially when considering that HA becomes unstable at temperatures above 1300 
ºC (Muralithran and Ramesh, 2000). The production of reproducible coatings with 
uniform thickness is a common problem which in turn can lead to weakening of the 
HA layer. A thickness of 50-75 µm has been employed by most manufactures for 
commercially used orthopaedic implants (Sun et al., 2001). However, HA coating 
thickness affects both its resorption and mechanical properties. Thicker coatings 
usually exhibit poorer mechanical properties. Whilst the efficacy of thin coatings 
produced from ion beam or RF spluttered coatings is unknown (Sampathkumaran et 
al., 2001), a CaP coating thickness of 10 µm is required for good bond apposition 
(Narayanan et al., 2008).  
 
Even in the commercial setting many of the coating methods listed would require a 
number of steps to be performed to prepare the implant surface before and after 
deposition. In many cases the surface needs to be roughened or acid etched for the 
HA coating to adhere to the surface of the implant (Schuh et al., 2004; Cho and Park, 
2003; Wennenberg et al., 1997). Also, many techniques require a post sintering step 
to improve coating density, crystallinity and adhesion (bond strength). Post treatment 
conditions include thermal treatment for 2-5 hours at 1000-1250 °C with a heating 
program at 0.5-3 °C/min (Oktar et al., 2004). ACP crystallises generally at a 
temperature of 700 °C leading to a mixture of HA, TTCP and CaO (Feng et al., 
2000a). As the process occurs at high temperature it also limits the co-deposition of 
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therapeutic drugs and biologics which would be destroyed or rendered irreversibly 
inactive (O’Hare et al., 2010). 
 
There are also similar problems encountered with wet chemical methods for the 
application of bioactive coatings. Many steps are often required to prepare the 
surface for the deposition of the HA layer, which are very time consuming, 
expensive and complicated. In addition a post treatment step may be required (Stoch 
et al., 2005; Yang et al., 2005; Oktar et al., 2004; Weng et al., 2003; Wang et al., 
2002). For this reason, very few have been commercialised.  
 
In general, the crystallinity of HA coatings on hard tissue implants ranges from 65-
75%. Crystalline HA coatings are required for long-term implantation however, 
lower crystallinity promotes faster initial bone fixation (Peraire et al., 2006; Xue et 
al., 2004; Overgaard et al., 1999). Irrespective of the short falls of wet chemical 
methods, they have great potential in producing HA materials with enhanced 
hydrophilicity, which will increase the osteoconductive properties of the coating. 
Massaro et al., (2001) reported that sol-gel coating (higher OH ion content) 
promoted high cell growth, greater ALP and greater osteocalcin production 
compared to the spluttered and plasma sprayed coating (lower OH ion 
concentration). Silver loaded apatites have been deposited using sol-gel, plasma, 
thermal spraying and ion beam techniques (Roy et al., 2012; Sandukas, 2011; 
Yonekura et al., 2011; Ruan et al., 2009; Chen et al., 2007b), however the same 
coating issues prevail.  
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1.6.1 CoBlastTM Process 
In order to overcome the drawbacks noted for some of the methods discussed 
previously a novel approach using a grit blasting technique, CoBlast, has been 
developed. It is a novel process for the modification of active metal and active metal 
alloy surfaces (Ti, NiTi, CoCr, etc.) utilising existing conventional microblasting 
processes which are commonly used to provide a clean and roughened surface on 
orthopaedic implants. Derived from sandblasting, microblasting mixes fine abrasive 
powders with dry air, which is then propelled through a small nozzle onto the 
implant surface. This impact removes any unwanted debris and also provides a 
roughened surface. Micro-abrasive blasting is a straightforward, cost-efficient and 
environmentally friendly way to perform a variety of surface treatments (Schuh et 
al., 2004; Cho and Park, 2003; Wennenberg et al., 1994). 
 
CoBlast uses two powders, an abrasive (e.g. alumina, apaptitic abrasive (MCD)) and 
a dopant (e.g. bioceramic). CoBlast is the controlled co-incidental blasting of 
abrasive and coating particles onto a reactive metal substrate. The process consists of 
either two separate flow systems or one combined flow of the abrasive and the 
dopant, Figure 1.5. The flow systems are microblasters which use dry compressed air 
to blast the abrasive and dopant powders through the respective nozzles or a single 
nozzle onto the surface. In the case of a dual nozzle system, both powder streams 
meet at the surface of the metal to be coated whereas there is a single stream of 
powders with a single nozzle regime. 
 
The substrate can be stationary on a stage or fixed on a rotationary axis. The nozzles 
move over the substrate in the X, Y and Z directions using a computer numerical 
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control table. The CoBlast process is a single step process that can be conducted at 
ambient temperature. The abrasive disrupts the oxide layer on the metal, removes 
any unwanted debris and also provides a roughened surface. Concomitantly, the 
exposed underlying pure metal is forced to passivate, through the formation of 
chemical bonds with the dopant particles. The passivating substrate has a higher 
affinity to bond with the desired coating over the abrasive and therefore produces a 
unique conformal surface typically devoid of abrasive particles (O’Donoghue and 
O’Neill, 2009). 
 
 
Figure 1.4: Schematic of the CoBlast process (O’Neill et al., 2009). 
 
Roughening of the metal surface using the grit blasting approach, creates active sites 
through the removal of the metal oxide layer, which subsequently provides for 
impregnation, mechanical locking and chemical bonding of the dopant (O’Hare et 
al., 2010). Modifications of less than 10 µm were observed using this technology 
(O’Neill et al., 2009). Tribochemical bonding as observed by Gbureck et al, is 
believed to produce a well adhered and stable uniform coating of the dopant on the 
Substrate
Abrasive Nozzle                                   Dopant Nozzle      
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metal using the CoBlast technology (Tan et al., 2012; O’Hare et al.,2010; Gbureck et 
al., 2003). 
 
Research has shown the deposition of various substituted apatites (fluoro apatite and 
carbonate apatite) on Ti substrates (O’Neill et al., 2009). CoBlast HA surface 
demonstrated enhanced osteoblast attachment in vitro and early stage lamellar bone 
growth (O’Hare et al., 2010). CoBlast deposition has been seen to produce 
bioceramic coatings consisting of HA, bioglass and HA/Bioglass. Bioglass derived 
surfaces demonstrated superior osteoconductity to HA (cell attachment, proliferation 
and osteogenic differentiation) (Tan, et al., 2011). CoBlast HA surface has been 
compared to a plasma sprayed HA surface in in vitro and in vivo (Tan et al., 2012). 
CoBlast HA surface was less rough with slower cell proliferation but exhibited 
enhanced hydrophilicity, higher crystallinity, improved stem cell adhesion and 
attachment compared to plasma sprayed HA in vitro. In an in vivo setting, the two 
HA coatings demonstrated enhanced osteointegration compared to the uncoated Ti 
surface, however, no significant differences in the torque out force values were seen 
between the HA surfaces irrespective of the coating technique (Tan et al., 2012). 
 
CoBlast offers the following advantages compared to the conventional coating 
methods used in the orthopaedic arena, these include: 
 It is a single step process carried out at room temperature and pressure. 
Therefore, the chemical composition of the dopant is preserved in the coating. 
This room temperature process also allows for the deposition of active 
pharmaceutical ingredients (Tan et al., 2012).   
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 It is a chemical free and therefore an environmentally friendly process 
(O’Donoghue and O’Neill, 2009). 
 Two-dimenstional (2D) and 3D substrates can be used. The system can cater 
for large implants such as hip arthroplasties as well as smaller fixation 
implants e.g. dental screws (O’Donoghue and O’Neill, 2009).  
 The deposited dopants are an integral part of the metal oxide layer and 
therefore no lamination of the surface modification occurs. As a result, it takes 
on the inherent strength of the bulk metal (O’Donoghue and O’Neill, 2009).   
 Easy integration of the CoBlast system into a manufacturing environment. The 
single CoBlast processing step (using conventional equipment) plus cleaning 
replaces five steps required to obtain a HA coating using the industry standard 
plasma spray, the CoBlast process integrates roughening and the application of 
the HA in one step (O’Donoghue and O’Neill, 2009). 
 Normal sterilisation such as chemical and irradation techniques can be used to 
sterilise CoBlast surfaces. 
 
1.7 Objectives  
The ultimate aim of this work was to develop and characterise novel coatings that 
will provide key benefits and added value to hard tissue implants. However, this 
work can be divided into three main objectives surrounding this central theme with 
specific research questions addressed: 
1. Evaluate HA coatings deposited using CoBlast technology in in vitro studies. 
(i) Can the technology effectively deposit a HA layer onto Ti substrates?  
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(ii) How does CoBlast HA surface compare to uncoated surface in a 
preliminary biological study? 
(iii) Can surface properties be altered or tailored into the modified surfaces? 
(iv) How does the surface compare to the competing technology such as 
plasma spraying process? 
2. Evaluate substituted apatites containing antimicrobial metals as an infection 
preventing strategy in in vitro studies. 
(i) Can CoBlast effectively deposit substituted apatites? 
(ii) Do CoBlast coatings of substituted apatites offer dual benefits of being 
anticolonising and osteoconductive? 
3. Evaluation of AgA as an infection preventing surface in in vivo model. 
(i) Do the in vitro and in vivo study results correlate? 
(ii) Does the surface elicit an inflammatory and cytotoxic response?  
(iii) Does the infection stay localised at the implantation site? 
(iv) What improvements are seen to the anticolonising impact in an infection 
model using S. aureus as the bacterial challenge? 
Chapter 2: General Materials and Methods 
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             Chapter 2 
2.0 General Materials and Methods 
In this chapter, an overview of the materials and methods used are given. Figure 2.1 
outlines the analysis performed on the CoBlast surfaces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: An outline of the analysis performed on the CoBlast samples (where 
EDX is energy dispersive X-ray; XPS is X-ray photoelectron spectroscopy; SEM is 
scanning electron microscopy; XRD is X-ray diffraction; ICP-OES is inductively 
coupled plasma optical emission spectroscopy; SBF is stimulating body fluid; MTT 
is 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide). 
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Surface Characterisation 
Assessment 
Cell Culture Assessment 
using Osteoblast MG-63 
Microbiological 
Assessment using 
S.aureus, and clinical 
strains (MSSA, MRSA and 
S. epidermis) as bacterial 
challenges 
In vivo Assessment of an 
infection model in nude 
mice using S. aureus as 
the bacterial challenge 
 Elemental analysis: EDX, XPS 
 Chemical composition: XRD, FTIR 
 Ion concentration and in vitro ion release studies: 
ICP-OES of acid and buffer samples 
 Morphology and topography: SEM 
 Surface roughness: surface profilometry 
 Coating thickness: thickness gauge 
 Coating mass: gravimetric analysis before and after 
acid etching 
 Coating bond strength: tensile adhesion test (ASTM 
F1147) 
 Bioactivity in vitro study of surfaces in SBF 
 Preliminary osteoconductivity study investigating 
osteoblast cell viability & cytotoxicity: MTT assay 
 Cell morphology: SEM  
 Antimicrobial activity: % kill from impact of 
leached ion and immobilised surface ion 
(modification of ASTM E2149-01) 
 Anticolonising activity: % Biofilm Inhibition. 
 Fluorescent images of stained biofilm  
 Anticolonising activity: % biofilm inhibition. 
 Images of surface: SEM 
 Systemic response: blood cultures 
 Anti-inflammatory response: chemilluminescence 
 Cytotoxicity: qualitative analysis of tissue 
surrounding implant 
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Due to the different studies investigated in each chapter (Chapters 3-7), variations 
in the experimental methodology were undertaken which was consistent with the 
research focus of each chapter. Surface characterisation was performed to determine 
elemental analysis, chemical composition, surface morphology, topography, coating 
thickness, coating mass, the concentration of ions released from the surface, coating 
adhesion strength. A MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide) assay was performed to determine the osteoconductive potential of the 
surfaces in a preliminary study which investigated the osteoblast viability and 
cytotoxicity. Scanning electron microcopy (SEM) images of osteoblast cultured on 
the surfaces were taken to investigate the attachment and spreading of the cells on 
HA surfaces. Microbiological assessments were performed to determine the impact 
of the leached ion from the surface as well as the surface effect from the immobilised 
ion and were expressed as % kill. The % biofilm inhibition was also assessed 
(anticolonising study). Fluorescent images were taken to illustrate the presence of 
active microbial cells on sample surfaces. Finally, an infection in vivo model was 
performed to evaluate the potential of CoBlast coated implants as an infection 
preventing surface in nude mice.   
 
Even though, this chapter outlines the materials used and methodology performed in 
the overall project, a brief summary of the analysis performed with details on sample 
numbers, time points and statistical analysis executed will be presented in the 
individual chapters. 
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2.1 Materials 
Titanium (Grade 5, Ti-6Al-4V) coupons (15mm x 15mm x 1mm), were obtained 
from Lisnabrin Engineering Ireland. Titanium (Grade 5, Ti-6Al-4V) Kirskner wires 
(K-wire) 0.8 mm x 180 mm were obtained from Smantec.USA. Crystalline HA 
powder was sourced from Science Applications Industries, France. Silver substituted 
apatite (5% and 12% wt AgA), strontium substituted apatite (5% and 12% wt SrA), 
zinc substituted apatite (5% and 12% wt ZnA) and co-doped silver strontium 
substituted apatite (12% wt AgSrA) were sourced from Himed Inc. (NY, USA). The 
substituted apatites were described as being low crystallinity in the unsintered 
condition. The alumina abrasive was purchased from Comco (NY, USA). The MCD 
apatite abrasives (MCD-106, MCD-180 and MCD-425) were all purchased from 
Himed Inc. (NY, USA). The dopants (HA, AgA, SrA, ZnA, AgSrA) and the 
abrasives (alumina and MCD series) were all biomedical grade materials. HPLC 
grade 1M hydrochloric acid (HCl), de-ionised water, isopropanol (IPA), ethanol, 
phosphate buffer solution (PBS), potassium bromide (KBr) FTIR grade, tris 
(hydroxmethyl) aminomethane, sodium chloride (NaCl), sodium bicarbonate 
(NaHCO3), potassium chloride (KCl), dipotassium hydrogen phosphate trihydrate 
(K2HPO4.3H2O), magnesium chloride hexahydrate (MgCl2.6H2O), calcium chloride 
(CaCl2), sodium sulphate (Na2SO4) and hydroxymethylaminomethane 
(CH2OH)3CNH2), trypsin, ethylenediaminetetraacetic acid (EDTA), MTT assay kit, 
ACS reagent grade dimethyl sulphoxide, paraformaldehyde, glutaraldehyde, osmium 
tetroxide and hexamethyldisilizane (HMDS), Luria Bertoni (LB) broth, LB agar, 
brains heart infusion (BHI) broth, BHI agar, acridine orange, dextrose, tryptone soya 
broth (TSB) and tryptone soya agar (TSA), Columbia blood agar plates and 
Columbia agar were all purchased from Sigma-Aldrich, UK. MG-63 osteoblast cells 
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were obtained from American Type Culture Collection (ATCC), (UK). Minimum 
Essential Medium (MEM), foetal calf serum, penicillin G sodium, streptomycin, 
amphotericin B were purchased from PAA Laboratories GmbH, Austria. S. aureus 
(ATCC 1448) was obtained from the laboratory of Prof. Alan Dobson at the 
Microbiology Department, University College Cork. The clinical isolates, MRSA 
(BH1CC), MSSA (BH48) and S. epidermis (BH1457) were sourced from Dr. James 
O’Gara (Microbiology Department, University College Dublin). Catheter needles 
(BD 16 G Pro Venflon) were sourced from Becton, Dickinson and Company, UK. 
Vetbond was sourced from 3M, UK. Commercially available Biorad Pastorex Staph-
Plus latex (Biorad Laboratories, UK) was used as the agglutination test. 
Chemiluminescent kit was purchased from Knight Scientific, UK.   
 
2.2 Sample Preparation 
Prior to surface modification, the coupons were cleaned ultrasonically in 1M HCl 
and then in isopropanol to remove any contaminants. The HA and substituted 
apatites were deposited onto the titanium coupons using EnBIO’s proprietary 
CoBlast technique according to the deposition conditions outlined in Table 2.1 for 
the various studies (Chapters 3-7). The working distance of the dopant and abrasive 
nozzles were approximately 20 mm and 8 mm from the surface, respectively with a 
speed of 13 mm/sec.  
 
The microblast surfaces were prepared under the same corresponding conditions as 
above, however no HA was delivered through the dopant nozzle (Chapters 3 and 4). 
After the surface treatment step, all samples were air-cleaned for 30 seconds to 
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remove any loose powder from the surface. The CoBlast surfaces in Chapters 3, 4 
and 7 were ultrasonically washed in de-ionised water for 3-5 minutes. HA plasma 
coated Ti substrates were prepared by APS Materials, Ireland (Chapter 4). The in 
vivo implants in Chapter 7 were sterilised by gamma radiation with a dose of 29.1-
29.7 kGy according to EN552:1994 (British Standards Institution, 1994). 
 
Table 2.1: CoBlast Deposition Process Conditions. 
Chapter Study Abrasive Dopant Pressure (psi) 
Dopant/Abrasive 
 
3 Physicochemical and biological 
characterisation of CoBlast HA surface 
 
MCD-106, MCD-
180, MCD-425 
HA 90/75 
 
4 A comparison of CoBlast and plasma 
sprayed HA coating stability following 
SBF immersion 
 
Al2O3 HA 90/75 
90/60 
5 Deposition of substituted apatites with 
anticolonising properties onto titanium 
surfaces using CoBlast technology 
 
Al2O3 HA, ZnA, 
SrA, AgA, 
90/60 
6 Evaluation of increased ion 
concentration on the antimicrobial and 
anticolonising properties of substituted 
apatite coatings 
 
MCD-106 HA, ZnA, 
SrA, AgA, 
AgSrA 
90/75 
7 In vivo evaluation of silver substituted 
apatite coatings to combat infection on 
hard tissue implants 
 
MCD-106 HA, AgA 90/75 
 
 
2.3 Sample Characterisation 
Surface characterisation can be divided into elemental and chemical analysis, in vitro 
ion release studies, physical analysis, mechanical analysis and bioactivity study in 
SBF. These were performed on a range of CoBlast surfaces. 
 
2.3.1 Elemental and Chemical Composition  
The elemental composition of the powders and the coatings was carried out using a 
Jeol JSM 5510 scanning electron microscope (SEM) in conjunction with an INCA 
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X-sight Energy Dispersive X-ray (EDX) spectroscopy detector (Oxford Instruments,  
UK). X-ray photoelectron spectroscopy (XPS) was performed using a Kratos 
Analytical Axis Ultra photoelectron spectrometer with a monochromated aluminium 
(Al Ka) X-ray source. X-ray diffraction (XRD) data was collected on a Siemens 
GAXRD diffractometer using CuKα1 radiation, with an anode current of 30 mA and 
an accelerating voltage of 40 keV. Data was collected in the range of 20 to 60 2θ 
degrees with a step size of 0.02 and a scan rate of 1 second per step. A Perkin Elmer 
Spectrum One Fourier Transform Infrared Spectrometer (FTIR) was used to 
determine the structural fingerprint of the powders and the coatings. The coating was 
scrapped off and pressed into a KBR disc (2% wt sample in KBR). The sample in 
KBR discs were analysed in transmittance mode with an average of 20 scans taken 
for each sample. A background scan of a blank KBR disc was automatically 
subtracted from the sample spectrum. The spectra gave approximately 70-90% 
transmittance however the results are presented in an overlay fashion. Powders (HA, 
MCD series, Al2O3) for FTIR analysis were prepared in a similar manner. The 
concentration of the various ions present in the coatings was determined by 
dissolving the coating in 1M HCl and analysing the solution using a Thermo IRIS 
Advantage Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES).  
 
2.3.2 In vitro Ion Release Studies 
The study which compares CoBlast HA surface to a plasma spray HA coating 
(Chapter 4), calcium (Ca) and phosphorus (P) release from the HA surfaces into 
buffer were analysed using ICP-OES. Tris buffer was prepared by preparing 50 mM 
tris (hydroxmethyl) aminomethane and adjusting the pH to 7.4 using 50 mM HCl. 
Samples were placed in 20 ml tris buffer (pH 7.4) and incubated in a shaking 
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incubator at 37 °C and removed after time-points, 1, 2 and 3 days (n=3) for 
elemental analysis using ICP-OES.   
 
For the substituted apatite coatings (Chapters 5 and 6), the coated coupons were 
placed in 20 ml PBS and incubated under physiological conditions (pH 7.4, 37 ºC 
and agitated at 150 rpm, n=3). The coated coupons were withdrawn from the PBS 
solution after day 1 and placed into fresh PBS (20 ml) and returned to incubation. 
This was repeated for the remaining time points. The ion release at each time point 
was determined using ICP-OES.  
 
2.3.3 Physical Analysis 
SEM analysis was performed using an FEI Quanta 200 Focused Ion Beam and 
Scanning Electron Microscope in backscattered electron mode. The high voltage was 
set at 10kV and an approximate working distance of 20 mm was used. Gravimetric 
analysis of the surface treatments deposited on Ti was used to determine the coating 
mass using an Ohaus DV314C analytical balance by measuring the sample before 
and after an acid wash (ultrasonic treatment in 20 ml 1M HCl for 10 minutes). 
Coating thickness was measured using a PosiTector 6000 N thickness gauge 
(DeFelsko, NY, USA). An average of six readings was used to determine each value. 
The surface roughness in nanometers (Ra, nm) and microns (Ra, µm) was measured 
using different profilometers. The surface roughness (Ra, nm) of the coatings was 
determined using a Veeco Dektak 8 Advanced Development Profiler. Measurements 
were taken across 5 positions of each sample in a quincunx manner at a scan length 
of 1000 μm over a 30 seconds time period. A 12.5 mm diameter diamond tipped 
stylus was employed at a force of 15 mg. The surface roughness (Ra, µm) was also 
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determined using a Talsurf 10 surface profilometer (Talyor Hobson, UK) on 3 
random points on each sample. 
 
2.3.4 Mechanical Analysis 
The ASTM F1147 tensile test is recommended for tension testing the calcium 
phosphate (CaP) coatings on metal substrates, and can provide information on the 
adhesive strength of coatings under uniaxial stress (ASTM Standard, 2011). The test 
pieces used were as specified per ASTM F1147 with a substrate cross-sectional area 
of 5.07 cm2 upon which the coating was applied. Adhesive FM 1000 with a thickness 
of 0.25 mm was placed on the coated side of the test piece. A blank piece was placed 
on top. Care was taken to ensure the adhesive was aligned in the centre of the surface 
coating. A constant force of 20 psi was applied to the assembly. The assembly was 
cured in an oven at 176 °C for 2-3 hours. Once cured, the assembly was removed 
from the oven and allowed to cool in air. Any excess glue was removed from the 
edges with care taken not to affect the integrity of the coating. The specimen 
assembly was placed in the grips of the tensile tester (Lo-Cap 2000, Tinius Olsen, 
UK) ensuring the long axis of the assembly coincides with the direction of the load. 
A tensile load was applied to each assembly at a cross head speed of 0.25 cm/min. 
The maximum load applied was recorded and the failing stress in MPa of adhesive 
bond area was determined.  
 
2.3.5 Bioactivity Study in Stimulated Body Fluid  
Simulated body fluid (SBF) was prepared according to Ohtsuki et al. (Ohtsuki et al., 
1991). The different agents were added in the exact sequence as listed in Table 2.2 
and the pH was adjusted to 7.4 at 25 ºC. Samples were added to 20 ml SBF with the 
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coated side down as outlined by Kokubo et al. (Kokubo et al., 2006). Samples were 
incubated at 37 ºC. The incubation time periods were 1, 3, 7, 14 and 30 days. At each 
time point, the sample was removed from the SBF and rinsed with deionised water 
and dried in a desiccator overnight. Samples were analysed for chemical 
composition, coating mass, XRD, FTIR, SEM and adhesion testing.  
 
Table 2.2: Reagents for preparation of SBF (pH 7.4, 37 °C, 1l). 
Order Reagent Amount 
1 NaCl 7.996 g 
2 NaHCO3 0.350 g 
3 KCl 0.224 g 
4 K2HPO4・3H2O 0.228 g 
5 MgCl2・6H2O 0.305 g 
6 1 M HCl 40 ml 
7 CaCl2 0.278 g 
8 Na2SO4 0.071 g 
9 (CH2OH)3CNH2 6.057 g 
10 1 M HCl pH adjusted to 7.4 
 
2.4 In Vitro Cell Culture Assessment 
Prior to cell culture analysis, each sample set was steam autoclaved at 121 C for 20 
minutes. MG-63 cells derived from an osteosarcoma of a 14-year-old male were 
used to assess cell viability. Cells were cultured in the MEM media supplemented 
with 10% foetal calf serum and antibiotic/antimycotic (penicillin G sodium 100 
U/ml, streptomycin 100 μg/ml, amphotericin B 0.25 μg/ml) in 75 cm3 tissue culture 
flasks. Cells were maintained in a humidified atmosphere with 5% CO2 at 37 °C and 
were sub-cultured when they reached confluence using 0.25% Trypsin EDTA 
solution to provide adequate numbers of cells for the various in vitro culture studies 
undertaken. 
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2.4.1 Cell Viability 
MG-63 cell attachment to the various treated and untreated Ti substrates was 
determined after 4 hours in culture using a commercial MTT assay and employing a 
modified Mosmann method (Mosmann, 1983). Cells were seeded onto the samples 
at a concentration of 1x105 cells/cm2and allowed to adhere during incubation at 37 
C in 5% CO2 for 4 hours. The MTT assay reagent was prepared as a 5 mg/ml stock 
solution in PBS, sterilised by filtration, and stored in the dark. An aliquot of the 
MTT stock solution (10% of total volume) was added to each well of a six well plate 
containing the samples. After 3 hour incubation at 37 °C in 5% CO2, 200 μl of 
dimethyl sulphoxide was added to dissolve the formazan crystals. The solution was 
agitated for 15 minutes on a shaker to ensure adequate dissolution. The optical 
density of the formazan solutions was read by spectrophotometry using an ELISA 
plate reader (Tecan Sunrise, Tecan Austria) at 570 nm with the background 
absorbance value measured at 650 nm. The absorbance values recorded were 
determined to be proportional to the number of cells attached to the surface in each 
case. All data reported are expressed as mean ± standard deviation (SD). Sample 
numbers between 3-5 were used. 
 
2.4.2 Cell Morphology 
MG-63 cells were seeded onto each of the above substrates at a cell density of 5 x105 
cells/cm2 in 6-well plates and were incubated for 24 hours. After cell culture, the 
samples were gently rinsed with PBS to remove any unattached cells and fixed in a 
modified Karnovsky’s fixative (2% paraformaldehyde/ 2% glutaraldehyde in PBS) 
for 1 hour. The samples were then rinsed in PBS and post-fixed in 1% osmium 
tetroxide and rinsed three times with PBS. The specimens were dehydrated by 
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rinsing in an alcohol series (20, 30, 50, 70, 80, 90 and 95% ethanol), and finally 
rinsing 3 times in 100% ethanol. The samples were then were chemically dried in 
hexamethyldisilizane (HMDS) overnight. A 50 nm layer of gold-palladium was 
deposited onto the substrates using a Polaron E5000 SEM Sputter Coating Unit. The 
sputtering conditions used included a set voltage of 1.4 kV, with a plasma current of 
18 mA (argon gas), a deposition time of 2 minutes at a vacuum pressure of 0.05 
Torr. The samples were then analysed using the Jeol JSM 5510 SEM and 
subsequently using a FEI Quanta 200 Focused Ion Beam and SEM in backscatter 
electron mode.  
 
2.5 Microbiology Assessment using S. aureus as the Bacterial 
Challenge 
This is divided into antimicrobial and anticolonising studies using S. aureus (ATCC 
1448) as the bacterial challenge.   
 
2.5.1 Antimicrobial Studies using S. aureus 
Antimicrobial testing consisted of two test methods. A modification of the ASTM 
standard E2149-01 protocol was used to determine the antibacterial effect of 
permanent, non-leaching surfaces (ASTM Standard, 2010; Murata, 2007). A second 
test also based on the E2149-01 standard was employed to assess the potential 
antimicrobial impact of eluted ions from the sample surfaces.  
 
Growth of the S. aureus challenge organism was achieved by the aseptic inoculation 
of a discrete colony from the surface of LB agar, into 30 ml of fresh LB liquid media 
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and allowed to grow overnight at 37 oC in a shaking incubator at 180 rpm, to provide 
adequate oxygenation for abundant cell growth. Typically, overnight cultures 
achieved a cell density of 108-109 CFU/ml, which was subsequently diluted with 
sterile PBS buffer to provide a standardised microbial challenge load of 
approximately 1 x 106 CFU/ml. 
 
2.5.1.1 Antimicrobial Activity of the Surface Ion using S. aureus 
The activity of the coatings was performed on coupons following deposition (air-
cleaned) and also on coupons following 30-day incubation in PBS buffer (pH 7.4, 37 
ºC and 150 rpm). Coupons for assessment were sterilised by immersion in 70% 
ethanol and allowed to dry at a 45o angle in sterile 12 well titre plates in a LAF hood. 
Once dry, 2 ml aliquots of the microbial suspension containing 1 x 106 CFU/ml were 
added to each coupon containing well and the plates incubated at 37 oC in a shaking 
incubator at 200 rpm for 1 hour.  
 
2.5.1.2 Antimicrobial Activity of the Released Ion using S. aureus 
Coupons for assessment via the leach test were sterilised as previously described and 
2 ml of freshly prepared, sterile PBS (pH 7.4) added to each coupon containing well 
to provide a medium for ion release. Plates were subsequently placed in a shaking 
incubator (150 rpm) at 37 oC for the required length of the trial period, (1, 8 and 16 
days). The test volume of 2 ml was maintained during extended trial periods by 
making appropriate additions of PBS during the incubation period. At the end of the 
test period PBS containing leached ions was aseptically removed from each well. In 
a clean, sterile 12 well plate, 0.5 ml of the microbial challenge (2 x 106 CFU/ml) was 
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mixed with 0.5 ml of respective leachate and the plates incubated at 37 oC, shaking 
at 150 rpm for a period of 1 hour. 
 
2.5.1.3 Quantification of Antimicrobial Impacts 
0.1 ml of each test sample (from leach and non leach test) was aseptically transferred 
to a 1.5 ml microcentrifuge tube containing 0.9 ml of sterile PBS to achieve a 10-1 
dilution. For each sample coating, tests were conducted in triplicate. Each 1 ml 
solution was vortexed for 5 seconds to achieve thorough mixing and 0.1 ml was 
again transferred to a fresh 0.9 ml of PBS and thoroughly mixed to provide a 10-2 
dilution. The serial dilution procedure above was repeated to produce 10-3 and 10-4 
dilutions. To enumerate the microbial content of a sample, sterile, solid LB agar 
plates were divided into four quadrants i.e. 10-1-10-4. Subsequently 3 discrete 10 μl 
drops from a single dilution sample were added within the respective quadrant. Once 
dot plating of dilutions 10-1 to 10-4 had been conducted the drops were allowed to 
diffuse into the media by air drying in the fume hood. Dried plates were 
subsequently incubated overnight (in an inverted position) in a 37 oC incubator for a 
maximum period of 14 hours. Colonies present on the plates were enumerated and 
used to calculate the potential antimicrobial impact of the apatite coating and leached 
ion by comparison with control samples (HA coating). The results are presented as 
% kill (Eq 2.1) (CFU data are presented in Appendix II and III). 
100% x
CFU
CFUCFU
Kill
HA
SampleHA        (Eq 2.1) 
 
 
 
Chapter 2: General Materials and Methods 
 
Page | 67  
 
2.5.2 Anticolonising Studies using S. aureus 
To investigate the potential anticolonising efficacy of the respective sample coatings, 
a quantitative assessment of biofilm formation was carried out at various points over 
a 14 day period. The approach used was based upon the previously reported method 
of Chae and Schraft (Chae and Schraft, 2000).  
 
S. auerus cultivation and coupon sterilisation was carried out as previously 
described. To facilitate bacterial attachment and biofilm initiation, 100 μl of 
undiluted S. aureus culture (108-109 CFU/ml) was aseptically spotted onto the 
surface of each sample coupon in discrete wells. Plates were then incubated at 37 oC 
for 3 hours without shaking. Post incubation, coupons were gently rinsed with 10 ml 
sterile PBS in the laminar air flow hood to remove planktonic cells, before being 
placed in plate wells containing 2 ml of sterile LB media, with the coating surface 
facing upward. After 24 hours, and at 48 hour intervals thereafter, coupons were 
aseptically removed from plates, rinsed with 10 ml of sterile PBS and placed in fresh 
plate wells again with 2 ml LB media. At time points 1, 7 and 14 days, coupons were 
aseptically removed from wells and rinsed with 10 ml of sterile PBS to wash off 
planktonic cells. Attached organisms were then collected by swabbing the coupon 
surface 100 times with a sterile cotton bud, which was subsequently placed in 2 ml 
of sterile PBS and vortexed vigorously for 10 seconds to remove collected cells. 
Serial dilutions (10-1-10-4) of the microbial colonies of the test samples were 
prepared and dot plating procedure performed, as previously described. Enumeration 
of resultant colony growth associated with the respective coating surfaces, relative to 
the HA experimental control, were used to determine the % biofilm inhibition of the 
apatite coatings (CFU data are presented in Appendix II and III).  
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100% x
CFU
CFUCFU
InhibitionBiofilm
HA
SampleHA   (Eq 2.2) 
 
 
2.5.3 Fluorescence Microscopy and Biofilm Staining Studies  
A qualitative approach based on acridine orange staining and fluorescence 
microscopy (Leica DM300 microscope with Leica EL6000 fluorescent light source, 
Leica Microsystems, Germany) imaging of coupon associated biofilms was also 
performed. The imaging approach sought to establish the validity of the quantitative 
data generated and to provide in situ visualisation of the impact of apatite coating on 
biofilm formation by S. aureus. Sample preparation involved the removal of 
respective coupons after 1, 7 and 14 days incubation in LB and rinsing with 10 ml of 
sterile PBS. Coupons were subjected to drying and heat fixing of biofilm in an oven 
at 105 oC for 3 minutes. A staining solution of acridine orange dye was prepared by 
dissolving 2 mg/ml of the dye in deionised water. A 1:100 dilution in de-ionised 
water was then performed and the resulting 20 μg/ml working solution was sterilised 
by passage through a 0.45 μm syringe filter. Two millilitres of the 20 μg/ml acridine 
orange stain was added to plate wells containing the heat fixed coupons, and 
incubated at room temperature in the dark for 5 minutes to allow nucleic acid and 
stain interactions sufficient time to occur. Coupons were subsequently removed from 
the solution and rinsed with sterile PBS, air dried and stored in the dark at room 
temperature.  
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2.6 Microbiology Assessment using Clinical Isolates as the Bacterial 
Challenge 
 
Similar methods to Section 2.5 were used. However, in this study clinical isolate 
organisms MRSA (BH1CC), MSSA (BH48) and S. epidermis (BH1457) are the 
bacterial challenges and different recovery methods were used. 
 
2.6.1 Antimicrobial Studies using Clinical Isolates 
The antimicrobial behaviour of the samples was assessed using a modified ASTM 
standard E2149-01 protocol, which was used to determine the antibacterial effect of 
the released ions from the sample surfaces (ASTM Standard, 2010). A second test 
also based on this ASTM standard was used to assess the activity of antimicrobial 
agents immobilised on the surfaces. The modified methods have been detailed 
previously (O’Sullivan et al., 2010).    
 
Standard overnight cultures of the clinical isolate organisms MRSA (BH1CC), MSSA 
(BH48) and S. epidermis (BH1457) were prepared in 30 ml of fresh BHI broth and 
allowed to grow overnight at 37 °C in a shaking incubator at 150 rpm when typical 
cell density values of 108–109 CFU/ml in BHI broth were reached. The cultures were 
subsequently diluted with an appropriate volume of sterile PBS buffer to provide a 
standardised microbial challenge load of approximately 1x106 CFU/ml.  
 
Coated coupons were sterilised using 70% ethanol and were then placed in 2 ml 
sterile PBS in a 12-well plate and incubated for 7, 14 or 30 days (pH 7.4, 150 rpm, 
37 °C). The test volume of 2 ml was maintained during extended trial periods by 
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making appropriate additions of PBS during the incubation period. At the end of the 
test period, PBS containing leached ions (leachate) was aseptically removed from 
each well. In a clean, sterile 12-well plate, 0.5 ml of the microbial challenge was 
mixed with 0.5 ml of respective leachate and the plates were incubated at 37 °C, 
followed by agitation at 150 rpm for a period of 1 hour (n=3) to assess the efficacy 
of the leachate at each timepoint. The amount of viable bacterial cells present in the 
above test samples were quantified using a standard dot plate counting of serial 
culture dilutions on BHI agar (O’Sullivan et al., 2010). The results were presented as 
% kill determined from Eq 2.1. 
 
The antimicrobial activity of the immobilised ion on the coating surface was 
assessed before (day 0) and after an incubation period of 7, 14 or 30 days in 2 ml 
PBS. The coated coupons were removed from the PBS at each time point and 
sterilised using 70% ethanol. Once dried the coupons were challenged by incubation 
with 2 ml aliquots of the clinical isolate suspension containing approximately 1 x106 
CFU/ml for 1 hour (37 °C, 150 rpm, n=3). The dot plating procedure of the serial 
dilutions on BHI agar was performed to quantify the number of living cells present 
in the samples (O’Sullivan et al., 2010). The results were presented as % kill (Eq 
2.1). 
 
2.6.2 Anticolonising Studies using Clinical Isolates 
Further anticolonising tests were performed using the clinical isolates MRSA, MSSA 
and S. epidermis in BHI broth to investigate the potential to inhibit biofilm growth 
on the sample surface. The same anticolonising test procedure was performed as 
described earlier with similar wash procedures adhered to. However, a simpler 
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ultrasonic method was used in this case to collect the attached bacterial cells from 
the coupon surface. After incubation in BHI broth at day 1, 7, 14 and 30 days, the 
coupons were removed and washed with 10 ml sterile PBS. The washed coupons 
were then placed in a sterile vial containing 5 ml PBS and ultrasonicated for 10 
minutes. Enumeration of the attached bacterial cells was again conducted using serial 
dilutions (101 to 104) of the microbial colonies and the dot plating procedure. Data 
was presented as % biofilm inhibition for each of the apatite coatings with respect to 
the HA control (Eq 2.2).  
 
2.7 In Vivo Assessment 
The in vivo model and analysis in this study was based on previous studies (Adams 
et al., 2008, Antoci et al., 2008; Van Wijngaerden et al., 1999). The species chosen 
for the in vivo study were nude mice. Four coated Ti (V) K-wires (0.8 mm x 8 mm 
dimensions) were surgically implanted subcutaneously into each mouse with 12 mice 
studied per material type. An inoculum of bacteria was introduced and the mice were 
sacrificed after 2 days. The implants were removed and the % biofilm inhibition was 
determined. SEM analysis was performed on the K-wires post incubation for 
presence of bacteria colonisation (1 implant from each mouse). Blood samples were 
collected to indicate possible systemic infection and the presence of key 
inflammatory markers.  
 
2.7.1 Bacterial Challenge 
S. aureus ATCC 1448 was cultivated in 5 ml of tryptone soya broth (TSB) 
supplemented with dextrose (1.5%) and incubated with agitation (250 rpm) at 37C 
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for 16 hours. Bacterial cells were harvested by centrifugation (1200 rpm for 4 
minutes), washed once and re-suspended in sterile saline. The suspension was 
diluted to a concentration of 1.5 x 108 CFU/ml as determined by adjusting the 
suspension to 0.5 McFarland using a densitometer. After further adjusting the 
suspension to 4 x 107 CFU, ten-fold serial dilutions were made to obtain a 
suspension containing approximately 4 x 105 CFU/ml of S. aureus, prior to 
inoculation of 250 µl into the host.  
 
Each nude mouse (approximately 22 g) was anesthetised through inhalation of 
nitrous oxide, oxygen and isofluorane in a closed tank. The sterilised catheter needle 
(loaded with the coated implants) pieced a hole in the back of the mouse and was 
used to create a channel subcutaneously to all four limbs. The implants were 
deployed at the intended site using a wire through the needle. Through the same 
point of entry 250 µl of 4 x 105 CFU/ml inoculum was introduced. Upon exiting 
cyanoacrylate (vetbond) was used to seal the incision. Each mouse was placed back 
in containment and the procedure was repeated for the remaining mice. One coating 
type was used per mouse and the coating type was assigned to each mouse by 
random sampling. 
 
After two days of husbandry, the mice were euthanised by placing each animal in a 
closed tank containing CO2. Cardiac puncture was performed to obtain blood 
samples for blood culture and free radical analysis. Two 1 ml aliquots of whole 
blood were collected in a sterile tube containing EDTA as an anticoagulant.  
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2.7.2 Anticolonising Activity 
To estimate the number of non-attached bacteria, each retrieved implant was rolled 
onto a Columbia blood agar plate, incubated at 37ºC for 24 to 48 hours and colonies 
counted. To quantify adherent bacteria, the K-wire was transferred into 2 ml of TSB, 
sonicated for 7 minutes, and vortexed for 3 minutes. One hundred microlitres of this 
solution was plated on tryptone soya agar (TSA), incubated at 37 ºC for 24 to 48 
hours and colonies counted. Ten-fold serial dilutions were made and plated on TSA, 
incubated as above, and colonies counted (Adams et al., 2008, Antoci et al., 2008). 
The CFU data from the diluted samples was used to determine the % biofilm 
inhibition. The % biofilm inhibition was determined for 5% wt and 12% wt AgA 
relative to the HA control. It was noted that some samples following explantation did 
not show CFU on the agar plates on which the samples were rolled. This suggests 
that the inoculum did not reach the biomaterial’s surface resulting in successful 
colonisation. To avoid discrepancies in the results, samples that showed <100 CFU 
on the rolled agar plate were omitted from the results. SEM images were taken of the 
samples to investigate bacteria attachment. Samples were prepared using the fixation 
method as outlined in Section 2.4.2.  
 
2.7.3 Blood Cultures 
Quantitative whole-blood culture was performed using a pour plate method 
described previously by Wain et al. (Wain et al., 1998). Briefly, a 1 ml aliquot of 
blood was mixed with 19 ml of molten (50 °C) Columbia agar in a sterile Petri dish, 
allowed to set, and then incubated at 37 °C. Colonies were enumerated after 2 to 4 
days and expressed as CFU/ml.  
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2.7.4 Chemiluminesence Test 
Initially, reagents pholasin (10 mg/l), adjuvant K, formyl-methionyl-leucyl-
phenylalanine (fMLP) (10 μmol/l) and phorbol 12-myristate 13-acetate (PMA) (10 
μmol/l) were reconstituted as recommended by the manufacturers’ instructions and 
added to appropriate wells of a white 96 well plate (n=4). Whole blood samples were 
diluted 100 fold in blood dilution buffer to give a concentration of 1.6x107cells/ml. 
Approximately 10 μl of the cell suspension was added to each well, incubated at 37 
oC for 40 minutes, throughout which chemiluminescence was measured using a 
luminometric plate reader (FLUOstar OPTIMA, BMG LABTECH, UK), after which 
fMLP was added to each well by automated injector to stimulate activation of the 
leukocyte surface. Following that peak in activation, PMA was injected (70 minutes) 
to stimulate extracellular leukocyte degranulation. Controls were included, which 
consisted of identical incubations as described previously in the absence of material, 
to deduce the amount of cell activation inherent in the assay materials and 
procedures. In addition, incubations in the absence of both cells and material were 
performed to confirm the absence of background luminescence from pholasin and 
verified that increases in the observed chemiluminescence were a function of the 
excitement of pholasin by leukocyte secreted ROS. 
 
2.8 Statistical Analysis 
In Chapters 3-7, statistical analysis was performed using IBM SPSS 19 software. 
For two group comparison, a 2 sample independent t-test was performed whereas a 
statistical one way analysis of variance (ANOVA) was performed on three or more 
groups to determine statistical differences between samples (p<0.05). Post-hoc 
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analysis used included Dunnett’s test and Tukey honest significant difference (HSD) 
test. In Chapter 6, equivalent non parametric tests were conducted. Non parametric 
tests performed included Mann-Whitney U test for two group comparisons (p values 
<0.05 was significant) and Kruskal-Wallis test was conducted for three or more 
group comparisons. Where a significant difference of p<0.05 was obtained (Kruskal-
Wallis test), Dunn’s test was performed. Details of statistical analysis performed and 
significant levels identified are given in each chapter. 
 
2.9 Other Analysis 
In Chapter 3, various powders were analysed for chemical and elemental analysis as 
described above. In addition, particle size analysis was performed using a laser light 
technique (Mastersizer S, UK). 
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Chapter 3 
3.0 Physicochemical and Biological Characterisation of 
CoBlast HA Surface  
Results and discussions published in Coatings (2011), 1(1): 53-71. 
Abstract:  
Hydroxyapatite (HA) coating of hard tissue implants is widely employed for its 
biocompatible and osteoconductive properties as well as its improved mechanical 
properties. Plasma technology is the principal deposition process for coating HA on 
bioactive metals for this application. However, thermal decomposition of HA can 
occur during the plasma deposition process, resulting in coating variability in terms 
of purity, uniformity and crystallinity, which can lead to implant failure caused by 
aseptic loosening. In this study, CoBlast, a novel blasting process has been used to 
successfully modify a titanium (Ti) (V) substrate with a HA treatment using a 
dopant/abrasive regime. The impact of a series of apatitic abrasives under the trade 
name MCD, was investigated to determine the effect of abrasive particle size on the 
surface properties of both microblast (abrasive only) and CoBlast (HA/abrasive) 
treatments. The resultant HA treated substrates were compared to substrates treated 
with abrasive only (microblast) and an untreated Ti. The HA powder, apatitic 
abrasives and the treated substrates were characterised for chemical composition, 
coating coverage, crystallinity and topography including surface roughness. The 
results show that the surface roughness of the HA blasted modification was affected 
by the particle size of the apatitic abrasives used. The CoBlast process did not alter 
the chemistry of the crystalline HA during deposition. Cell proliferation on the HA 
surface was also assessed, which demonstrated enhanced osteoblast cell viability 
compared to the microblast and blank Ti. This study demonstrates the ability of the 
CoBlast process to deposit HA coatings with a range of surface properties onto Ti 
substrates. The ability of the CoBlast technology to offer diversity in modifying 
surface topography offers exciting new prospects in tailoring the properties of 
medical devices for applications ranging from dental to orthopaedic settings.  
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3.1 Introduction 
HA, a proven bioceramic for coating medical device implants is widely known, not 
only for its biocompatible and osteoconductive properties, but also for its increased 
mechanical properties when applied to bioinert metals for orthopaedic use, as 
previously mentioned in Chapter 1 (Borsari et al., 2005; Oh et al., 2005; Stoch et 
al., 2005; Lu et al., 2004). Implant surface modifications are often required in order 
to prescribe a particular surface roughness and increase surface area for osteoblast 
attachment, as well as to enhance the bioactive and osteoconductive properties of the 
underlying substrate. Such surface treatment methods include sand- or grit-blasting 
using abrasives, chemical treatments and deposition of calcium phosphate (CaP) 
coatings (Gil et al., 2007; Nakada et al., 2007; Stoch et al., 2005; Oh et al., 2005; 
Stoch et al., 2001; Lu et al., 2004; Abron et al., 2001; Wennerberg et al., 1997). 
 
Abrasive blasting involves impacting the implant metal surface with abrasive 
particles under pressure to roughen the surface. Roughening orthopaedic and dental 
implants utilising alumina (Al2O3) abrasives is a common practice to enhance 
implant osteointegration in vivo (Abron et al., 2001; Wennerberg et al., 1997). 
However, the use of apatite abrasives are often preferred as it enhances bone 
formation (Nakada et al., 2007; Mano et al., 2002). It has been shown that this 
technique can be effective in depositing a thin layer of CaP on the surface being 
roughened (Mano et al., 2002; Ishikawa et al., 1997). A number of other HA coating 
deposition techniques have been employed to confer a bioactive layer onto metallic 
and other inert substrates including plasma spraying, which is one of the most 
common types of coating process for the generation of CaP thin films (Li et al., 
Chapter 3: Physicochemical and Biological Characterisation of CoBlast HA Surface  
 
Page | 78  
 
2009; Heimann and Wirth, 2006; Oh et al., 2005; Lu et al., 2004; Gross and Berndt, 
1998; Gross et al., 1998; Weng et al., 1997; Chen et al., 1994). Other deposition 
techniques include PLD, RF magnetron sputtering, sol-gel immersion and 
electrophoresis as summarised in Table 1.3. However, there are a number of 
problems associated with these deposition techniques as outlined in Section 1.6 
(expensive, time consuming, crystallinity, reproducibility etc.).  
 
More recently, a novel approach using the blasting technique CoBlast has been 
shown to deposit HA and substituted apatites onto Ti substrates (O’Hare et al., 2010; 
O’Sullivan et al., 2010; O’Neill et al., 2009). The CoBlast technique is based on the 
convergent flow of an abrasive and a dopant stream onto the implant surface which 
can effectively impregnate the metal with the dopant material (Section 1.6.1). HA 
coatings prepared using the CoBlast technique demonstrated enhanced osteoblast 
attachment in vitro and early stage lamellar bone growth in vivo compared to 
microblast and untreated Ti surfaces (O’Hare et al., 2010). The established research 
showed that less than 10 m thick coatings were applied with this technique 
employing alumina as the abrasive and that there was no evidence of alumina being 
incorporated into the modified surface (O’Hare et al., 2010). Previous studies using 
the CoBlast technique used slightly different processing conditions. 
 
In this study, a series of apatitic abrasives (sintered CaP) under the trade name MCD, 
were used in both the microblast and the CoBlast (dopant/abrasive regime) 
techniques to modify Ti surfaces. These MCD abrasives included MCD-106, MCD-
180 and MCD-425 which corresponds to the grade of MCD with d(90) particle size 
values of 106, 180 and 425 microns respectively. The controls used included those 
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prepared with the abrasive only (microblast) roughening technique and also an 
untreated Ti substrate (blank Ti). Chemical composition and coating coverage of 
these substrates were examined with a view to determining the effect of abrasive 
particle size on the properties of the modified surfaces. The osteoblast cell viability 
was assessed using MG-63 cells on surfaces modified using the CoBlast and 
microblast surface modification approaches and also on a blank Ti sample. 
 
3.2 Materials and Methods 
Materials and methods used for work carried out in this chapter are outlined in 
Chapter 2. The various powders (HA, MCD-106, MCD-180 and MCD-425) used in 
this section were characterised for median particle size using laser light technique 
(n=3 samples), elemental and chemical composition (EDX and FTIR) and 
crystallinity (powder X-ray diffraction (PXRD)). HA coatings were deposited onto 
Ti substrates using MCD apatitic abrasives of various particle size and the modified 
surfaces were subsequently analysed for elemental and chemical composition (EDX, 
FTIR), crystallinity (XRD), surface morphology (SEM), surface roughness (Taylor 
Hobson profilometer (n=3 samples)), coating thickness (PosiTector thickness gauge 
(n=3 samples), coating mass (gravimetric analysis before and after acid etching the 
surface (n=3 samples)). Sample modifications prepared using CoBlast HA/MCD-106 
and microblast MCD-106 and the blank Ti were evaluated for cytotoxicity and 
osteoconductivity using cell culture analysis at days 1 and 5 (MTT assay (n=4 
samples)) and SEM image analysis of the cultured cells on HA surfaces.  
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Statistical analysis was performed on the surface roughness and the MTT data. One 
way analysis of variance (ANOVA) was performed to determine if significant 
differences existed between samples (p<0.05). Where a significant difference was 
obtained, multiple comparisons of surface response were performed using Tukey’s 
post-hoc analysis (surface roughness (Ra)) and Dunnett’s test in the case of samples 
compared to the HA control (MTT assay). Significant levels of p<0.05 and 0.001 
were observed for statistical analysis using the Tukey's post-hoc analysis. 
 
3.3 Results  
3.3.1 Chemical Characterisation of HA and MCD Abrasive Powders 
The particle size of the HA and MCD abrasives were measured using a laser light 
technique (Mastersizer S), Table 3.1.  
 
Table 3.1: Median particle size analysis and EDX analysis of the powders (n=3 
samples). Median particle size values are reported as ±2 x standard deviations (2SD). 
Powder Median particle 
size (m) 
O 
% atm 
 
P 
% atm 
 
Ca 
% atm 
 
Ca/P 
ratio 
 
HA 40 (±8) 
 
71 
 
11 
 
18 
 
1.66 
MCD-106 44 (±4) 
 
72 
 
10 
 
18 
 
1.76 
MCD-180 124 (±12) 
 
73 
 
10 
 
17 
 
1.73 
MCD-425 355 (±12) 
 
77 
 
10 
 
13 
 
1.29 
 
The median particle size (d(0.5)) increased in the following order: HA<MCD-
106<MCD-180<MCD-425. The various powders were analysed for their chemical 
composition using energy dispersive X-ray (EDX) analysis, Table 3.1. The calcium 
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phosphate powders (HA and MCD abrasives) were found to be composed of oxygen 
(O), phosphorous (P) and calcium (Ca). The Ca/P ratio for stoichiometric HA was 
found to be similar to the previously reported value of 1.67 (Kim et al., 1998). The 
increase in Ca/P ratio for MCD-106 and MCD-180 as seen in Table 3.1, suggests the 
presence of impurities. However, the Ca deficient nature for MCD-425 results in a 
reduced Ca/P ratio (1.29). 
 
Relative crystallinity of each powder was investigated using PXRD, (Figure 3.1). 
HA was found to be highly crystalline with well defined narrow peaks. The main 
characteristic peaks associated with HA can be assigned to the 002, 102, 210, 211, 
112, 300 and 202 reflections corresponding to 25.9, 28.1, 28.9, 31.9, 32.2, 33.1 
and 34.1, as previously reported (Kim et al., 1998). 
 
 
Figure 3.1: PXRD spectra of the powders (■ denotes HA peaks and * represents 
TCP). 
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The resulting PXRD patterns for the MCD apatite series indicate a lower crystallinity 
relative to the HA powder. A small peak present at 31.0 and 34.4 was attributed to 
the TCP phase (Fathi et al., 2008). Also in the MCD-425 pattern, peaks are poorly 
resolved with low intensity relative to the other apatites, demonstrating the more 
amorphous nature of this material (Fathi et al., 2008; Kim et al., 1998).  
 
The Fourier transform infrared spectrometer (FTIR) spectra of the powders in the 
range 1600-450 cm-1 are presented in Figure 3.2. The most intense peaks observed 
for the crystalline HA powder are those attributable to vibrations of the PO43- groups; 
the ν1 and ν3 phosphate bands in the region of 900-1200 cm-1 and ν4 absorption bands 
in the region of 500-700 cm-1, which are used to characterise apatite structure. The 
peak at 962 cm-1 is assigned to the ν1 symmetric P-O stretching vibration of the PO43- 
and the ν3 asymmetric P-O stretching mode are indexed at 1090 and 1045 cm-1. The 
bands at 601 and 571 cm-1 are assigned to ν4 vibration mode of the phosphate group, 
which occupies two crystal lattice sites (O-P-O bending mode) according to previous 
studies (Varma and Babu, 2005). The HA adsorption bands of the ν1 and ν4 of the 
PO43- groups determined here are those of stoichiometric HA (Hong et al., 2007). 
The bands at 631 and 474 cm-1 correspond to the vibrations of OH- groups in the 
structure (Varma and Babu, 2005). The MCD series showed similar finger-print 
bonds for calcium phosphate bonds but with broader definition, which is 
representative of the increased amorphous content of these CaP materials (Pleshko et 
al., 1991).  
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Figure 3.2: FTIR spectra of the various apatite powders. 
 
3.3.2 Characterisation of the Modified Titanium Substrates 
Ti (V) was used as the base substrate and the untreated Ti surface was determined to 
contain 23% O and 77% Ti using EDX analysis. The chemical composition of the 
microblast surfaces (abrasive blast only, no dopant) are presented in Table 3.2 and 
were analysed for O, Ca, P and Ti only.  
 
The % atm Ti determined reflects the exposure of the underlying substrate and can 
be used to represent the degree of coverage resulting from apatite materials. A high 
Ti level represents a thin or patchy coating and conversely, a low Ti concentration 
signifies a thicker coating. The EDX results reveal that after a wash treatment, the 
MCD microblast surfaces show a reduction in Ti concentrations to 21-27% atm, and 
the presence of Ca and P which are the main constituents of the MCD abrasive. This 
illustrates that a thin coating of Ca/P material has been blasted onto the surface and 
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successfully deposited as a stable layer onto the Ti surface. The Ca/P values obtained 
for the microblast samples treated with the MCD series of the abrasives ranged 
between 1.53 and 1.57 which is consistent with similar grit blasted studies (Mano et 
al., 2002).  
 
Table 3.2: EDX analysis, coating thickness (PosiTector thickness gauge) and 
coating mass of the modified surfaces (n=3 samples). 
Modification Identification O 
% 
atm 
 
P 
% 
atm 
 
Ca 
% 
atm 
 
Ti 
% 
atm 
 
Ca/P Coating 
Thickness 
(µm) 
(±2SD) 
Coating 
Mass 
(mg/cm2) 
(±2SD) 
Blank Ti 23 
 
- 
 
- 
 
77 
 
- 0 - 
Microblast MCD-106 59 
 
8 
 
12 
 
21 
 
1.56 3±1 - 
 MCD-180 56 
 
6 
 
10 
 
27 
 
1.53 3±1 - 
 MCD-425 55 
 
7 
 
11 
 
27 
 
1.57 3±2 - 
CoBlast HA/MCD-106 63 
 
13 
 
21 
 
2 
 
1.59 
 
6±3 0.48±0.4 
 
 HA/MCD-180 67 
 
12 
 
18 
 
3 
 
1.53 
 
6±1 0.44±0.4 
 HA/MCD-425 65 
 
12 
 
20 
 
5 
 
1.61 
 
7±3 0.44±0.3 
 
The chemical composition of the CoBlast surfaces (blasting with both abrasive and 
dopant) on Ti are also presented in Table 3.2. For CoBlast coatings, the levels of O, 
P, Ca and Ti obtained were determined to be in the range of 63-67%, 12-13%, 18-
21% and 2-5% atm, respectively. The reduced level of Ti detected in these samples, 
compared to the Ti substrate and microblast surfaces, is indicative of a high degree 
of coating coverage across all CoBlast samples. The Ca/P values were found to 
display a ratio of between 1.53 and 1.61, which are relatively close to the value for 
stoichiometric HA (Kim et al., 1998). The % atm Ti, determined using EDX 
analysis, was observed to increase as the MCD series particle size order increased, 
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indicating a decrease in the thickness of the deposited layer, as outlined in Table 3.2. 
This suggests that the smaller the particle size of the MCD abrasive the more HA 
was deposited, although the coating thickness determined using the PosiTector 
thickness gauge, and the coating mass values were found to be similar. The coating 
thickness of all the CoBlast samples was <10 microns which is in agreement with a 
previous study which used Al2O3 as the abrasive (O’Neill et al., 2009).  
 
The SEM image of the untreated Ti substrate can be seen in Figure 3.3 (a) which has 
similar topography to that observed in a previous study (Abron et al., 2001). This 
image reveals a very smooth surface and the morphology of a machined metal. The 
SEM images of the microblast MCD-106 surfaces, as well as the corresponding 
CoBlast HA/MCD-106 surfaces, are presented in Figure 3.3 (b) and (c), respectively 
(More images can be seen as supporting information in Appendix I). As expected, 
the microblast process was observed to roughen the untreated Ti surface. 
Examination of the CoBlast surfaces suggests that the co-introduction of the HA 
with the abrasive appears to have in-filled some of the surface features that are 
evident on the microblast surface and also shows the presence of coarser deposits. 
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(a) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) 
   
Figure 3.3: SEM images (x1000 magnification): (a) untreated titanium; (b) 
microblast MCD-106; (c) CoBlast HA/MCD-106. 
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The surface roughness was measured using a stylus method and the results obtained 
are given in Figure 3.4. The arithmetical mean roughness (Ra) was used as a measure 
of the surface roughness, which tended to increase as the particle size of the abrasive 
increased. Significant differences were observed between the surface treated and the 
untreated Ti. The average surface roughness of the blank Ti (0.4 µm) increased to 
0.5, 0.8, 1.4 µm when MCD-106, MCD-180 and MCD-425, respectively were 
employed for microblast treatments. It has been previously reported that an increase 
in surface roughness was observed with the introduction of HA with the Al2O3 
abrasive using the CoBlast technique and the same trend was observed here on the 
introduction of HA with the MCD abrasives (O’Hare et al., 2010).  
 
Statistical significant differences were noted between all samples analysed (p<0.05) 
using one way ANOVA and multiple comparisons between all samples were 
analysed using Tukey’s post-hoc test. All treatments were observed to be 
significantly rougher compared to untreated Ti with the exception of the microblast 
surface using MCD-106. Microblast treatment prepared using MCD-425 was found 
to be statistically rougher compared to all microblast surfaces examined in addition 
to the blank Ti (p<0.001). The introduction of HA to MCD-425 resulted in a 
significant increase in surface roughness compared to all surfaces analysed (p 
<0.001) with the exception of the microblast treatment using the same abrasive 
(MCD-425). There were statistically differences between the CoBlast HA surfaces 
using abrasives MCD-106 and MCD-180.  
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Figure 3.4: Surface roughness (Ra) of the various modifications (n=3 samples 
±2SD). Statistical significance was determined using Tukey’s post-hoc analysis (* 
denotes p <0.05 and ** ascribes p< 0.001 between the sample and the untreated Ti 
whereas * denotes p <0.05 and ** ascribes p<0.001 between the CoBlast samples 
indicated).  
 
Figure 3.5 shows the XRD pattern of the CoBlast HA coated substrates. Due to the 
thin nature of the deposited material and the interference of the background Ti metal, 
detailed analysis of the XRD profiles was not possible. However, for the CoBlast 
substrates, the peaks detected clearly correspond to that of HA powder employed. 
The additional 2θ peaks observed at 35.3 and 38.5 were assigned to the Ti 
substrate. No evidence of the TCP phase was detected (31.0 and 34.4), which 
suggests that no compositional or crystallographic changes occurred to the HA 
powder during the blasting process, with negligible uptake of the abrasive, which is 
in keeping with previous studies (O’Hare et al., 2010). 
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Figure 3.5: XRD of the CoBlast HA modifications (■ denotes HA peaks;*denotes 
Ti peaks). 
 
Figure 3.6 shows the FTIR spectrum in the range 1600-450 cm-1 for the HA coated 
substrates. The FTIR spectra for all CoBlast HA coatings irrespective of the abrasive 
used are very similar and display the characteristic features of the HA powder used, 
as discussed earlier. There was no evidence of hydration (broad banding at 3450 cm-
1), further demonstrating a pure HA coating has been deposited. Also, the position of 
the characteristic peak at 962 cm-1 represents a highly ordered, non-carbonated 
apatite and indicates a highly crystalline material (Hong et al., 2007). The banding 
assignments are in agreement with those of the HA powder as seen in Figure 3.2 
suggesting that the chemistry is retained during the deposition process. This also 
supports the XRD analysis discussed above, which suggests that there has been 
minimal uptake of the abrasive powders during sample preparation. 
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Figure 3.6: FTIR analysis of the CoBlast HA surface modifications. 
 
3.3.3 Cell Culture Analysis 
3.3.3.1 Cell Proliferation and Cytotoxicity 
Cytocompatibility of the modified surfaces was determined via an MTT assay and 
the osteoblast proliferation results are presented in Figure 3.7. Microblast and 
CoBlast surfaces prepared using the MCD-106 abrasive were selected for 
comparison. There was no significant difference in the cell viability between samples 
analysed at day 1. However, at day 5 a significant difference (p<0.05) between 
samples was noted using the one-way ANOVA. Comparison between groups at day 
5 using Dunnett’s test indicated that there was a significant difference between the 
CoBlast surface and both the blank Ti and the microblast surface (p<0.01) whereas 
the difference between the blank Ti and microblast surfaces was not significantly 
different (p>0.05). No evidence of cytotoxicity was observed using MG63 cells on 
any of the samples evaluated. 
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Figure 3.7: MTT assay data for MG-63 cells on modified Ti surfaces over 5 days in 
vitro (*ascribes statistical difference between the CoBlast (HA/MCD-106) surface 
and the blank Ti and the CoBlast (HA/MCD-106) and the microblast (MCD-106) 
surface at day 5 (p<0.01) determined using Dunnett’s test) (n=4 samples ±SD). 
 
3.3.3.2 Cell Morphology 
Figure 3.8 shows various images of MG63 cells that were cultured on the untreated 
Ti substrates (Figure 3.8 (a)), microblast MCD 106 surface (Figure 3.8 (b)) and 
CoBlast HA/MCD-106 (Figure 3.8 (c)) after 24 hours. Cells attached well to the 
untreated Ti surfaces and displayed a fibroblastic morphology synonymous with that 
of this osteoblastic cell line. The cells are typically polarised in one direction with 
the average cell length measuring roughly 76±30 μm (n=15) (Figure 3.8 (a)). 
Furthermore, lamellipodia and filopodia extensions (cytoskeletal organisation) from 
the main body of cells onto the surface are observed. The presence of these processes 
suggest good cell-substrate interactions where the cell is actively probing for specific 
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topographical features and connects the cell to the substrate (via filopodia) from the 
lamellipodia, which is the protrusion of their leading edge indicative of cell 
spreading and migration. However, the presence of numerous spherical cells 
indicates that not all cells are actively involved in spreading and migration. The cells 
cultured on microblast surface (Figure 3.8 (b)) display morphologies similar to that 
observed on the untreated Ti surfaces.  
 
Figure 3.8 (c) shows an image of MG-63 cells cultured on the CoBlast after 24 
hours, it can be seen that these differed from those of the untreated and microblast Ti 
in terms of morphology where they had a polygonal shape rather than a polarised 
fibroblastic morphology indicating increased cell spreading. The cells also tended to 
align to the surface features created by the addition of the bioactive layer, which was 
earlier observed to increase the surface roughness (Figure 3.4). An abundance of 
lamellipodia and filopodia were present on the CoBlast surface. The addition of a 
HA coat to the Ti surface, resulted in a higher order of cell spreading and cell focal 
adhesion attachment compared to the microblast surface (Figure 3.8 (b)).  
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(a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c)  
 
Figure 3.8: MG-63 osteoblasts cultured for 24 hours on (a) untreated Ti and (b) microblast 
MCD 106 treatment and (c) HA/MCD-106 surfaces (CoBlast treatment) (x 500 
magnification). 
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3.4 Discussion 
Implants with rougher surfaces result in a higher removal torque force and 
demonstrate excellent osteointegration when compared to those with smoother 
surfaces (Wennerberg et al., 1997). As seen in this study, microblasting offers 
increased roughening of machined Ti substrates as expected and the use of MCD 
abrasives results in the deposition of a thin coating layer of calcium phosphate. 
Furthermore, the roughness of the microblast process can be tuned between 0.5-1.4 
µm depending on the particle size of the apatite abrasive employed (Figure 3.4). This 
is consistent with previously studies (Abron et al., 2001; Wennerberg et al., 1997). 
Unfortunately, the coatings deposited using this microblast process have 
demonstrated poor adhesion to the metal and have not been widely employed as final 
surface treatments for this reason (O’Hare et al., 2010).  
 
For the CoBlast samples, the tribochemical bonding which results from surface 
roughening, activation and subsequent bonding of the powder to the substrate has 
been shown to improve the HA bonding to the Ti (O’Hare et al., 2010; O’Neill et al., 
2009). The deposition of HA via the CoBlast process combines the benefits of 
increased roughness and enhanced deposition of a bioceramic coating, the bioactive 
property of which can improve osteointegration compared to the microblast surfaces 
(Figure 3.4 and Table 3.2). The surface treatment effect was also dependant on the 
particle size of the abrasive, with the larger particle size producing greater surface 
erosion and a rougher topography resulting in reduced coating thickness as 
evidenced by an increase in % atm Ti (EDX analysis).  
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In literature, HA coatings deposited using the standard high temperature plasma 
spray deposition technique have been reported to contain a variety of crystalline 
phases and the presence of altered chemical functionality (Chen et al., 1994). This 
can lead to the formation of intermediates such as calcium oxide (CaO), octa-
hydroxyapatite (OHA), α-tricalcium phosphate (α-TCP), β-tricalcium phosphate (β-
TCP) and tetra-calcium phosphate (TTCP) (Gross and Brendt, 1998; Gross et al., 
1998). The presence of these impurities in a HA modified surface can decrease the 
crystallinity and subsequently make it more prone to dissolution. The increased 
solubility of these phases can eventually lead to the poor apposition of bone and 
compromise the mechanical stability of the implant (Heimann and Wirth, 2006). 
This can occur when the coating itself delaminates over time due to poor bonding 
strength of the HA onto the underlying surface or as the coating itself resorbs into 
the surrounding environment (Mohammadi et al., 2008).  
 
CoBlast demonstrated the ability to deposit a well adhered HA coating with no major 
evidence of contamination with additional CaP phases. This is in contrast to the 
variety of crystalline phases and the presence of altered chemical functionality 
produced during the standard high temperature plasma spray deposition process. The 
XRD and FTIR analysis does not suggest formation of any such impurities within 
the CoBlast samples indicating that the HA coating on the CoBlast samples has 
retained the same properties as the starting crystalline HA powder employed 
(Figures 3.1, 3.2, 3.5 and 3.6). Therefore, it is anticipated that HA modified surfaces 
prepared using CoBlast should not exhibit the problems associated with the presence 
of impurities observed for HA modified surfaces deposited using standard high 
temperature plasma spray as outlined above.  
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Osteoblasts are the key cells involved in the osteoconduction process. The success of 
the implantation is strongly influenced by how well the first phase of the attachment 
and adhesion of these cells will occur, which will then lead to the subsequent 
proliferation and osteogenic differentiation upon contact with the implant surface. 
CoBlast surfaces deposited using alumina abrasives have exhibited excellent 
osteoblast attachment and proliferation in vitro compared to their respective controls 
(O’Hare et al., 2010; O’Neill et al., 2009). Here the introduction of the bioactive HA 
layer through the CoBlast process using apatitic abrasives was shown to offer 
significantly higher levels of cell viability after 5 days compared to the untreated Ti 
and microblast surfaces which is attributed the combination of surface topography 
(increased surface roughness) and bioactive surface chemistry. It was noted that the 
cell proliferation on the modified surfaces were all roughly comparable at 24 hours. 
 
Surface modification techniques are extremely important for evoking desired cellular 
responses through tailoring the implants surface properties. The osteointegration 
process is greatly enhanced by these modifications, which in turn increases the 
longterm success of the implant. As previously mentioned, HA is well known for its 
osteoconductive properties and its ability to influence cell adhesion and interaction at 
the implant-host interface. It is generally accepted that alongside chemical 
compatibility, the three dimensional surface topography (shape, size and surface 
texture) of the implant also influences early tissue response. The cells appeared to 
follow the contours of the MCD blasted surface where they would sit in the defects 
on the surface and align themselves along grooves or dents in a process referred to as 
‘contact guidance’. An increase in the surface roughness (determined to be 0.4, 0.5 
and 0.7 µm for the blank Ti, microblast MCD-106 and the CoBlast HA/MCD-106, 
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samples respectively) of the samples coincided with enhanced cell contact with the 
CoBlast substrate. This has important consequences as contact guidance effect has 
commonly been associated with increased cell proliferation and differentiation 
(Anselme, 2000). 
 
Research has proven that early controlled osteoblast alignment was demonstrated on 
patterned substrates (Pukett et al., 2008). Therefore, due to the patterned nature of 
the HA surface after CoBlast treatment, a more favourable surface resulted for cell 
spreading which subsequently lead to increased cell viability compared to the 
microblast and blank Ti surfaces. In vivo evaluation of CoBlast substrates prepared 
using an alumina abrasive have already demonstrated early stage lamellar bone 
growth (O’Hare et al., 2010), however this study demonstrates the capacity to 
enhance bone-implant contact in vivo by employing differing grades of MCD 
abrasive in the CoBlast process to achieve greater control over surface topography. 
Further in vitro evaluations such as dissolution studies and bioactive studies in 
stimulated body fluid must be investigated to support these capabilities.  
 
3.5 Conclusions 
Detailed surface studies have shown that the combination of an apatite abrasive and 
a HA dopant in the CoBlast process produces surfaces with a combination of 
optimised apatite chemistry and controlled surface structure. The CoBlast process 
has the ability to retain the chemistry of the starting HA material. This offers 
advantages over conventional high temperature plasma processing which alters the 
HA material from its desired chemical, structural and dissolution requirements for its 
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use as an in vivo implant material. The study also shows that employing MCD 
abrasives offer an alternative to alumina for deposition using CoBlast process. In 
vitro studies clearly show that increased roughness of treated surfaces favours 
enhanced cell viability and the CoBlast process offers the ability to tailor the surface 
texture to produce an optimised surface for osteointegration of a HA modified 
implant. Enhanced cell viability was observed for CoBlast modified surfaces 
compared to the microblast surface. The ability of the CoBlast technology to offer 
diversity in modifying surface topography is clearly shown in this and previous 
studies and represents foundation work, which supported by bioactivity studies and 
in vivo trials, offers exciting new prospects in tailoring the properties of medical 
devices for applications ranging from dental to orthopaedic settings.  
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    Chapter 4 
4.0 A Comparison of CoBlast and Plasma Sprayed HA 
Coating Stability Following SBF Immersion 
 
Results and discussion submitted to Surface Coatings and Technology 
 
Abstract: 
Hydroxyapatite (HA) coatings were applied to titanium substrates using either a 
blasting technique known as CoBlast or the traditional plasma spray method. The 
coatings were compared after incubation in simulating body fluid (SBF) using 
standard in vitro techniques and the results were interpreted in view of chemical, 
mechanical and biological properties of the coatings. The data strongly suggests that 
the presence of additional phases in the plasma coating limits the chemical, structural 
and mechanical stability of the surface. The CoBlast surface was shown to produce a 
more uniform and crystalline structure that produced excellent coating adhesion, 
lower dissolution and higher levels of mechanical and chemical stability in SBF and 
which resulted in higher levels of osteoblast proliferation in vitro.   
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4.1 Introduction 
HA is widely used and well established as a biocompatible coating on metallic 
implants (Tanzer et al., 2001; Furlong and Osborn, 1991; Geesink, 1989). Numerous 
studies have clearly shown that the presence of a HA coating on hard tissue implants 
encourages osteoblast proliferation (Rosa et al., 2003; Massaro et al., 2001), 
facilitates early bone fixation (Vani Vasudev et al., 2004; Burr et al., 1993) and 
provides positive outcomes during clinical trials (Hansson et al., 2008; Oliver et al., 
2005; Cross and Parish, 2005; Geesink, 2002).  
 
At present, HA deposition is dominated by plasma spraying and most orthopaedic 
companies offer some version of plasma HA. Despite the clinical success seen to 
date (Oliver et al., 2005; Cross and Parish, 2005; Røkkum et al., 1999; Dorr et al., 
1998), significant issues exist which can limit the effectiveness of plasma deposited 
coatings (Gross et al., 2004; Geesink., 2002; LeGeros et al., 1991). In particular, the 
plasma HA adhesion can be adversely affected by coating quality (Sun et al., 2001). 
This is generally reflected in significant variations in mechanical (Dalton and Cook, 
1995), structural (Xue et al., 2004) and chemical properties (Heimann, 2006) of the 
coatings. Despite these problems being well known for some time (Chang and Khor, 
1996; Søballe and Overgaard, 1996) these issues still persist. Furthermore, the 
compatibility of plasma processing with the trend towards porous three dimensional 
surface finishes is questionable, as the thick plasma coatings have a tendency to in-
fill and block the pores (Hayashi et al., 1994).  
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This has led to numerous attempts at producing an alternative HA surface deposition 
technique which would retain the benefits of the HA material without compromising 
the uniformity of the coating. Electrochemical deposition (Wang et al., 2006) has 
been one of the more successful approaches and Stryker Orthopaedic (New Jersey, 
USA) have launched a number of products using this coating approach (Hansson et 
al., 2008). However, these processes are based on wet chemical processing with all 
the inherent complications and difficulties therein associated. Other researchers have 
investigated dry processes for depositing HA (Ishikawa et al., 1997). Apatitic grit 
blasting with sintered apatites and CoBlast process, which combines both abrasive 
and dopant (HA) (O’Sullivan et al., 2011; O’Hare et al., 2010) have also been 
discussed earlier in Section 1.6.1.  
 
In this Chapter, HA coating surfaces deposited by the CoBlast technology are 
compared to a standard industrial plasma HA coating using in vitro responses. The 
chemical stability, mechanical adhesion and bioactivity of the HA coatings are 
examined over time in simulated body fluid and the results used to elucidate in vitro 
cell proliferation results. The surface changes are discussed with reference to 
detailed surface characterisation studies.  
 
4.2 Materials and Methods 
Various analytical techniques were employed to determine the surface properties of 
the two HA surfaces (CoBlast and plasma sprayed surfaces): elemental and chemical 
composition (EDX (n=3 samples); XRD, FTIR) physical analysis: coating mass 
(gravimetric analysis (n=3 samples); surface roughness (Ra, n=3 samples); surface 
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topography (SEM); ion release (ICP-OES) and mechanical analysis (ASTM F1147 
(adhesion test), n=3 samples). The surface roughness in nanometers and microns was 
measured using different profilometers (Veeco Dektak 8 Advanced Development 
Profiler, n=3 samples) and Talsurf 10 surface profilometer (Taylor Hobson, n=3 
samples). In vitro ion release studies were performed as outlined in Section 2.3.2. 
Surfaces were incubated for 1, 3, 7, 14 and 30 days in SBF to determine the 
bioactivity of the two HA surfaces (n=3 samples) (Section 2.3.5). Surface analysis 
(EDX, XRD, FTIR, SEM) were performed on the surfaces following SBF 
immersion. The ASTM F1147 tensile test was also performed on the surfaces post 
incubation in SBF (ASTM Standard, 2011). Cell proliferation and cytotoxicity 
studies at day 1 and 5 using a MTT assay (n=4 samples) and cell morphology of the 
cultured osteoblasts on the surfaces were executed.  
 
A statistical one-way analysis of variance (ANOVA) was performed to determine 
statistically significant differences between the sample types ( p<0.05). Where 
significant differences were found, Dunnett’s test was used to compare the sample 
data to those of the untreated Ti samples (MTT assay) and multiple comparisons 
between all samples were analysed using Tukey’s post-hoc test (surface roughness 
(AFM)). Comparison between the CoBlast HA and plasma HA surfaces was 
performed using the independent 2-sample t-test (tensile bond strength), with 
significance level of p<0.05 noted. 
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4.3 Results 
4.3.1 Surface Characterisation 
Chemical analysis of the untreated titanium (Ti), CoBlast HA coated Ti and plasma 
HA coated Ti was carried out via EDX and the results are shown in Table 4.1. For 
both the CoBlast and the plasma HA surfaces, the surfaces contained high levels of 
calcium (Ca), phosphorous (P) and oxygen (O), which are typical of an apatite rich 
surface. Titanium was detected on the CoBlast but not on the plasma HA surface, 
indicating that a thicker coating was applied using the plasma process. Ca/P ratios 
were obtained for these processes which are close to stoichiometric HA (1.67) (Kim 
et al., 1998).  
 
Table 4.1: Chemical composition using EDX analysis (% atm) and surface 
characteristics of the HA modifications (n=3 samples). Coating thickness, coating 
mass and surface roughness values are reported ±2SD. 
Modification O 
 
 
 
P 
 
 
 
Ca 
 
 
 
Ti 
 
 
 
 
Ca/P
 
 
Coating 
Thicknesss
(µm) 
Coating 
Mass 
(mg/cm2) 
Surface Roughness 
Ra (nm) 
Veeco 
Dektak 8 
Ra (µm) 
Taylor 
Robson 
Blank Ti 23 
 
- 
 
- 
 
77 
 
- 0 - 155±4 0.39±0.05 
CoBlast HA 66 
 
11 
 
16 
 
7 
 
1.56 
 
7±2 0.53±0.2 
 
546±110 1.24±0.20 
Plasma HA 72 
 
11 
 
17 
 
0 
 
1.63 
 
65±6 11.0±0.4 965±86 >5 
 
The coating thickness and the coating mass per unit area results given in Table 4.1 
confirmed the EDX analysis of the surfaces, which indicated that the plasma HA 
coating was thicker than the CoBlast HA coating and these values are broadly in 
agreement with previous studies of CoBlast HA surfaces (O’Sullivan et al., 2011; 
O’Hare et al., 2010). The plasma samples were found to exhibit higher levels of 
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surface roughness (micron features and nano features) compared to the CoBlast 
samples, which in turn were rougher than the untreated Ti (Veeco Dektak (nm) and 
Taylor Robson (µm) data). Multiple comparisons between groups (AFM data) 
revealed statistical differences between all samples (p<0.001) using the Tukey’s 
post-hoc analysis.  
 
The release profile of Ca and P ions from the HA coated surfaces are given in Figure 
4.1.  
 
  
Figure 4.1: Ca and P ion release in tris-HCl buffer (37 °C, pH 7.4, 150 rpm, n=3 
samples ±2SD).  
 
The CoBlast surface was observed to release a lower concentration of Ca and P ions 
from its surface compared to the plasma sample, in agreement with previous studies 
(Tan et al., 2012). At day 1, 11 ppm Ca ions were released from the plasma HA 
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surface which was seen to increase to 67 ppm at day 3. However, at day 1 maximum 
Ca release was observed from the CoBlast surface (4 ppm). Low levels of P ions 
were released (<8 ppm) from the plasma and CoBlast surface (<4 ppm) throughout 
the analysis period.  
 
4.3.1 Bioactivity Study 
The surface analysis of the HA modifications before and after incubation in SBF are 
presented in Figures 4.2-4.9. The Ti and Ca/P levels were monitored using EDX  
analysis over a 30 day period following incubation in SBF (Figure 4.2).  
 
 
Figure 4.2: Ti levels (primary y-axis) and Ca/P (secondary y-axis) of the HA 
modifications following incubation in SBF solution (n=3 samples ±2SD). 
 
Titanium was not detected for the plasma sample suggesting that the thick apatite 
coating remained on the surface over the 30 day period. The Ca/P levels for the 
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plasma sample were seen to increase to 2.18 at day 30 indicating a sizeable change 
from the initial stoichiometric HA chemistry. The CoBlast surface which was a 
thinner coat to begin with, following incubation in SBF the Ti % atm was observed 
to increase at day 1 and then decrease to 0.4 % atm Ti at day 3 with no Ti detected 
thereafter. The Ca/P ratios for the CoBlast surface ranged between 1.4 to 1.7 over the 
30 days, remaining close to the pure HA value. An increase in coating mass was 
observed for the plasma HA coating at day 1 whereas the coating mass remained 
unchanged for the CoBlast HA, Figure 4.3. The coating mass was observed to 
increase between day 7 and 14 for both HA surfaces. However, there was a 
noticeable difference between the coating mass of the CoBlast HA surface and the 
plasma HA surface with an increased mass noted in the case of the latter following 
incubation in SBF. 
 
 
Figure 4.3: Mass of SBF deposit per unit surface area with SBF soakage time (n=3 
samples ±2SD).  
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The crystal structure of the HA modified surfaces was also investigated using XRD 
(Figure 4.4).  
 
 
Figure 4.4: XRD spectra of HA coated surfaces before (day 0) and after incubation 
in SBF over a 30 day period.  
 
As shown in Figure 4.4, prior to SBF soakage both samples produce data consistent 
with the deposition of HA (day 0). The five strongest lines in the XRD pattern are 
002, 211, 112, 300 and 202 reflections from HA corresponding to approximately 
25.9, 28.9, 31.9, 32.2, 34.1° 2θ. The CoBlast HA sample also contains a number of 
additional peaks which can be attributed to the Ti substrate and a higher degree of 
signal to noise, indicating that the coating is quite thin. On the contrary, the plasma 
sample is largely devoid of Ti features and is dominated by the HA peaks, as would 
be expected from a thick coating. Impurities such as tricalcium phosphate (TCP), 
tetracalcium phosphate (TTCP) and calcium carbonate (CaCO3) were detected in the 
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plasma HA coating analysed (Li et al., 2009; Fathi et al.; 2008; Gross et al., 1998) 
suggesting that a less pure HA coating was detected. Increasing SBF soakage time 
resulted in the disappearance of the TCP and TTCP phases and the sustained 
presence of CaCO3 for the plasma HA surface. CaCO3 peaks were observed on the 
CoBlast surface following maturation in SBF over a day 30 period. 
 
The FTIR spectra of the CoBlast HA surface before and after immersion in SBF is 
presented in Figure 4.5.  
 
Figure 4.5: FTIR analysis of CoBlast HA surface before and following incubation in 
SBF over 30 day period. 
 
These include the O-P-O bending vibrations (700 – 300 cm-1), the P-O stretching 
vibrations (1200 – 900 cm-1) and the O-H stretching vibrations (3571 cm-1 and 630 
cm-1) (Fathi et al., 2008). The resolved PO4 bands (1200 – 900 cm-1) indicate that 
crystalline HA was deposited. Also, the small peak present at 962 cm-1 was assigned 
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to the P-O symmetric stretching mode and represents a highly ordered, non-
carbonated apatite and is indicative that the material is well crystallised (Hong et al., 
2007). 
 
The FTIR spectra for the SBF immersed CoBlast HA coatings shows that the surface 
chemistry remains unchanged at day 1. However at day 3, the PO4 modes exhibited a 
broad overlap from 880 cm-1 to 1250 cm-1 indicating a deviation of the phosphate 
ions from the tetrahedral configuration (Zhang et al., 2003) in addition to changes of 
the O-P-O bending vibrations (700 – 400 cm-1). Water was absorbed in the layer as 
indicated by the broad bands from 3700 to 2500 cm-1, with the presence of structural 
OH groups (approximately 1640 cm-1) in the apatite lattice can be seen in the 
spectrum from day 3 onwards (Weng et al., 1997). Following maturation in SBF 
beyond day 3, the spectra shows the presence of prominent carbonate (CO32-) bands 
(1423-1473 cm-1 and 873 cm-1) had grown suggesting an obvious change in 
composition. This suggests the formation of a carbonated hydroxyapatite (CHA) at 
day 3, and the structural changes are in agreement with literature (Zhang et al., 
2003).  
 
The FTIR spectra of the plasma HA before and after immersion in SBF is presented 
in Figure 4.6. The more amorphous character of the plasma HA coating was clearly 
evident with the broad nature of the PO4 bands between 750 to 1300 cm-1, which is a 
feature of the different phases present (TCP, TTCP) as well as the carbonate peaks 
present (1493-1433 cm-1) (Figure 4.6). Structural changes characteristic of CHA 
growth are evident at day 1, with the increased broadness of the above PO4 modes, 
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carbonate peaks (1493-1433 and 875 cm-1) as reported by Zhang et al. and adsorbed 
water (3700 to 2500 cm-1 and 1650 cm-1) (Zhang et al., 2003). 
 
 
Figure 4.6: FTIR analysis of plasma HA surface before and following incubation in 
SBF over a 30 day period.  
 
The SEM images provide evidence as to what was occurring at the surface during 
incubation in SBF. The images of the CoBlast surface before and after SBF 
immersion are shown in Figure 4.7 (a)-(f). The images of the plasma HA surface 
before and after SBF immersion are shown in Figure 4.8 (a)-(f). 
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(a)  (b)  
(c)  (d)  
(e)  (f)  
 
Figure 4.7: Images of CoBlast HA coating following incubation in SBF at (a) 0 day; 
(b) 1 day; (c) 3 days; (d) 7 days; (e) 14 days ((a)-(f) x2000 magnification); (f) 30 
days x10000 magnification. 
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 (a)  (b)  
(c)  (d)  
(e)  (f)  
 
Figure 4.8: Plasma HA samples in SBF following incubation at (a) 0 day; (b) 1 day; 
(c) 3 days; (d) 7 days; (e) 14 days ((a)-(e) x2000 magnification); (f) 30 days x10000 
magnification. 
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The CoBlast treatment results in a roughened, highly regular and uniform surface 
(Figure 4.7 (a)). At day 1 no evident change resulting in an altered coating 
morphology was observed. However, at day 3 nucleation of globular precipitates had 
occurred which completely changed the original morphology of the coating at day 0. 
This is the CHA layer that has formed through precipitation as indicated by FTIR 
results. In literature, it has been described as a dune-like layer, characterised by 
many cracks of tortoise–shell appearance that completely covers the surface (Weng 
et al., 1997). At days 7, 14 & 30, the globular surface features were still evident, 
which on closer investigation were found to possess a subtle texture of needle-like 
crystallites (Figure 4.7 (f)), which supports observations by Leeuwenburg et al. 
(Leeuwenburg et al., 2006).   
 
Figure 4.8 (a) reveals a typical HA plasma treated surface, which as expected, gives 
a rough morphology with large spherical agglomerates and typical deposits of 
bioceramic material evident on the surface. Nucleation had occurred rapidly after 
immersion in SBF and was evident on day 1. As the soaking time increases the 
granules become larger and evolved into a more dense dune-like layer as a result of 
increase apatite growth. Established research has observed similar findings (Gu et 
al., 2003; Weng et al. 1997). Again, needle-like surface texture was observed under 
higher magnification (Figure 4.8 (f)). However, a smoother morphology of 
crystalline formation with nanopores after incubation in SBF was observed for the 
CoBlast surface compared to the globular surface of the plasma coating.  
 
Mechanical adhesion testing of the HA coatings was undertaken as per the ASTM 
F1147 standard test method for tension testing of CaP and substrate coatings and the 
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results are presented in Figure 4.9 (ASTM Standard, 2011). The results reveal that 
the CoBlast HA coating had a significantly higher bond strength (p<0.05) compared 
to the plasma HA coatings at day 0. Following immersion in SBF, the bond strengths 
were seen to decrease with immersion time. However, significantly higher bond 
strength values were observed for the CoBlast HA surface compared to the plasma 
HA surface throughout the entire 30 days following submersion in SBF. A 
statistically significant decrease in the bond strength was observed for the plasma 
HA surface after submersion in SBF at 14 compared to day 0. Although the average 
CoBlast HA coating adhesion value also dropped at day 14, this was not deemed to 
be statistically significant (p>0.05). 
 
 
Figure 4.9: Tensile bond stress values of the HA modifications (ASTM F1147) (n=3 
samples ±2SD) (* represents p<0.05 determined using independent 2-sample t-test).  
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4.3.3 Cell Culture Analysis 
4.3.3.1 Cell Proliferation 
MG-63 osteoblastic cell proliferation studies were carried out on the plasma and 
CoBlast HA surfaces and the results are presented in Figure 4.10. Cell proliferation 
data at day 1 were comparable. Statistically differences between samples were found 
only at day 5 (p<0.05) using one way ANOVA. At day 5, there was a significant 
increase in cell proliferation on the CoBlast HA coated substrate (p<0.01) compared 
to the untreated Ti, whereas no significant difference was observed between the 
plasma and the Ti sample (Dunnett’s test). No evidence of cytotoxicity was observed 
using MG63 cells for any of the samples evaluated. 
 
 
Figure 4.10: MTT assay data for MG-63 cells on modified Ti surfaces over 5 days 
in vitro (n=3 samples ±SD) (* represents statistical significance between the CoBlast 
HA sample and the titanium control at day 5 (p<0.01) determined using Dunnett’s 
test). 
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4.3.3.1 Cell Morphology 
The morphology of the MG-63 cells on each surface was investigated using SEM 
imaging and typical results are presented in Figure 4.11. The cells on both HA 
surfaces exhibit polygonal shapes rather than a polarised fibroblastic morphology 
indicating increased cell spreading. In addition, there was also an abundance of 
lamellopodia and filopodia present on both HA surfaces signifying good cell 
adhesion. However, cells appeared to preferentially reside in the pits of the plasma 
HA surface where the optimal cell adhesions could be achieved. 
  
 
(a) 
  
(b) 
 
Figure 4.11: MG-63 osteoblasts cultured on (a) CoBlast HA surface x1000 
magnification and (b) plasma HA surface x1000 magnification. Red arrows indicates 
the presence of lamellipodia and blue arrows highlights the presence of filopodia. 
 
4.4 Discussion 
From the results generated in this study, it is clear that the structure of the final HA 
coating and its behaviour in SBF is largely dependent on the processing method used 
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to apply it onto the surface. Surface analysis of the coated samples prepared herein 
indicates that both CoBlast and plasma spraying are effective mechanisms of 
creating a HA rich surface on Ti metal. In both cases, EDX clearly shows that the 
surface has been covered with a CaP layer. However, the morphology and uniformity 
of both coatings is considerably different. It is evident that a much thicker coating is 
applied with the plasma technique compared to the blasting method (Table 4.1). 
While analysis of the CoBlast samples produce results that are consistent with the 
presence of a thin and homogeneous HA surface, the plasma process was found to 
produce a thick deposit with significant variations in structure and chemistry. The 
impact of the high velocity spraying of molten HA powder onto an implant surface, 
which rapidly cools, is the formation of a dense coating with a morphology 
consisting of bioceramic deposits on the plasma surface (Campbell, 2003). 
Crystallographic examination clearly shows that the plasma process contains 
secondary CaP phases which can be attributed to the thermal degradation of the HA 
precursor during the deposition process, which is in agreement with the FTIR spectra 
(broad PO4 bands between 750 to 1300 cm-1). SEM image analysis reveals the 
morphology of the surfaces and provides evidence of a more uniform coating from 
the CoBlast treatment compared to a rougher and irregular HA surface deposited 
using the plasma spray method (Figures 4.7 (a) and 4.8 (a)). Controlling the 
deposition parameters of such high temperature methods of the plasma technology 
can be difficult to achieve. In contrast, the CoBlast process produces a more pure, 
crystalline HA layer on the Ti surface with no major evidence of contamination from 
additional CaP phases (supported by XRD and FTIR analyses).  
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The presence of impurities such as CaO, OCA, α-TCP, β-TCP and TTCP in a HA 
material have been reported to decrease the crystallinity and subsequently, increase 
dissolution rate (Gross and Berndt, 1998; Gross et al., 1998; Zyman et al., 1998). Ion 
release from the various coatings are given in Figure 4.1, and when combined with 
the disappearance of the TCP phases in the XRD analysis, the data clearly shows that 
the thicker plasma HA dissolves at a quicker rate and releases more Ca and P ions 
compared to the CoBlast coatings as a direct result of the presence of such 
impurities. There are a number of problems associated with increased solubility of 
the secondary impurity phases in plasma coatings as outlined in Section 1.7 (reduced 
mechanical stability, delamination etc.) (Mohammadi et al., 2007, Heimann and 
Wirth, 2006, LeGeros, 1991).  
 
The bond strength of the HA coatings on the Ti implant material is very much 
critical as it has to withstand crevice and bone growth stress in addition to its load 
bearing activities. Consequences of poor adhesion strength may lead to wear debris 
accumulation resulting in inflammation, osteolysis and implant loosening (Long and 
Rack, 1998). The adhesive strength of the coatings under investigation was measured 
by tensile adhesion test which measures the combination of cohesive strength (within 
the coating) and adhesive strength (coating to substrate) (Yang and Chang, 2001). It 
has been reported that cohesive strength is dominated by coating properties such as 
crystallinity and microstructure (dense or porous) while the adhesive strength is 
affected by coating properties, residual stress and surface roughness (Yang and 
Chang, 2001). Amorphous coatings have a more brittle nature and exhibit less 
adhesion strength compared to the crystalline coatings (Clèries et al., 2000). In 
addition, Filiaggi reported that bond strength is dependent on coating thickness, 
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coatings of 240 µm had lower bond strength compared to coatings of 50 µm (Filiaggi 
et al., 1991). In comparison with measured values herein and literature values, the 
bond strength values determined suggest that the CoBlast HA coatings produces 
higher adhesion levels than industry standard plasma coatings (20-48 MPa) (Røkkum 
et al., 1999; Dorr et al., 1998) and also other deposition processes such as sol-gel, 
ion beam and spluttered coatings (25-30 MPa) (Chen et al., 2007a; Fujihara et al., 
2004; Lee et al., 2002; Piveteau et al., 2000). The increased strength of the CoBlast 
surface can be attributed to a combination of highly crystalline HA deposition 
combined with direct tribochemical bonding of the bioceramic to the metal substrate 
(O’Hare et al., 2010) whereas a lower bond strength was obtained from the less 
crystalline and thicker nature of the plasma coating. However, these effects are only 
significant if they can be maintained over time in a biological environment.  
 
It is well known that the formation of bone like or CHA layer plays an important role 
in establishing through bone-bonding interactions between the implant and living 
tissues promoting fast fixation and long term stability (Sun et al., 2001; LeGeros, 
1991). According to Kokubo et al, SBF has approximately the same ion 
concentration as that of the human blood plasma and the in vitro immersion of 
bioactive materials in SBF is thought to reproduce the in vivo surface structure 
changes. Therefore, bioactivity of biomaterials in SBF is an important factor to 
assess and provides a good model for monitoring biological responses in vitro 
(Kokubo et al., 1990).  
 
The SBF studies here clearly show that the plasma HA has an early onset of CHA 
formation (day 1) compared to the CoBlast HA surface (day 3) as demonstrated by 
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the FTIR and XRD analysis. The formation of the CHA layer is a complex process 
involving the release of both Ca and P ions through dissolution resulting in an 
increase in super-saturation in the localised area around the coating which correlates 
with increased Ca ion release from the plasma surface. The results presented are in 
agreement with literature, as the amorphous phases of plasma coatings increase the 
dissolution rate of the HA with the granular feature of the apatitic precipitation 
process observed between 6-12 hours in SBF (Weng et al., 1997). The formation of a 
carbonated CaP layer plays an important role in bone fixation of the implant to the 
living tissue in-vivo (Sun et al. 2001; LeGeros et al., 1998; LeGeros and Craig, 
1993). During the formation pores or microcracks in recessed regions of the coating 
may be observed. The presence of nanopores on the CoBlast surface was observed 
after incubation in SBF for 30 days, Figure 4.7 (f) while large fissures were evident 
in the plasma sample, Figure 4.8 (f). The increase in surface roughness as a result of 
dissolution is favourable for nuclei to anchor resulting in precipitation of bone-like 
apatite onto the HA surface (Sun et al. 2001; Weng et al., 1997; LeGeros, 1991).   
 
In comparison, there are very low levels of ions released from the CoBlast coating 
over the three days (<4 ppm) (Figure 4.1), however carbonate apatite was evident on 
the coating at day 3 (Figures 4.5-4.8). In addition, a lower deposition mass and a 
smoother morphology of the CHA resulted on the CoBlast surface compared to the 
plasma coating, further suggesting that the lower dissolution of ions from the 
CoBlast surface limited the CHA growth. The Ca/P ratios did not change from day 7 
to day 30 for the CoBlast surface suggesting that the deposit maintained a relatively 
high phosphate content. In contrast, an increase in the Ca/P ratio was observed after 
Chapter 4: A Comparison of CoBlast and Plasma Sprayed HA Coating Stability Following SBF 
Immersion 
 
Page | 121  
 
day 7 for the plasma surface suggesting that the deposit contains significant 
carbonate substitution for the phosphate within the apatite structure.  
 
These variations in timing, chemistry and morphology suggest that perhaps there is a 
different mechanism for apatite growth for the crystalline CoBlast HA surface. 
LeGeros et al. described one model that is based on a dissolution and precipitate 
phenomenon, where the release of Ca2+ and other ions leads to the small interfacial 
region becoming highly saturated, thereby inducing precipitation of carbonated 
apatites, leading to re-crystallisation on the surface (LeGeros, 1991). Other models 
have been proposed that ion-exchange occurs at the interface between the 
physiological solution that transforms the HA surface into other CaP phases 
(Bertazzo et al., 2010; Ducheyne and Qui, 1999), which may subsequently lead to 
the formation of the CHA layer in vivo (Chen et al., 2004). These models support the 
observed changes in the plasma HA coating in SBF where the impurity phases 
rapidly dissolve and can thereby participate in the formation of the CHA layer. 
However, the low levels of ion elution, the Ca/P ratio and slow growth of apatite on 
the crystalline CoBlast surface suggests that the deposit may form through ion 
exchange at the surface. This in vitro study may indeed mimic the growth model put 
forward by Hench to describe how crystallised HA can cause the epitaxial growth of 
bone mineral towards it, eventually fusing in a cement-like matrix (Cao and Hench., 
1996). This complex process of osteointegration is dependent on surface reaction 
which includes the chemical (composition and dissolution), biological (osteoblast 
cell attachment and proliferation) and mechanical (bond strengths) interactions 
between the implant and the host. Here it is suggested that relative dissolution rates 
are determined by the chemical composition and the crystallinity of the HA (Cao and 
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Hench, 1996). This response suggests the crystalline CoBlast offers a stable surface 
both in vitro and in vivo when compared to the rapid dissolution of the plasma 
surface. This rapid alteration of the plasma HA surface could therefore compromise 
the stability of the implant when compared to the more crystalline CoBlast surface. 
 
This analysis is supported by the mechanical testing of the bond strength of the HA 
coatings following soakage in SBF. Obviously, the heterogeneous nature of the 
plasma coating (uniformity, crystallinity and thickness) and the increased 
degradation of the coating as a result of the rapid dissolution of the TCP and TTCP 
phases combined with the formation of the thicker carbonate apatite layer had a 
definite impact on the bonding strength of the plasma HA. The bond strength was 
seen to degrade concomitant with the process of chemical dissolution and the 
deposition of a thicker amorphous coating. As seen in the dissolution studies, the 
CoBlast HA surface was seen to offer minimal dissolution and delivered a different 
mechanism for the carbonate apatite formation and hence the bond strength of the 
CoBlast samples was higher than that of the plasma samples at each time point. This 
indicated that the CoBlast HA coating is more physically stable and less prone to 
biological demineralisation as proven by the later onset of CHA formation and this 
may be expected to have an impact in vivo.  
 
It was observed in this study that cell proliferation on the modified surfaces were all 
approximately comparable at day 1, however after 5 days the CoBlast surface 
outperformed the plasma surface which may be attributed to a combination of 
surface structure and chemistry. The CoBlast sample was found to have significantly 
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higher levels of cell proliferation (p<0.01) when compared to the control surface 
after 5 days incubation.  
 
It is well established that topography plays a major role in the alignment, adhesion 
and subsequent spreading of osteoblast cells across the surface, with rougher 
surfaces often reported to increase cell adhesion and proliferation. However, this was 
not seen here. The increased surface roughness of the plasma HA did not increase 
cell proliferation compared to the smoother CoBlast surface (Table 4.1 and Figure 
4.10) After 24 hours, SEM imaging revealed significant MG-63 cell growth and 
proliferation on the surface of both the plasma and CoBlast HA samples 
demonstrating the cytocompatible nature of these surfaces. However, a more regular 
alignment was observed on the CoBlast surface compared to the more sunken 
cellular behaviour on the plasma surface (Figure 4.11). The increased viability on the 
smoother CoBlast HA surface may be attributed to the regular HA surface produced 
by the blasting technology coupled with a highly stable structure that facilitated 
proliferation. In contrast, the highly variable plasma process produced a surface that 
altered over time due to the dissolution and recrystallisation of the semi-crystalline 
and amorphous phases, as detected in the ion elution and SBF studies. This unstable 
and altering surface topography may have disrupted the growth and proliferation of 
the osteoblast cells. It has previously been shown that highly stable crystalline 
coatings offer superior outcomes in vivo (Dekker et al., 2005; Xue et al., 2004). 
 
Modifications are needed at varying degrees to modify the HA material to meet the 
desired chemical, structural and dissolution requirements for its use as an in vivo 
implant material without jeopardising the long term mechanical stability of the 
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implant. The importance of material formulation is fundamental so that the bioactive 
coating will confer adequate dissolution properties needed to induce the complex 
process of the osteointegration process and quality lamellar bone formation. In this 
study, the deposition process used is an important consideration as this will influence 
the chemistry and composition of the resultant HA coating which will then in-turn 
affect the stability of the implant.  
 
4.5 Conclusions 
The in vitro studies described herein have shown that the introduction of HA onto 
the surface produced highly cytocompatible and bioactive surfaces. The thermal 
plasma spray process produced a thicker, heterogeneous, amorphous HA coating 
with lower bond strength and lower in vitro stability when compared to the 
crystalline CoBlast HA surface. The presence of secondary crystalline phases in the 
plasma sample resulted in a rapid dissolution in SBF and thereby reduced the bond 
strength of the coating. The crystalline CoBlast surface was found to be much more 
stable and produced a different response profile in an SBF immersion trial with 
minimal dissolution and retention of excellent coating adhesion throughout. It is 
postulated that a different mechanism for apatite growth is at play in SBF for the 
CoBlast surface, however further studies are required to confirm this. Enhanced 
osteoblast proliferation was observed for CoBlast modified surfaces compared to the 
thicker and rougher plasma spray coating and this may be explained by the highly 
stable surface structure of the CoBlast HA which offers a more predictable and 
regular surface for cells to adhere to and proliferate upon. 
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             Chapter 5 
5.0 Deposition of Substituted Apatites with Anticolonising 
Properties onto Titanium Surfaces using CoBlast 
Technology 
 
Results and discussion published in Journal of Biomedical Materials Research B: 
Applied Biomaterials, (2011), 95(1):141-149. 
 
Abstract:  
A series of substituted apatites have been deposited onto titanium (V) substrates 
using a novel ambient temperature blasting process. The potential of these deposited 
substituted apatites as non-colonising osteoconductive coatings has been evaluated in 
vitro. XPS, EDX and gravimetric analysis demonstrated that a high degree of coating 
incorporation was observed for each material. The modified surfaces were found to 
produce osteoblast proliferation comparable to, or better than, a hydroxyapatite (HA) 
finish. Promising levels of initial microbial inhibition were observed from all of the 
substituted surfaces, with the strontium (Sr) surface showing prolonged ability to 
reduce bacteria numbers over a 30 day period. Ion elution profiles have been 
characterised and linked to the microbial response and based on the results obtained, 
mechanisms of kill have been suggested. In this study, the presence of coated 
substrate surfaces was observed to be a significant contributing factor to the 
antimicrobial performance and the anticolonising activity. The silver substituted 
apatite (AgA) was observed to out-perform both the strontium (SrA) and zinc 
substituted apatites (ZnA) in terms of biofilm inhibition.  
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5.1 Introduction 
Biomaterial-associated infections (BAI) pose great surgical problems, as revision 
surgery is not always easy and patients suffer severe discomfort (Schmidmaier et al., 
2006). Such infections are common in orthopaedic surgery where infection rates 
range from 0.5% to 5%, irrespective of the utilisation of strict hygienic protocols 
(aseptic and sterilisation procedures) and also the systemic administration of 
antibiotic prophylaxis (Hetrick and Schoenfisch, 2006; Virk and Osmon, 2001; 
Lidwell et al., 1984). These infections are the result of bacterial adhesion and 
subsequent colonisation leading to the inevitable biofilm formation at the 
implantation site (Van de Belt et al., 2001; Dougherty, 1988). The introduction of 
bacteria such as Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis 
(S. epidermidis) onto implant surfaces before or during surgery have been 
highlighted as the main causes of such infections (An and Friedman, 1996). 
Therefore, there is a need for a bioceramic coating that will not only have 
osteointegrative properties but can also effectively resist bacterial colonisation. 
 
With regards to this aim, substituted apatites which can deliver added functionality 
to the HA bioactive surfaces, through their antimicrobial impact are of major 
interest. Investigations into the use of ions such as silver (Ag) and zinc (Zn) 
incorporated into HA have shown positive antimicrobial effects (Zhou et al.; 2008; 
Kim et al., 1998). Strontium ions (Sr), typically present in trace quantities in the 
mineral phase of bone, have been reported to have an antimicrobial effect in vitro 
(Lin et al., 2008; Guida et al., 2003). The presence of Zn and Sr has also been shown 
to increase the activity of osteoblast cells in vitro (Capuccini et al., 2008; 
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Caverzasio, 2008; Ito et al., 2002). Several proposed mechanisms have been reported 
for the antimicrobial mode of action for these metal ions, but results have been 
mixed and the mechanisms by which the surfaces produce an antibacterial effect has 
not been fully elucidated. Reported mechanisms include disruption of electron 
transport chain, inhibition of DNA replication, DNA cleavage, membranous 
disruption, reactive oxygen formation and enzyme inhibition (Applerot et al., 2009; 
Park et al., 2009; Feng et al., 2000b; Kim et al., 1998; Faigan et al., 1986; Richards 
et al., 1984; Yakabe et al., 1980; Bragg and Rannie, 1975; Kasahara and Anraku, 
1974). 
 
In this study, CoBlast technology was used to deposit various substituted apatites as 
well as HA onto titanium (Ti) substrates. A range of in vitro tests were undertaken to 
determine if the dopant materials could produce a modified surface which possess 
simultaneously osteoconductive and anticolonising potential and the results were 
interpreted in view of detailed surface characterisation studies.  
 
5.2 Materials and Methods 
The materials and methods used in this chapter are outlined in Chapter 2. Surface 
characterisation techniques were employed to analyse the CoBlast surfaces (HA, 
AgA, SrA, ZnA). This included elemental composition (EDX (n=3 samples)), XPS 
(n=3)), ion concentration (ICP-OES of dissolved coatings in acid (n=3 samples)), 
SEM images of topography and surface roughness (Taylor Hobson (n=3 samples)). 
The in vitro ion release from the surfaces into PBS over 30 days were analysed using 
ICP-OES (n=3 samples). Cell culture tests were performed on the CoBlast surfaces 
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using the commercially available MTT assay which assessed cell viability at day 1 
and 3 (n=4 samples). Information relating to the osteoblast cell viability and 
cytotoxicity are obtained. The antimicrobial efficacy and anticolonising performance 
of the coatings were also assessed using S. aureus (ATCC 1447) as the challenge 
organisms (CFU data are presented in Appendix II). The impact of the released ion 
into PBS over 30 days (n=3 samples) as well as the surface effects of the 
immobilised ion before and after incubation at 30 days was assessed (n=3 samples). 
 
A statistical one-way analysis of variance (ANOVA) was performed to determine 
statistically significant differences between the sample types with a value of p<0.05 
considered to be statistically significant. Following this, the Dunnett’s test was 
applied, to compare values between all the sample data to the control HA sample 
(surface roughness data, MTT assay data, antimicrobial and anticolonising data). 
Two levels of significance was noted for the statistical analysis performed on the 
MTT data using the Dunnett’s test (p<0.01 and 0.001). Multiple comparisons were 
performed between substituted sample types using the Tukey’s post-hoc analysis 
(surface roughness data). 
 
5.3 Results 
5.3.1 Surface Characterisation 
The XPS analysis of the HA coating revealed a surface rich in calcium (Ca), 
phosphorous (P) and oxygen (O), as shown in Table 5.1 and Table 5.2. The modified 
apatites presented with low dopant ion levels of less than 5% atm with the Ag 
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producing the lowest level of dopant ion incorporation and Zn producing the highest 
levels.  
 
Table 5.1: Elemental composition of the coatings via XPS (% atm). 
Coating C O P Ca Ti Ion 
 
HA 17.1 53.9 10.0 15.5 0.6 N/A 
 
AgA 11.3 57.7 13.9 15.6 0 Ag – 0.9 
 
SrA 8.4 53.5 18.2 14.6 0 Sr – 1.9 
 
ZnA 10.0 56.3 13.5 15.2 0 Zn – 3.6 
 
 
Adventitious carbon was also present on all coatings analysed using XPS, as is 
common on apatite coatings. The XPS analysis was largely devoid of Ti signals, 
while low Ti levels were detected in the EDX analysis. This suggests that the low 
levels of Ti detected by EDX are due to high sampling depth (10 µm) of this method 
and not due to incomplete coverage of the surface by the apatite. This would suggest 
that the coating applied is less than 10 µm in thickness as reported elsewhere (O’ 
Neill et al., 2009). On the basis of the low levels of Ti in the EDX results, the Sr 
substituted materials appear to have a higher depth of surface treatment than the 
other materials.  
 
Table 5.2: Elemental composition of coated samples via EDX (% atm). 
Coating O P Ca Ti Ion 
 
HA 65.8 6.7 9.2 14.7 N/A 
 
AgA 69 8.8 10.6 10.1 Ag – 0.6 
 
SrA 68.4 13.0 15.6 1.6 Sr – 1.1 
 
ZnA 68 11.0 12.7 4.5 Zn – 1.9 
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This is supported by gravimetric analysis which revealed a coating mass of between 
0.32 and 1.6 mg/cm2 per coupon, with the Sr substituted apatite coating exhibiting 
the greatest coating mass (Figure 5.1). The concentration of the dopant ions present 
in each coating was determined by dissolving the complete coating in acid and then 
determining the ionic concentrations using ICP analysis (Figure 5.2).  
 
 
Figure 5.1: Coating mass of the various modifications (gravimetric analysis, n=3 
samples ±2SD). 
 
The combination of ICP ion levels, gravimetric analysis and low Ti readings in EDX 
suggests that the highest coating deposition rates were obtained for the Sr and Zn 
substituted materials, with lower levels of deposition being recorded for the HA and 
Ag substituted ceramics. This appears to correlate with the surface roughness values 
detected, with Ra values of 1.7, 2.2, 2.9 and 3.6 µm for HA, AgA, SrA and ZnA 
respectively (Table 5.3).  
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Table 5.3: Surface roughness analysis (Ra, n=3 samples). 
Coating Surface Roughness (µm) (±2SD) 
 
Uncoated Ti 0.4±0.1 
 
HA  1.7±0.3 
 
AgA 2.2±0.3 
 
SrA 2.9±0.3 
 
ZnA 3.6±0.3 
 
 
The surface roughness of SrA and ZnA were observed to be significantly greater 
compared to the HA (p<0.01) (Dunnett’s test). In addition, there were significant 
differences (p<0.01) between all the substituted apatite surfaces using Tukey’s post-
hoc analysis. ICP was used to determine the concentration of ions released into PBS 
buffer from each coating. The % ion release was determined using the initial 
concentration of ions in the coating before elution (Figure 5.2) and the amount 
released in the elution samples over 30 days (Figure 5.3). As seen from Figure 5.3, 
low levels of ions were released over the 30 day period with ZnA producing the 
lowest level of dopant ion release. 
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Figure 5.2: Concentration of dopant ion present in the coatings (ICP-OES analysis, 
n=3 samples ±2SD). 
  
  
Figure 5.3: Cumulative ion release from the coatings over 30 days determined using 
ICP-OES (37 ºC, 150 rpm, n=3 samples ±2SD). 
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It was found that over 90% of the Sr and Zn still remained in the coatings at 30 days 
(Figure 5.4), whereas 90% of the Ag was released, which was found to have a direct 
impact on the antimicrobial properties of the treated surfaces. 
 
 
Figure 5.4: % Ion released from the various coatings over 30 days (37 ºC, 150 rpm, 
n=3 samples ±2SD). 
 
5.3.2 Cell Proliferation and Cytotoxicity 
The extent of osteoblast cell proliferation on the substituted apatite substrates is 
presented in Figure 5.5. Significant differences were noted between sample types at 
day 1 and 3 using one way ANOVA (P<0.05). After 1 day there was a significant 
increase in proliferative rates on the SrA surface (p<0.01) compared to the control 
HA surface. At day 3 there was also a significant increase in cell proliferation on 
both the SrA (p<0.001) and ZnA (p<0.01) surfaces in comparison to the control HA 
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surface, indicating that the surfaces possess osteoconductive potential. No evidence 
of cytotoxicity was observed using MG-63 cells on any of the samples evaluated. 
  
Figure 5.5: Optical density measurements for MG-63 cell proliferation after 1 and 3 
days of incubation (n=4 samples ±SD) (* denotes statistical significance compared to 
the HA control (p<0.01) and ** represents statistical significance compared to the 
HA control (p<0.001) at respective time-points determined using Dunnett’s test)   
 
5.3.3 Antimicrobial Studies 
The antimicrobial properties of the samples were determined for freshly prepared 
samples and for samples that were allowed to elute ions over 30 days. As can be seen 
from Figure 5.6, both AgA and SrA offer promising antimicrobial coatings with 57% 
and 49% kill respectively when freshly prepared. A significant difference was 
determined between sample types at day 0 (p<0.05 using one way ANOVA). The 
AgA surface was observed to have significant effect compared to HA control 
(p<0.05) prior to incubation (Dunnett’s test). On the contrary, ZnA demonstrated 
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low antimicrobial performance (26% kill) against the Gram positive bacterium. After 
30 days of incubation the antimicrobial surface activity of AgA had decreased to 9% 
bacteria cell reduction while the SrA activity remained unchanged (Figure 5.6). One 
way ANOVA revealed no statistical difference between samples at day 30 (p>0.05). 
 
 
Figure 5.6: Antimicrobial activity of the coatings expressed as % kill using S. 
aureus as the bacterial challenge organism before and after elution at 30 days (n=3 
sample ±SD) (* denotes statistical significance compared to HA control before 
incubation (p<0.05) determined using Dunnett’s test). 
 
As well as the antimicrobial properties of the coupons, the antimicrobial impact of 
the ions eluted from the coatings was also investigated by collecting the leachate and 
conducting a separate bacterial challenge and the results are displayed in Figure 5.7. 
In general, low antibacterial activity was observed for the leachate when compared 
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to results obtained from the non leach test. It was found that <26 % kill was obtained 
from the eluted ions irrespective of the surface under investigation.  
 
Figure 5.7: Antimicrobial activity of the released ion from the coatings expressed as 
% kill using S. aureus as the bacterium challenge (n=3 samples ±SD). 
 
5.3.4 Anticolonising Studies  
The ability of the surfaces to inhibit biofilm growth was also assessed over a 14 day 
period and the results are presented in Figure 5.8. All coatings produced a similar 
result at day 1 (32-42% biofilm inhibition). However, the Ag substituted apatite 
coating outperformed the other two surfaces at day 7 and 14. One way ANOVA 
revealed that there were no statistical differences between samples at day 1 and 30 
(p>0.05). However, there was a significant reduction in bacterial numbers recovered 
from the AgA sample at day 7 compared to the control HA surface (p<0.001 using 
Dunnett’s test). 
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Figure 5.8: Anticolonising activity of the coatings expressed as % biofilm inhibition 
using S. aureus as the bacterium challenge (n=3 samples ±SD) (* denotes statistical 
significance between AgA surface and control HA surface at day 7 (p<0.001) 
determined using the Dunnett’s test). 
 
Fluorescent microscopy of the biofilm formation on the HA coated control and the 
AgA sample at day 7 can be seen in Figure 5.9. These images highlight the orange 
stained particles which represent the metabolically active bacterial cells on the 
surface. As can be seen, the AgA sample revealed reduced microbial colonisation 
compared to the HA coated control, as evidenced through dramatically reduced 
levels of viable bacterial cells on the Ag substituted surface.  
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(a) (b) 
Figure 5.9: Fluorescent microscopy of biofilm formation at day 7 x400 
magnification of (a) HA coated control coupon and (b) AgA coated titanium coupon. 
Orange fluorescence indicates cell attachments. 
 
5.4 Discussion 
Irrespective of which coatings are applied on hard tissue implants to enhance the 
osteointegration process, the hosts tissue cells (osteoblasts) and bacterial 
microorganisms compete for the implants surface in a process coined as “race to the 
surface” (Gristina, 1987). Bacteria capable of attaching to the implant surface, 
synthesise a matrix consisting largely of extracellular polysaccharides that 
encompasses the cells to form a biofilm which enables the bacteria to escape the 
effects of antibiotics therapy and host clearance. A colonised implant may rapidly 
result in chronic infection and the only successful treatment is removal of the 
infected implant (Van de Belt et al., 2001). Inhibiting bacterial adhesion is regarded 
as the critical step in preventing implant associated infections thereby, promoting 
10 µm 
  
10 µm 
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tissue interactions with the implant (Jiranek et al., 2006). This study strongly 
supports the potential future use of substituted apatites as orthopaedic and dental 
coatings which could combine excellent osteoconductive properties with the key 
function of infection prevention. 
 
The CoBlast technique was used to deposit coating modifications of less than 10 µm 
resulted in this study. The combination of the ICP measurements, gravimetric 
analysis and low Ti readings in EDX suggests that the highest coating deposition 
rates were obtained for the Sr and Zn substituted materials, with lower levels of 
deposition being recorded for the HA and Ag substituted ceramics. Surface 
roughness is also a key parameter which governs cell attachment which leads to the 
subsequent cell proliferation stage. It has been reported that the CoBlast HA 
significantly increased the surface roughness of blank Ti which also demonstrated 
osteoblastic activity compared to an uncoated Ti surface (O’Hare et al., 2010). In 
this study, it was found that the deposition of the substituted apatites significantly 
increased the surface roughness compared to the HA control with ZnA and SrA 
creating the greatest effect. This would suggest that the thicker and better coating 
coverage associated with both ZnA and SrA (EDX and gravimetric results) lead to 
increased surface roughness as more of the dopant was deposited.  
 
The surfaces examined in this study were all shown to be cytocompatible with no 
evidence of cytotoxicity in the case of MG-63 osteoblast cells. The proliferation 
results (Figure 5.5) appear to agree with the findings of Capuccini et al., who found 
that in comparison to a HA control surface there was an increase in osteoblast 
activity on strontium-substituted hydroxyapatite coatings on a Ti substrate 
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(Capuccini et al., 2008). It has been suggested that Sr may affect cell replication by 
two possible mechanisms; through the triggering of mitogenic signalling pathways or 
the release of autocrine growth factors (Caverzasio, 2008). Ito et al have shown that 
the incorporation of Zn into implant materials may increase bone formation (Ito et 
al., 2002). Low levels of Ag ions are known to be clinically safe, with systematic 
accumulation of 4-6 g required to produce cytotoxic effects in humans (Hardes et al., 
2007; Gosheger et al., 2004). Exposure thresholds of 8.75 mmol/Kg/day of strontium 
produces toxic effects whereas no such data exists for Zn (D’Haese et al., 2000). The 
ion elution data produced herein reveal low levels of ion release, <1 ppm, over the 
duration of the study, which would correlate with the lack of toxicity towards 
mammalian osteoblast cells observed in vitro.  
 
Despite the absence of toxicity observed during the osteoblast proliferation study, the 
surfaces were found to have a significant toxic effect on bacterial cells which were in 
contact with the surface. While the ions eluted from the surface were found to have a 
low level of kill (Figure 5.7), the direct action of the modified surfaces on the 
bacteria produced measurable decreases in bacteria numbers for both the Ag and Sr 
substituted bioceramics (Figure 5.6). Zn was found to have minimal antimicrobial 
properties initially and after 30 days in solution had no measureable antibacterial 
effect against S. aureus.  
 
In the case of the silver coatings, the antibacterial effect was found to diminish with 
time and the coatings had minimal antibacterial properties at day 30. The ion elution 
studies indicate that the low level of Ag ions (4%) remaining in the surface after 30 
days elution is responsible for the reduced kill at this time point. Conversely, the 
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high levels of ions (90%) still present in the corresponding Sr substituted surface 
after 30 days would explain the retention of the antimicrobial properties of that 
surface over the 30 days of the trial.  
 
It is interesting to note that the leachates were not found to perform as well as when 
the modified surfaces were in contact with the microbes. In part, this could be 
attributed to the fact that the concentration of the ions released within the test time 
periods examined (1, 8, 16 days) was low relative to the MIC of the challenge 
organism, S. aureus. The MIC for Ag and Zn has been reported to be 0.5 mg-10 mg/l 
and 200-500 ppb respectively, however no such data exists for Sr (Tapiero and Tew, 
2005; Schierholz et al., 1998). Indeed, Jung et al., demonstrated that a Ag ion 
concentration of 0.2 ppm in solution is necessary to effect log reductions in a S. 
aureus test culture (Jung et al., 2008). However, the ion release rates indicated in 
Figure 5.3 of this study, reveal that such a concentration would not accumulate in the 
coupon leachate until approximately 15 days of incubation.  
 
On the basis of comparisons of the leaching and the non leach tests, the data 
presented herein suggests that the direct contact of microbes with the coating may be 
a significant contributing factor for the antibacterial activity of the samples, as the 
antimicrobial effect was significantly amplified by the presence of the substrate 
surfaces in the non leaching test. It has been reported that a dual antimicrobial 
mechanism exists for substituted apatites, where the antimicrobial action was not 
only attributed to the low release of ions but also from the generation of the free 
radicals from the apatite surface (Matsumoto et al., 2009; Hu et al., 2007). However, 
the mechanisms of kill may not be the same for each of the materials evaluated 
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herein and possible antimicrobial mechanisms are discussed below for each of the 
surfaces.  
 
From the results obtained, the release of Ag ions from the AgA coating would appear 
to contribute to the antimicrobial response, which is in agreement with the literature 
(Kim et al., 1998). However, the poor performance of the leachate in comparison to 
the potency of the direct contact with the surface (non-leach test) suggests other 
mechanisms of antimicrobial action may also be responsible for the activity of silver 
containing surfaces. It is important to note that high local concentrations of Ag ions 
at the surface of the coupon may be responsible for the higher potency observed 
during the non-leach studies compared to the leachate studies. 
 
The mechanistic action of Sr ion is less well understood than that of Ag. Previous 
studies have shown antibacterial effects of Sr ions released from glass cements and 
also Sr containing hydroxyapatites (Liu et al., 2008; Guida et al., 2003). Little is 
currently known with respect to microbial resistance to Sr, as only a limited number 
of published studies on the in vitro or in vivo antibacterial applications of the ion are 
available (Liu et al., 2008; Guida et al., 2003). However, the results suggest a 
significant potential for SrA coatings to be further investigated/developed in 
antimicrobial applications given the sustained antibacterial impact observed in this 
study, when compared with AgA coatings. Moreover, the beneficial effect of Sr ions 
on osteoblast cells creates the possibility to produce a surface which inhibits 
microbial colonisation while simultaneously promoting osteointegration, thereby 
providing an optimal surface for orthopaedic and dental implant fixation. Poor 
antibacterial effects of Zn compounds against S. aureus have been previously 
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reported (Kim et al., 1998) and in the current study, ZnA coatings were not found to 
have significant antimicrobial impact in both leach and non-leach antimicrobial tests. 
  
The % biofilm inhibition attributed to the various coatings assessed over a 14 day 
period illustrated the anti-colonisation potential of the surfaces. The anticolonising 
results revealed that the AgA coating had the greatest impact in preventing microbial 
attachment compared to the other coatings. Both the SrA and ZnA coatings produced 
similar anticolonising performance, although the impact was less effective than AgA 
after day 1. Subsequent qualitative analyses by fluorescence microscopy indicated 
that the AgA coating effectively prevented S. aureus attachment, as opposed to 
inhibiting the proliferation of attached cells as indicated by less orange stained cells 
compared to the HA, Figure 5.9. These observations correlate well with the earlier 
non-leach test results, suggesting the importance of microbe coating surface 
interactions in the observed antibacterial impact.  
 
It is generally accepted that the surface topography of the implants is one of the most 
important parameters that influence cellular reactions. In this study the surface 
composition played more of an important role in cellular adhesion and the 
subsequent proliferation was clearly evident in the MTT assay results. In addition, 
the less rougher surface of the control, HA sample, was observed to be more 
susceptible to colonisation in comparison to the rougher substituted apatite samples 
as seen in the % kill. Direct surface-bacteria interaction appears to control the 
colonisation process and is mediated through the impact of the dopant ion. This 
interaction appears to dominate the colonisation process irrespective of any surface 
topography or ion elution effects. 
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5.5 Conclusions 
A series of substituted apatites (AgA, SrA, ZnA) were effectively deposited onto 
biomedical grade titanium metal. The study presented demonstrates that the surface 
treatments investigated offer the dual benefits of cytocompatible properties essential 
for bone integration with the added potential of microbial colonisation inhibition 
without cyctoxic effects. The direct contact of the microbes with the coating may be 
a significant contributing factor to the anticolonising activity of the samples, as it 
was shown that the antimicrobial effect was significantly amplified by the presence 
of the substrate surfaces. AgA was observed to out-perform both the SrA and ZnA in 
terms of biofilm inhibition. Further optimisation of the coating performance can be 
achieved through varying the loading of the dopant ion, tailoring the elution profile 
and controlling the surface morphology. These novel coatings possess new 
opportunities in orthopaedic and dental applications for impeding infection while 
enhancing osteointegration, thereby increasing the success rate and improved patient 
outcomes for hard tissue implants.  
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    Chapter 6 
6.0  Evaluation of Increased Ion Concentration on the 
Antimicrobial and Anticolonising Properties of Substituted 
Apatite Coatings 
 
Abstract: 
Biomaterial associated infections (BAI) pose a challenge for coatings on hard tissue 
implants. 12% wt apatitic powders substituted with silver (AgA), strontium (SrA) or 
a co-substituted silver-strontium (AgSrA) were deposited. A novel ambient 
temperature blasting process was used to deposit substituted apatites onto biomedical 
grade titanium (V) metal. The potential use of these coatings as an infection 
preventing strategy for application on hard tissue implants was assessed. Surface 
physicochemical properties were determined using EDX, ICP-OES and surface 
proliferometry in addition to surface cytocompatibility assessments using an MG-63 
osteoblast cell line. The antibacterial potential of both the eluted and surface 
immobilised Ag ion to inhibit the growth of a number of clinically relevant strains 
was investigated. Strontium demonstrated enhanced osteoblast proliferation, 
however, a lower inhibition of biofilm (S. aureus) was observed at day 1 compared 
to the other surfaces. AgA exhibited sustained anticolonising activity over the 14 
days with log reduction in CFU achieved. The effects of the co-substituted AgSrA 
did not show enhanced osteoconductive potential or anticolonising properties 
compared to the SrA and AgA surfaces, respectively. As a result of the promising 
anticolonising activity of the AgA, its impact against clinical isolates (MRSA, MSSA 
and S. epidermis) was also investigated. The results revealed that the AgA surface 
demonstrated good antibacterial activity (eluted and immobilised ion) against MRSA 
followed by MSSA, however only good anticolonising activity was observed at day 1 
against MRSA. The AgA surface displayed poor impact against S. epidermis 
compared to the other clinical isolates examined. AgA demonstrates promising 
potential as a coating to combat biomaterial associated infections. 
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6.1 Introduction 
Common clinical problems such as poor bone-implant integration and long term 
stabilisation result from the formation of BAI. Bacterial adherence to biomaterials 
appears to be a pivotal step in the pathogenesis of such infections as it results in the 
formation of a biofilm. Extensive research has been performed to develop surfaces 
for orthopaedic and dental applications, which inhibit bacterial attachment and 
subsequent biofilm formation. Moreover, much interest exits in antimicrobial 
bioceramic surfaces that enhance tissue integration and resist microbial colonisation.  
 
Studies using antimicrobial ions such as silver (Ag), zinc (Zn), copper (Cu) and 
strontium (Sr), which were formulated into calcium phosphate (CaP) materials have 
shown positive in vitro results against different bacterial micro-organisms 
(Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa, Escherichia coli, 
Staphylococcus epidermis (S. epidermis)) (O’Sullivan et al., 2010; Matsumoto et al., 
2009; Chen et al., 2008; Lin et al., 2008; Zhou et al., 2008; Hu et al., 2007). The 
release of Ag ions ensured excellent antibacterial activity (95% kill) from silver 
containing hydroxyapatite (HA) coating against S. aureus (Chen et al., 2008) and 
similar findings were observed in other studies (O’Sullivan et al., 2010). Recently, it 
has been reported that Ag loaded HA demonstrated good osteogenic properties with 
low toxicity in vitro (Roy et al., 2012; Sandukas et al., 2011; Ruan et al., 2009). 
Antibacterial activity against MRSA in vitro (Ando et al., 2010) and in vivo 
(Shimazaki et al., 2010) has also been reported. The redox nature of the Ag and Cu 
formulated into HA was responsible for producing radicals and together with 
released antibacterial ions were responsible for its antibacterial activity (Hu et al., 
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2007). A synergistic effect was observed by Matsumato et al. when a co-substituted 
HA apatite consisting of AgZn or AgCu was used (Matsumoto et al., 2009).  
 
In Chapter 5, CoBlast was used to deposit a series of substituted apatites (5% wt 
AgA, ZnA and SrA) on Ti substrates. AgA was observed to outperform the other 
samples analysed while SrA demonstrated enhanced osteoblast proliferation. It was 
found that 5% wt AgA exhibited promising results in preventing microbial 
attachment over a 14 day period with 91% biofilm inhibition at day 7.  
 
In this study, 12% wt AgA and SrA was assessed for improved performance 
compared to the lower substituted ion content (5% wt). Additionally, based on the 
promising results in earlier studies a co-substituted apatite incorporating Ag and Sr 
(AgSrA) at a concentration of 12% wt was also examined. A preliminary study was 
undertaken to investigate the anticolonising and osteoconductive potential of a series 
of apatite surfaces HA, AgA, SrA and AgSrA using a standard strain S. aureus 
(ATCC 1448) and MG-63 osteoblast cells, respectively. This was performed to 
define the best surface for subsequent microbial studies using clinical isolate strains 
relevant for orthopaedic applications. The efficacy of the chosen surface was 
examined using methicillin resistant S. aureus (MRSA), methicillin susceptible S. 
aureus (MSSA) and S. epidermis. The isolates used in this study were isolated from 
device-related infections by the clinical microbiology laboratory of Beaumont 
Hospital, Dublin, Ireland.  
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6.2 Materials and Methods 
The materials and methods used in this chapter are summarised in Chapter 2. 
Surface characterisation techniques were employed to analyse the CoBlast surfaces 
(HA, AgA, SrA, AgSrA). This included elemental composition (EDX (n=3 samples), 
ion concentration (ICP-OES (n=3 samples), surface roughness (Taylor Hobson, (n=3 
samples). The in vitro ion release from the surfaces into PBS over 30 days (days 1, 7, 
14 and 30) were analysed using ICP-OES (n=3 samples). The MG-63 cell 
proliferation was determined by measuring the optical density (OD) after 1 and 4 
days incubation to determine osteoblast cell viability as an indication of 
osteoconductivity and surface toxicity (n=3 samples). To investigate the 
anticolonising activity of the substituted apatite coatings, an initial quantitative 
assessment of biofilm formation on the coated coupons was carried out at day 1 and 
14 after incubation in LB broth using S. aureus (ATCC 1448) as the bacterial 
challenge organism. Following this analysis, one CoBlast surface was chosen for 
further microbiological studies using clinical isolates as outlined in Section 2.6. The 
antimicrobial efficacy of the released ion into PBS at different time points (7, 14, 30 
days) was assessed (n=3 samples). The antimicrobial effects of the surface 
immobilised ion before and after incubation at various time points (7, 14, 30 days) 
was assessed (n=3 samples). Finally, the anticolonising activity of the CoBlast 
surfaces at day 1 and 14 were assessed.  
 
One way analysis of variance (ANOVA) was used to determine statistical 
differences between samples, with p values <0.01 deemed significant. Comparison 
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with HA was performed using Dunnett’s test (surface roughness (Ra), anticolonising 
data using S. aureus). Tukey’s post-hoc analysis was used to determine statistically 
significant differences between substituted apatite samples (surface roughness (Ra)). 
Kruskal-Wallis test was conducted to determine if there was a significant difference 
between samples. Where significant levels of p<0.05 were determined, Dunn’s test 
was performed (MTT assay). Mann-Whitney U test was performed to compare two 
samples (antimicrobial activity and anticolonising data using the clinical isolates). 
 
6.3 Results 
6.3.1 Surface Characterisation 
EDX analysis was carried out to determine the elemental composition of the 
coatings. The results obtained are presented in Table 6.1, which illustrates that the 
surfaces are composed largely of calcium (Ca), phosphorous (P) and oxygen (O). 
The underlying Ti substrate was not observed for the SrA and AgSrA coatings 
indicating that good coverage and a thick coating was deposited (10 µm). However, 
the Ti levels of AgA and the HA control was determined to be 9% atm and 20% atm 
respectively suggesting that the thinnest coating was obtained for AgA. The 
substituted ion concentrations in the coatings were determined to be 1 and 5 % atm 
for the AgA and SrA coatings respectively, whereas the AgSrA coating was 
composed of 1 % atm Ag and 3 % atm Sr. ICP-OES analysis of the coatings revealed 
similar trends. The levels of Sr ion present in SrA and AgSrA were observed to be 
higher than the Ag content in AgA and AgSrA. The surface roughness values 
obtained, outlined in Table 6.1, reveal that the substituted apatite coatings were 
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significantly rougher (2.0-2.3 µm) (p<0.05) compared to the HA control (1.2 µm) 
(Dunnett’s test). However, there was no significant difference between the 
substituted apatite samples (p>0.05) (one way ANOVA). 
 
Table 6.1: Surface characterisation of the coated samples including EDX, surface 
ion concentration, surface roughness and % ion release at day 30 (n=3 samples). 
Surface roughness, surface ion concentration and % ion release values are reported 
±2SD. 
 SEM-EDX (% atm) Surface 
roughness 
Ion (ppm) % Ion 
Release at 
day 30 
Coating O Ca P Ti Ion Ra (µm) (ICP-OES) (ICP-OES) 
HA 65 12 15 9 N/A 1.2±0.2 N/A - 
 
AgA 64 7 8 20 1 
 
2.2±0.5 7.0±0.4 17±5 
SrA 68 12 15 0 5 2.0±1.0 55.0±22.9 6±3 
 
AgSrA 68 13 15 0 1-Ag, 
3-Sr 
2.3±0.5 7.0±0.5 Ag, 
30.0±0 Sr 
16±1 Ag,  
13±2 Sr 
 
 
In vitro ion release in PBS over 30 days was quantified using ICP-OES (Figure 6.1). 
The total ion release at day 30 expressed as a percentage of total ion content present 
in the coated sample is listed in Table 6.1. There was a linear release of the Ag ion 
from the AgA coating from 0.3 ppm at day 1 to 1.2 ppm at day 30 (R2=0.9922), 
which corresponded to 17% of the total Ag ion present in the coating being released. 
A lower % ion release was observed for the SrA coating with 6% Sr release at day 
30 (3.4 ppm). Both the concentration of Sr and Ag ions from the AgSrA coating 
were seen to gradually increase from day 1 (0.3 ppm Ag, 1.8 ppm Sr) to day 30 (1.1 
ppm Ag, 4 ppm Sr). The overall % ion release from the AgSrA coating at day 30 was 
determined to be 16% Ag and 13% Sr. Similar % Ag release was noted, with higher 
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% elution of Sr ions from the AgSrA surface when compared to the single doped 
samples (Table 6.1).  
 
  
Figure 6.1: Ion release from the substituted apatite samples over 30 days as 
determined by ICP-OES (n=3 samples ±2SD).  
 
6.3.2 Cell Proliferation and Cytotoxicity  
Cytocompatibility of the modified surfaces was determined via a MTT assay and the 
osteoblast proliferation results are presented in Figure 6.2. Significant differences 
between samples for day 1 and 4 were noted using the Kruskal Wallis test (p<0.05). 
After day 1 and 4, SrA was seen to have a significant impact on cell viability 
(p<0.01) compared to the HA control surface indicating the osteoconductive 
potential of this coating (Dunn’s test). At day 1 and 4, the cell proliferation results of 
the AgA and the AgSrA surfaces were comparable to the HA surface with no 
statistical differences noted (p>0.05) (Dunn’s test). The combination of Ag with Sr 
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in the AgSrA coating resulted in decreased MG-63 cell proliferation on the surface 
compared to the SrA sample at day 1 and 4. Irrespective of these finding, cell 
proliferation was observed on all surfaces at day 4, however AgA and AgSrA did not 
match the performance of the well documented osteoconductive HA surface 
(Arinzeh et al., 2005; Borsari et al., 2005; Stoch et al., 2005). There was no evidence 
of cytotoxicity observed using MG-63 cells on any of the surfaces assessed.  
 
 
Figure 6.2: Optical density measurements of MG-63 osteoblast cells at day 1 and 
day 4 (n=3 samples with median values presented) (* denotes statistical significance 
compared to the HA control (p<0.01) using Dunn’s test).  
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6.3.3 Preliminary Study to Ascertain the Best Anticolonising Coating Using a 
Standard Strain  
The anticolonising behaviour of the 12% wt substituted apatite coatings at day 1 and 
14 (Figure 6.3) was evaluated using S. aureus in order to select the 12% wt coating 
with the most promising anticolonisation potential for subsequent microbiology 
characterisation using clinical isolate strains (CFU data presented in Appendix III).  
 
 
Figure 6.3: Anticolonising activity of the coatings using S. aureus as the challenge 
organism (ATCC 1448) at day 1 and 14 (n=3 samples ±SD) (* denotes statistical 
significance compared to the HA control (p<0.05) and ** represents statistical 
significance compared to the HA control (p<0.01) at respective time points using 
Dunnett’s test). Inset, the log reduction in CFU is also presented. 
 
AgA was found to demonstrate a 100% biofilm inhibition at day 1 and was 
statistically significant (p<0.01) at day 14 (90% biofilm inhibition) (Dunnett’s test). 
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In addition, a significant anticolonising impact (p<0.05) was revealed for the AgSrA 
surface at day 1. As can be seen from Figure 6.3, the AgA coating was observed to 
give the best performance in preventing microbial attachment as indicated by the % 
biofilm inhibition data and the log reduction in CFU data over the time scale. 
 
Despite the favourable impact on the viability of osteoblastic cells demonstrated by 
SrA, it exhibited the lowest anticolonising performance compared to the other 
surfaces analysed (0.3-0.1 log reduction in CFU). As a result of the promising 
osteoconductive potential of the 5% wt SrA and the anticolonising activity of the 5% 
AgA and SrA surfaces evaluated in a previous study (O’Sullivan et al., 2010), a 
combination apatite AgSrA, was specifically investigated for improved performance 
in this study. As the Ag concentration and release profile of the AgSrA were similar 
to the AgA surface (Table 6.1 and Figure 6.1), it was expected to perform at least as 
well as AgA if not better due to the potential for a synergistic effect by incorporating 
Sr in the AgSrA coating. The AgSrA resulted in 71% biofilm inhibition at day 1 
however, this was observed to decrease to 13% at day 14 and to perform better than 
SrA at day 1 only. The outcome from this study was that 12% wt AgA surface was 
chosen for subsequent antimicrobial and anticolonising studies using clinical isolate 
strains.  
 
6.3.4 Antimicrobial Studies 
In this study, the microbial impact (expressed as CFU, % kill and log kill) of the 
released Ag ion from the coupon surface as well as from the immobilised ion on the 
12% wt AgA surface was investigated. The antibacterial effect of the released Ag ion 
towards the clinical isolates is given in Table 6.2.  
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Table 6.2: Antimicrobial activity of the released Ag ion from AgA coating using 
clinical isolates (MRSA, MSSA, S. epidermis) as the bacterial challenge organisms 
(n=3 samples with median values presented for CFU which was used to calculate the 
% kill and log kill). 
    day 7 day 14 day 30 
Strain Sample 
CFU 
median 
 
% 
kill 
  
log 
kill 
CFU 
median 
 
% 
kill 
 
log 
kill 
CFU 
median  
 
% 
kill 
 
log 
kill 
MRSA HA 3.1E+06  -  - 7.0E+06  -  -  5.7E+06  -  - 
  AgA 3.3E+04 99 2.0 2.5E+03 100 3.4 5.3E+05 91 1.0 
MSSA HA 8.3E+06 -  -  2.9E+07  -   -  1.5E+07  -   -  
  AgA 5.1E+06 39 0.2 2.0E+06 93 1.2 4.0E+06 73 0.6 
S. 
epidermis HA 1.9E+07  -  - 1.7E+07  -  -  1.7E+07  -   -  
  AgA 4.0E+06 79 0.7 1.0E+06 94 1.2 5.0E+06 71 0.5 
 
The released Ag ion exhibited excellent antimicrobial activity against MRSA over the 
30 days (91-100%), which corresponds to >1 log reduction in CFU observed over 
the time period. Statistical analysis revealed significant differences (p<0.05) between 
AgA and HA at day 7 and 30 (independent-sample Mann-Whitney U test). The 
susceptibility of MSSA ranged between 39-93% whereas the released Ag ion 
demonstrated a 71-94 % bactericidal effect against S. epidermis. A lower reduction 
in CFU (log kill) for the MSSA and S. epidermis isolates compared to the MRSA with 
maximum impact achieved at day 14 in both cases was observed. 
 
The antibacterial activity of the Ag ion immobilised on the surface against the 
clinical isolates strains prior to and after incubation in PBS (7-30 days) is presented 
in Table 6.3. This analysis represents the bactericidal activity of the ions present on 
the surface which are in direct contact with the bacteria before and after ion elution. 
Before incubation in PBS, the impact of the AgA surface was determined to be 98%, 
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94% and 92% against MRSA, MSSA and S. epidermis, respectively, Table 6.3. 
Statistical analysis revealed significant surface impact at day 0 for AgA against 
MRSA (p<0.05) (Mann-Whitney U test). Following incubation, the surface effect of 
the residual Ag ion at day 14 maintained an excellent antibacterial effect (100%) 
against the MRSA cells, however this was seen to reduce to 73% kill at day 30. The 
impact of the AgA surface against MSSA and S. epidermis ranged between 88-94% 
over the 14-30 day incubation period which approximates to a log reduction in CFU 
values of 1. 
 
Table 6.3: Antimicrobial activity of the immobilised ion in the AgA coating against 
clinical isolates (MRSA, MSSA, S. epidermis as the bacterial challenge organisms 
before (day 0) and after coupon incubation for 14 and 30 days (n=3 samples with 
median values presented for CFU which was used to calculate the % kill and log 
kill). 
 incubation   day 0 day 14 day 30 
Strain Sample 
CFU  
 
% 
kill 
  
log 
kill 
CFU  
 
% 
kill 
 
log 
kill 
CFU  
 
% 
kill 
 
log 
kill 
MRSA HA 2.8E+06  -   - 4.2E+06  -   -  1.5E+07  -   -  
  AgA 6.4E+04 98 1.6 1.00E+00 100 6.6 4.0E+06 73 0.6 
MSSA HA 9.7E+06  -   -  1.8E+07  -   -  1.9E+07  -   -  
  AgA 6.0E+05 94 1.2 1.0E+06 94 1.3 2.0E+06 89 1.0 
S. 
epidermis HA 8.9E+06  -   -  1.9E+07  -   -  1.9E+07  -   - 
  AgA 7.5E+05 92 1.1 2.0E+06 89 1.0 2.33E+06 88 0.9 
 
6.3.5 Anticolonising Studies 
The anticolonising effect of the AgA coating against the clinical strains MRSA and 
MSSA is presented in Figure 6.4 (CFU data is presented in Appendix III). This 
analysis focuses on the combination of the immobilised surface ion and ion release 
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to prevent bacterial attachment. The AgA was seen to inhibit MRSA biofilm growth 
by 90% at day 1 which reduced to 54% at day 14. Whereas biofilm formation 
associated with MSSA growth was inhibited by 50% at day 1, no impact was 
observed at day 14. The AgA surface was not seen to demonstrate any inhibitory 
activity against S. epidermis attachment over the 14 days (0% biofilm inhibition). 
The only log reduction in bacteria attachment achieved was at day 1 against MRSA, 
however statistical analysis revealed no significant differences between samples at 
the different time points (p>0.05 using the Mann-Whitney U test).  
 
 
Figure 6.4: Anticolonising effect of the AgA coating using the clinical strains MRSA 
and MSSA as the bacteria challenges. S. epidermis is not presented here as it failed to 
inhibit biofilm formation (n=3 samples).  
 
Fluorescent microscopy of the biofilm formation on the HA control and the AgA 
substrates at day 1 using the three clinical isolate strains can be seen in Figures 6.5-
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6.7. The orange stained particles seen in these images indicate the presence of 
metabolic active bacterial cells. In the case of surfaces incubated with MRSA it can 
be seen that a reduced number of microbial colonies are attached to the AgA surface 
(Figure 6.5 (b)), compared to the control HA surface (Figure 6.5 (a)). Evidence of a 
reduction in metabolically active MSSA cells was observed on the AgA surface 
(Figure 6.6 (b)) compared to the HA control (Figure 6.6 (a)). However, this was not 
observed in the case of the S. epidermis strain Figure 6.7. These images suggest that 
AgA performed the best against MRSA which supports the findings as detailed in 
Figure 6.4. 
 
(a) 
 
  
(b) 
Figure 6.5: Fluorescent microscopy of biofilm formation at day 1 x400 
magnification using MRSA as the bacterial challenge organism on the (a) control HA 
coating and (b) AgA coating. 
10 µm 
  
10 µm 
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(a) (b) 
Figure 6.6: Fluorescent microscopy of biofilm formation at day 1 x400 
magnification using MSSA as the bacterial challenge organism on the (a) control HA 
coating and (b) AgA coating. 
 
(a) (b) 
Figure 6.7: Fluorescent microscopy of biofilm formation at day 1 x400 
magnification using S. epidermis as the bacterial challenge organism on the a) 
control HA coating and b) AgA coating. 
 
 
10 µm 
  
10 µm 
  
10 µm 
  
10 µm 
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6.4 Discussion 
It is well established that biofilm formation, characterised by micro-colonies 
enveloped in a protective extracellular biopolymer matrix is often associated with 
implant infection. Such infections are caused by bacteria introduced from trauma, 
surgery, implant use, by direct colonisation from a proximal infection or via systemic 
circulation (Wu and Grainger, 2006; An and Friedman, 1996). Biofilm forming 
bacteria exhibit increased protection from the hosts defence mechanism and 
enhanced resistance to antibiotic treatment (Zilberman and Elsner, 2008; Hetrick and 
Schoenfisch, 2006; Rupp et al., 1999; Van de Belt et al., 1999) which drastically 
leads to the failure in eradicating BAI. A large proportion of all BAI are caused by 
the gram positive staphylococcus genus, S. aureus and S. epidermis (Campoccina et 
al., 2006; An and Friedman, 1996) with prevalence of methicillin resistant strains 
emerging (Van Houwelingen, 2012). It has been reported that out of 81% of S. 
aureus infections recorded, 61% of these were MRSA in origin. S. epidermis is the 
most frequently isolated species of coagulase negative staphylococcus (CNS) 
isolated form BAI (Rupp et al., 1999). 
 
To address this problem, this study examines the use of a coating system based on a 
CaP material loaded with metal ions, which has potential antibacterial and 
osteoconductive properties to overcome the limitations associated with current 
treatment regimes. This study further supports the findings from a previous study by 
O’Sullivan et al., which investigated the use of 5% wt substituted apatites (AgA, 
ZnA, SrA) and concluded that AgA demonstrated promising anticolonising 
properties without compromising the osteocompatibility of the bioactive CaP surface 
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layer. The anticolonising activity of the substituted apatites was the result of the 
combined antibacterial properties of both the released and the immobilised ions on 
the coating surface (O’Sullivan et al., 2010) 
 
The 12% wt AgA demonstrated excellent inhibition of S. aureus attachment (>90%) 
over the 14 days and outperformed the other surfaces assessed in this study. It was 
also observed to be superior to the 5% wt AgA sample evaluated previously which 
only resulted in 18% biofilm inhibition at day 14. (O’Sullivan et al., 2010). Even 
though, there was only 1.21 ppm of Ag released over the 30 days, the lowest 
increment released was 0.3 ppm, which is more than the minimum concentration (0.2 
ppm) required to elicit a log reduction response to S. aureus (Jung et al., 2008). In 
addition, 83% of the Ag ion had remained on the surface at day 30 for 12% AgA 
(Table 6.1) compared to only 10% for 5% wt AgA (O’Sullivan et al., 2010). The 
difference in the initial concentration of Ag ions present in the coating between the 
5% and 12% wt loadings (1 ppm and 7 ppm, respectively) greatly influenced the 
amount of ion released and the concentration of the Ag remaining on the surface 
following ion elution over a 30 day period. It is obvious, that the higher loading of 
the 12% wt AgA contributed to the enhanced anticolonising activity observed 
compared to the 5% wt AgA. The 12% wt AgA proved successful in preventing the 
growth of the S. aureus biofilm in the anticolonising studies performed. However, 
irrespective of the increased ion concentration (6-7 times more Ag and Sr for AgA 
and SrA) for the 12% wt apatites, comparable surface roughness values of 2.0-2.3 
µm were observed for the 5% wt and 12% wt substituted apatites (O’Sullivan et al., 
2010).  
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While Ag possesses antibacterial properties for a broad spectrum of bacterial strains, 
it is relatively non-toxic to human cells (Alt et al., 2004). The maximum amount of 
Ag that could be released in this study (7 ppm) is below the critical level of 
cyctotoxicity reported in literature (10 ppm) (Vik, 1985), and supports the findings in 
this study that demonstrated the cytocompatibility of the AgA coating. In a previous 
study by Ruan et al., <1 ppm of Ag ions were released over 49 days and the research 
also demonstrated that that the osteoconductivity of the HA coating was not reduced 
with the addition of the Ag (Ruan et al., 2009). A balance between 
osteocompatability and antimicrobial property was achieved with 2-4% wt Ag in a 
HA coating, however reduced osteoblast cell proliferation was observed when 6% wt 
Ag was incorporated into a HA coating (Roy et al., 2012). There was no evidence of 
cytotoxicity observed using MG-63 cells on any of the surfaces assessed in this 
study, however SrA did demonstrate enhanced viability of osteoblastic cells 
compared to the other apatitic surfaces assessed. This is in agreement with previous 
studies using the 5% wt SrA (O’Sullivan et al., 2010) and other research (Capuccini 
et al., 2008). The 12% wt AgA was found to be cytocompatible with comparable 
levels of cell proliferation to the HA surface, however further in vitro and in vivo 
measures of osteoconductivity are required to elucidate it potential as an 
osteoconductive surface. This study highlights the importance of material 
optimisation in formulating implant coatings with comparable osteoconductive 
properties to HA and with an added anticolonising behaviour. 
 
Established studies have reported an enhanced antibacterial activity when the 
bioceramic was loaded with two metal ions such as AgCu or AgZn (Matsumoto, 
2010) and Sr and fluoride (F) (Guida et al., 2003). Despite the potential for 
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synergistic behaviour in the combined AgSrA coating, it did not perform as well as 
the single substituted apatites. Enhanced anticolonising behaviour was observed at 
day 1 only for the AgSrA surface with no significant difference in osteoblast cell 
viability compared with that of AgA. Even though more Sr was present for the 12% 
wt SrA (4.5 times) which resulted in 3 times more Sr being eluted from the surface 
over the 30 days compared to the 5% wt SrA, poor anticolonising activity was 
observed for both loadings over the two week incubation period with S. aureus (43% 
and 3% biofilm inhibition for 12% and 5% wt respectively) (O’Sullivan et al., 2010). 
This would suggest that SrA was not as effective an antibacterial metal ion compared 
to Ag. It is obvious that the addition of the Sr undermined the performance of the 
Ag. There is very little understanding of the antibacterial mechanism of Sr only that 
the release of the ion (Sr2+) is important for the antibacterial action (Lin et al., 2008). 
The oxidative state of the poorly soluble Ag ions may have also contributed to this 
unexpected result as the antibacterial activity of Ag is dependent on the Ag cation 
(Ag+) (Chen et al., 2008; Chen et al., 2006). If the silver is bound then it has no 
function (Hardes et al., 2007). It is reported that the addition of metal ions change 
the overall structure of the CaP (Matsumoto et al., 2009; Guida et al., 2003) and 
perhaps this may have influenced the variability in performance observed for the 
samples. The combination of Sr and Ag in the coating may have affected not only 
the ion loading but also the distribution, solubility and release of the active metal 
ions from the surface. In a study by Lin et al., they reported that the morphology, 
crystallinity and the antibacterial properties of HA were altered when half or all the 
Ca ions were substituted with Sr (Lin et al., 2008). Further work would be required 
to elucidate this.  
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More recently, the antimicrobial action has been attributed to not only the low levels 
of Ag released but also from the formation of lethal free radicals as a result of the 
redox nature of silver on the surface (O’Sullivan et al., 2010; Matsumoto et al., 
2009; Hu et al., 2007). All these mechanisms contribute to the complete 
degeneration and ultimate death of the bacterial cells. To demonstrate antibacterial 
efficacy, a reduction of three or more orders of magnitude in the number of CFU is 
needed (Troitzsch et al., 2009). From the antimicrobial studies, the bactericidal 
effect of the released Ag ion against MRSA was evident over the 30 days (91-100%), 
whereas the highest % kill was only achieved at day 14 only for MSSA and S. 
epidermis (93% and 94% respectively). MRSA was more susceptible to the released 
Ag ion compared to the other two clinical isolates with a log kill of 3.4 at day 14 
whereas a 1 log reduction in CFU numbers was only achieved at day 14 for both 
MSSA and S. epidermis. 
 
The surface impact of the immobilised Ag ion demonstrated the highest 
antimicrobial activity before incubation in the order of MRSA (98%), MSSA (94%) 
and S. epidermis (92%). Subsequent analysis of the surfaces after ion release 
revealed approximately 1 log kill against MSSA and S. epidermis with improved log 
kill observed against MRSA (1.6-6.6) up to day 14 but decreased to <1 log kill at day 
30. The AgA surface performed the best at preventing MRSA attachment (90% 
biofilm inhibition) followed by MSSA which had only impact at day 1 (50% biofilm 
inhibition). However, the AgA surface did not exhibit inhibition of S. epidermis 
colonisation. The combined antimicrobial effect from the released ion and the 
immobilised ion, which demonstrated approximately 1 log kill over the 30 days 
(Table 6.2 and Table 6.3), was not effective in eradicating the biofilm growth 
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associated with this strain. MSSA demonstrated some biofilm inhibition at day 1 
(45%) only. The combined results of the study suggest that MRSA was the most 
susceptible strain. A number of studies have reported the bactericidal effect of Ag 
loaded HA surfaces against MRSA in vitro which demonstrated higher impact 
compared to S. aureus strains (Yonekura et al., 2011; Noda et al., 2008).  
 
However, the difference in the clinical isolate performance can be attributed to the 
nature of the strains and the different factors which impact on adherence to surfaces 
and biofilm development for each strain. It has been reported that biofilm producing 
staphylococcus adhere to implants in greater numbers than non producing strains 
(O’Gara and Humphreys, 2001; Rupp et al., 1999). The images in Figure 6.6 (a), 6.7 
(a) and 6.8 (a), clearly indicates the presence of bacterial attachment on the HA 
control and also on the AgA sample for S. epidermis (Figure 6.8 (b)). However, there 
are reduced numbers of active microorganisms MRSA and MSSA on the AgA surface 
(Figure 6.6 (b) and 6.7 (b) which supports the biofilm inhibition data. The adherence 
of S. epidermis to the implant surface involves the rapid attachment mediated by 
non-specific factors such as surface properties of the implant and also by specific 
adhesins (e.g. polysaccharide intercellular adhesion (PIA) and accumulation 
associated proteins (AaP)). On the other hand, the adherence of MRSA is more 
dependent on the presence of the host-tissue proteins (fibronectin and fibrinogen) 
(O’Neill et al., 2009; O’Gara and Humphreys, 2001). The fact that the AgA has a 
higher surface roughness compared to the control may have affected the 
anticolonising behaviour of S. epidermis, as it is well established that rougher 
surfaces provide more favourable sites for S. epidermis colonisation (Sousa et al., 
2009).  
Chapter 6: Evaluation of increased ion concentration on the antimicrobial and anticolonising 
properties of substituted apatite coatings 
 
Page | 166  
 
Moreover, it has been reported that there is a processing window whereby 10 mg/l of 
Ag is the maximum toxic concentration for human cells (Vik et al., 1985). As a 
result, an increase in Ag content in the coating could be incorporated into the surface 
to adequately reduce bacterial adhesion and biofilm formation as well as minimising 
cytotoxic risks. CoBlast offers an alternative process for depositing silver loaded 
apatitic powders as it does not alter the chemical composition of the starting material 
(O’Sullivan et al., 2011). CoBlast offers a number of advantages over the traditional 
deposition processes used to coat metals with Ag loaded apatitic powders included 
plasma, sol-gel and thermal techniques. The sol-gel technique used by Chen et al., 
was a time consuming process where it was reported that a minimum of 6 days was 
required to produce the coatings (Chen et al., 2007b). The magnetron co-spluttered 
process required an additional heat treatment step so as to increase the crystallinity 
of the coating (Chen et al., 2006). Decomposition of the HA was reported during the 
thermal and plasma spraying processes (Roy et al., 2012; Ruan et al., 2009; Zheng et 
al., 2009; Noda et al., 2008; Chen et al., 2008; Chen et al., 2007b; Chen et al., 
2006). Secondary phases such as tricalcium phosphate (TCP), calcium oxide (CaO) 
and tetracalcium phosphate (TTCP) were all observed in the coating as a result of the 
high temperature deposition process of plasma spraying (Roy et al., 2012). 
Therefore, the antibacterial results here for the S. aureus related strains are promising 
and have important implications for the development of an antimicrobial strategy 
using metal ion based technology to control BAI.  
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6.5 Conclusions 
Silver has been known to have a strong inhibitory and bactericidal effect as well as a 
broad spectrum of antimicrobial activities. This study offers an AgA surface as a 
strategy to treat and prevent infections associated with hard tissue implants at the site 
of implantation in order to deliver antibacterial effect against harmful bacteria while 
maintaining cytocompatibility. Together with an increase in the release of the Ag ion 
and the residual surface Ag, it is not surprising therefore, that the AgA surface 
exhibited superior performance compared to the 5% wt AgA coating. AgSrA 
demonstrated promising anticolonising activity at day 1, however the effect 
decreased at day 14. No improvement in the anticolonising behaviour was observed 
with SrA even with increasing the Sr ion content of the coating. More research is 
required to establish the mechanism. Optimisation of the AgA formulation is still 
required to enable more profound impact on clinical relevant strains whilst 
developing its osteoconductive potential. Considering the demand for an 
antibacterial implant, the AgA demonstrates a great potential to be used in an in vivo 
setting.  
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      Chapter 7  
7.0 In Vivo Evaluation of Silver Substituted Apatite 
Coatings to Combat Infection on Hard Tissue Implants 
 
Abstract: 
Biomaterial associated infections (BAI) remain a serious complication in 
orthopaedic surgery. In addressing this problem, it has been previously reported that 
CoBlast was used to deposit apatitic powders onto biomedical grade titanium (Ti) 
Kirshner wires (K-wires) including a silver (Ag) loaded powder. The coating 
demonstrated anticolonising activity and uncompromised the osteoblast cell viability 
compared to a standard hydroxyapatite (HA) coating in in vitro studies. In this study 
the use of Ag loaded apatite at two different loadings are evaluated as an infection 
preventative coating for hard tissue implants using an in vivo study nude mouse 
model. Two Ag containing apatitic powders loaded at concentrations of 5% wt and 
12% wt were assessed and compared to a standard HA coating. Chemical 
composition and morphology of the surface were assessed using EDX and SEM. 
Assessment of bacterial adherence on coated K-wires following subcutaneous 
implantation in a nude mouse infection model for two days demonstrated that the 
12% wt surface outperformed the 5% wt AgA coating. Inflammation and systemic 
responses were investigated. Lower inflammatory responses were activated with the 
insertion of the Ag loaded K-wires, in addition the infection remained localised at 
the implantation site over the two day study period. These results indicate that the 
AgA coating on the surface of orthopaedic implants demonstrate good 
biocompatibility whilst inhibiting bacterial adhesion and colonising of the implant 
surface.  
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7.1 Introduction 
Staphylococci bacteria are a prevalent cause of BAI associated with prosthetic and 
indwelling medical devices such as orthopaedic implants. These infections are 
categorised as acute, subacute and late infections depending on the time of onset. 
Perioperative bacterial seeding has been highlighted as the main cause of acute and 
subacute infections detected twelve weeks to one year after the implant operation. 
However, the haematogenous transmission of bacteria has been reported as a 
possible cause of late infection which develops years after implantation (Gristina and 
Jolkin, 1993). These chronic infections are related to biofilm formation on the 
implant surface and bacterial adherence has been established as a critical step in the 
pathogenesis of BAI. Bacteria adherence is a complex multi-step process and was 
reviewed in Chapter 1. Biofilm formation poses a serious clinical complication as 
successful treatment often requires the removal of the contaminated implant coupled 
with extensive bone debridement, excision of infected tissues and bone and 
prolonged antibiotic treatment (Van Houwelingen, 2012).  
 
In recent years, Ag coated medical devices for heart valves, cardiac catheters and 
urinary catheters have been proven to reduce BAI (Brutel de la Riviere, 2000; 
Karchmer et al., 2000; Boswald et al., 1999). Its properties and application are 
reviewed in Chapter 1 and in vitro evaluation of its inclusion in CaP coatings for 
hard tissue applications are outlined in Chapters 5 and 6.  
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A number of techniques to deposit bioactive coating layers containing 
hydroxyapatite (HA) onto metallic and inert substrates for hard tissue implants have 
been investigated (Li et al., 2009; Stoch et al., 2005, Stoch, 2001). The drawbacks 
with these methods have also been reviewed in Chapters 1, 3 and 4.  
 
A number of studies have demonstrated the efficacy of these bioceramic coatings 
with antimicrobial activity against a wide range of bacterial strains in vitro 
(O’Sullivan et al., 2010; Matsumoto et al., 2009; Chen et al., 2008; Lin et al., 2008; 
Hu et al., 2007; Feng et al., 1998), however few have examined the coating 
performance in an in vivo model. Various animals models are available to study 
osteomyelitic infections, which include the direct inoculation of bacterium localised 
at the site of implantation, precolonising the implant with bacteria prior to 
implantation, the intravenous administration of the inocula post implantation or a 
mixture of these methods. How the inoculums are introduced greatly influences the 
bacteria growth (Van Wijngaerden et al., 1999). Studies investigating precolonised 
implant versus direct inoculation models have been investigated, mixed results have 
been reported (Sheehan et al., 2004; Kadurugamuwa et al., 2003). Comparing in 
vitro and in vivo results are often difficult due to the complexity of the factors 
affecting biofilm formation in vivo including the presence of matrix proteins on the 
implant surface and leukocytes, antibodies and other components of the host’s 
defence system that aid in the scavenging of foreign bodies such as microbes 
(Kadurugamuwa et al., 2003; Monzón et al., 2002). Subcutaneous models have been 
effectively used in previous studies to evaluate the interaction between different 
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microbial strains and biomaterials (Monzón et al., 2002; Monzón et al., 2001) and is 
used here. 
 
Such models were investigated to mimic contamination caused due to perioperative 
or late hematogeneous infection with repeatable results (Sheehan et al., 2004; 
Goshedger et al., 2004; Kadurugamuwa et al., 2003, Monzón et al., 2002, Gottenbos 
et al., 2001, Van Wijngaerden et al., 1999). However, many of these models were 
employed to investigate effective strategies for the prevention of BAI using 
antibiotics at the localised implantation site (Adams et al., 2009; Monzón et al., 
2001; Van Wijngaerden et al., 1999). Recently, Ag containing apatites have proven 
to be successful in exhibiting antibacterial activity with the added value of being 
cytocompatible with osteoblast cells in vitro (Roy et al., 2012; O’Sullivan et al., 
2010; Ruan et al., 2009). However, as previously stated only a few studies exist 
validating these observations in vivo. In a study by Shimazaki et al., 3% wt silver 
containing HA deposited onto Ti using a thermal technique, exhibited significant kill 
against methicillin-resistant Staphylococcus aureus (MRSA) compared to a HA 
coating when evaluated in a subcutaneous rat model (Shimazaki et al., 2010). In a 
second study, the same coating demonstrated low toxicity and good 
osteoconductivity 12 weeks after implantation into rat tibia (Yonekura et al., 2011). 
In Chapters 5 and 6, silver substituted apatites (AgA), deposited using CoBlast 
showed excellent antimicrobial activity against Staphylococcus aureus (S. aureus) 
without cytotoxicity in vitro (O’Sullivan et al., 2010).  
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In this study, the CoBlast deposition process was used to coat Ti K-wire implants 
with Ag substituted apatites (AgA). AgA powders with two silver loadings, 5% and 
12% wt powders were investigated. In order to prove efficacy in preventing bacterial 
adhesion and biofilm formation in vivo, a simple infection model using immune 
deficient mice was used to evaluate the AgA surfaces. In this study a direct 
inoculation model with S aureus as the challenge organism was used. A low 
inoculum in the order of 103 colony-forming units (CFU), which has been shown to 
establish a stable infection resembling the case in a clinical situation was used 
(Kadurugamuwa et al., 2003).  
 
7.2 Materials and Methods 
Materials and methods used in this study are summarised in Chapter 2. Ti K-wires 
(0.8 mm) were used as the implants and were coated with HA, 5 and 12% wt AgA. 
Implants were characterised using EDX analysis to determine elemental 
composition. As previously mentioned, the in vivo model and analysis in this study 
were based on established studies (Adams et al., 2009, Antoci et al., 2008; Van 
Wijngaerden et al., 1999). An infection model (S. aureus ATCC 1448) using nude 
mice was used where implants were subcutaneously implanted for 2 days. After 2 
days the implants were removed and the % biofilm incubated was determined. SEM 
images were taken of the samples. Blood cultures were taken to assess if a systemic 
infection was observed. Also, a chemiluminescence test was performed on blood 
samples taken to assess if an inflammatory response was noted. Also, the tissue 
samples at the localised site were qualitatively assessed for signs of cytotoxicity. 
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Statistical analysis (one way ANOVA) was performed on the biofilm data to 
determine if there was a statistical difference between samples. 
 
7.3 Results 
7.3.1 Surface Characterisation 
Figure 7.1 shows the images of the coated implants which were used in this in vivo 
study compared to an uncoated Ti (V) control. These images clearly show a change 
in appearance of the wire after coating deposition. 
 
Figure 7.1: Images of the coated K-wires: (0.8 mm x 180 mm); a) uncoated Ti (V) 
control; b) HA coated sample; c) 5% wt AgA coated sample and d) 12% wt AgA 
coated sample. 
 
(a) (b) (c) (d) 
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EDX analysis was performed to determine the elemental compositions of the coated 
K-wires. The chemical composition of the bare Ti K-wire consists of 18% atm 
aluminum (Al), 79.6% atm Ti and 2.4% atm vanadium (V). The results obtained are 
presented in Table 7.1 which illustrates that the coated surfaces are composed of 
oxygen (O), phosphorous (P), calcium (Ca) (apatitic nature of the coatings) and the 
Ti from the underlying K-wire was also evident. 
Table 7.1: EDX analysis of the coated implant surfaces. 
 
Coating 
O 
% atm 
P 
% atm 
Ca 
% atm 
Ti 
% atm 
Ion 
% atm 
HA 76.0 7.0 8.0 10 - 
5% wt AgA 74.8 7.2 8.2 8.5 0.6 
12% wt AgA 72.0 10.1 11.9 6.6 1.2 
 
The Ti levels which signifies the coating thickness ranged between 6.6-10% atm. 
Thus, the coating thickness was observed to follow the following order of HA < 5% 
wt AgA < 12% wt AgA. As expected, the 12% wt AgA surface contained a higher 
Ag content (1.2% atm) compared to the 5% wt AgA surface (0.6% atm). The SEM 
images of the uncoated and coated Ti (V) surfaces are presented in Figure 7.2. The 
introduction of the CoBlast surface exhibits higher levels of surface roughness than 
the bare metal. The images illustrate highly regular and uniform coatings. The 
process uses a combination of grit blasting to roughen the surface with the co-
introduction of a second dopant (HA, 5% wt and 12% wt AgA) which fills in the 
abraded surface producing a tribochemical bonded surface. The EDX and SEM 
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analysis are typical results for the CoBlast surfaces (O’Sullivan et al., 2011; 
O’Sullivan et al., 2010).  
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 7.2: SEM images of (a) bare Ti; (b) HA; (c) 5% wt AgA and (d) 12% wt 
AgA. 
7.3.2 Anticolonising Studies 
Anticolonising activity of the coated implant surfaces was evaluated after removal of 
non-attached bacteria by rolling the explanted implants on blood agar plates. The 
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blood agar plates also confirmed whether the Ti rods were colonised by the bacteria 
in vivo. The presence of CFU indicated that the bacterial inoculum introduced 
successfully colonised the implant surface. The number of adherent bacteria was 
quantified by sonicating the explanted implants in buffer which were subsequently 
diluted in order to enumerate the CFU. Images of the bacteria cultured on the agar at 
each stage, after rolling, initial sonication and dilution for the various coated 
implants are given in Figure 7.3. It is evident that the concentration of the bacteria 
recovered decreased from the agar plates in the order of 
rolled>sonication>sonication and dilution.  
a)  
b)  
c)  
              Rolling        Sonication     Sonication & 
             Dilution 
 
Figure 7.3: Images of bacteria cultured on agar plates for coated surfaces 
following explantation after 2 days: a) HA; b) 5% wt AgA and c) 12% wt AgA 
after rolling, after sonication and after sonication and dilution 
(rolled>sonication>sonication and dilution). 
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While many bacterial were visualised on the control plates (Figure 7.3 (a)), a lower 
number of bacteria were recovered from both the AgA surfaces, with 12% wt AgA 
demonstrating the greatest reduction in adherent bacteria (Figure 7.3 (c)). The 
number of adherent bacteria recovered were observed to decrease in the following 
order for all agar plates: HA>5% wt AgA>12% wt AgA. Qualitative analysis of the 
agar plates in Figure 7.3 highlights that the addition of Ag and the increase from 5 to 
12% wt led to a decrease in adherent bacteria, demonstrating the potential use of the 
AgA coatings as anticolonising surfaces. The CFU data from the diluted samples 
was used to determine the % biofilm inhibition of the AgA coatings relative to the 
HA coated control. The % biofilm inhibition for the AgA samples is presented in 
Figure 7.4. The 12% AgA was seen to prevent 95% S. aureus attachment whereas 
the 5% AgA surface demonstrated an impact of 68% growth inhibition. The 5% wt 
AgA shows considerable variation in the % biofilm inhibition data suggesting that 
the lower silver content was not as effective at preventing bacterial attachment 
compared to the 12% wt AgA. It was noted from the compilation of CFU data in 
Figure 7.4 that a wide variation exists. However, a 1 log reduction in CFU was 
observed with the 12% wt AgA suggesting that this surface performed the best in 
this study. 
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Figure 7.4: Biofilm inhibition data of 5% wt AgA and 12% wt AgA coated K-wires 
relative to the HA surface, evaluated in an in vivo model using S. aureus as the 
bacterium challenge. The insert presents the CFU data obtained. 
 
The results obtained here were in agreement with the findings in Figure 7.3 and are 
further confirmed by the SEM images of the explanted surfaces (Figure 7.5). There 
was definite evidence of bacterial attachment on the control HA coated surface with 
the presence of the characteristic spherical shape of cocci whereas reduced bacterial 
contamination was observed on the 12% wt AgA. However, one way ANOVA 
revealed that there was no statistical difference between samples (p>0.05). 
 
 
Chapter 7: In Vivo Evaluation of Silver Substituted Apatite Coatings to Combat Infection on Hard 
Tissue Implants 
 
Page | 179  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5: SEM images of the explanted K-wire following infection study: (a) 
control HA coating and (b) 12% wt AgA. Red arrows indicates the presence of S. 
aureus organism on the surface. 
 
7.3.3 Blood Culture Test 
The blood culture test was performed to determine whether a systemic infection 
resulted from the bacteria introduced at the localised implantation site. The test was 
performed using a commercially available agglutination test to simultaneously detect 
 
 
 
 
 
 
 
 
(a)  
 
 
 
 
 
 
 
 
(b)  
Chapter 7: In Vivo Evaluation of Silver Substituted Apatite Coatings to Combat Infection on Hard 
Tissue Implants 
 
Page | 180  
 
the presence of fibrinogen affinity factor, protein A and polysaccharides of the 
bacteria. The test is positive if coloured particles form indicating the presence of the 
above antigens (Weist et al., 2006) (Figure 7.6). The test was negative for the 
presence of coloured particles in the blood cultures indicating that there was no 
systemic infection obtained from the bacteria introduced at the localised implantation 
site for both the HA control and AgA samples (Figure 7.6).  
 
Figure 7.6: Image of a positive result (control (a)) and a negative result (12% wt 
sample (b)) for the agglutination test.  
The images of the blood cultures are given in Figure 7.7 which clearly shows no 
presence of S. aureus cells however skin microflora was observed. This 
contamination was more than likely introduced during the surgery.  
 
 (a) (b) (c) 
Figure 7.7: Images of Blood Cultures a) HA control; b) 5 wt AgA and c) 12% wt 
AgA. 
a
b
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7.3.4 Inflammatory Response  
The chemiluminesent test measures the real time production of reactive oxygen 
species (ROS) produced during the degranulation and the respiratory burst of 
leucocytes which are key inflammatory markers (Rohn et al., 1999). The release of 
ROS is accompanied by chemiluminescence or emission of light which can be 
monitored. The assay conducted analysed whole blood whereby the first step 
involves stimulation with N-formyl-methionyl-leucyl-phenylalanine (fMLP) and the 
second step is primed with phorbol-12-myristate-13-acetate (PMA). Exposure of 
neutrophils to chemoattractants such as fMLP results in marked increases in the 
surface expression of specific membrane-associated proteins resulting in chemotaxis, 
degranulation and generation of ROS (Prossnitz and Ye, 1997). PMA is a surface 
active agent which stimulates metabolic responses activated in neutrophils by 
particle ingestion thus it is responsible for inducing phagocytosis producing ROS 
(Antonini et al., 1994). fMLP and PMA stimulated chemiluminescence of whole 
blood samples recovered from the mice implanted with the different coated K-wires 
for 2 days was measured in this study (Figure 7.8).  
 
The results are presented in Figure 7.8 which revealed that the control HA coating 
activated an acute response whereas the 12% wt AgA response followed the same 
profile but was less activated. The 5% wt AgA response initially less activated but 
with time obtains a similar level of luminescence to the HA control and is at all times 
higher than the 12% wt AgA.  
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Figure 7.8: Chemiluminescence results from inducing inflammatory response using 
fMPL and PMA for blood samples from HA control, 5%wt AgA and 12% wt AgA. 
 
7.4 Discussion 
Previous studies have shown that the CoBlast process deposits micron thick, 
crystalline HA coats which have good adherence to the underlying Ti substrate 
without leading to the formation of unwanted calcium phosphate phases (O’Hare et 
al., 2010; O’Sullivan et al., 2010). In this study, the CoBlast deposition process was 
used to effectively coated a 3 dimensional (3D) implant and demonstrates potential 
use as an antimicrobial surface against S. aureus in a subcutaneous mouse model. 
The coating thickness can be indicated by the levels of Ti present using EDX 
analysis. There was reduced variation in Ti levels obtained for the 3D surfaces 
compared to previous results where coatings on flat 2 dimensional (2D) Ti surfaces 
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were evaluated. In previous studies, the Ti levels obtained included 9-14.7% atm for 
HA, 10.1% atm for 5% wt AgA and 20% atm Ti for 12% wt AgA (O’Sullivan et al., 
2010 and Table 6.1) whereas in this study comparative Ti levels were obtained for 
all surfaces (6.6-10% atm). More importantly, the Ag ion content on the 3D surfaces 
(0.6 % atm for 5% wt AgA and 1.2% atm for 12% AgA), which is responsible for 
the antimicrobial activity was consistent with previous studies on 2D surfaces (0.6 % 
atm for 5% wt AgA and 1% atm for 12% AgA) (O’Sullivan et al., 2010 and Table 
6.1). The highly regular and roughened morphology of the surfaces obtained from 
the CoBlast process are similar with a previous study where 2D substrates were used, 
Chapters 5 and 6 (O’Sullivan et al., 2011).  
 
Depending on the method of inoculation, biofilm growth was observed as quickly as 
one hour following bacteria introduction (Kadurugamuwa et al., 2003). Sheehan et 
al. also investigated the impact of a Ag coated K-wire after 2 days in a rat model and 
concluded that 2 days was sufficient for biofilm formation (Sheehan et al., 2004). It 
has also been shown that the Ag concentration in the substituted apatites greatly 
influenced the bactericidal activity of the coated surfaces as the 12% wt Ag content 
exhibited better performance compared to the 5% wt loading (O’Sullivan et al., 
2010). In this study similar findings were observed for the in vivo study compared to 
previous in vitro studies, Chapters 5 and 6 (O’Sullivan et al., 2010). To determine 
whether the bacteria colonised the various rods in vivo, the rods were rolled on the 
agar plates. A reduced number of bacteria colonies were evident on the 12% wt AgA 
surface compared to the other coated rods. Analogous to previous studies, % biofilm 
inhibition was used to determine the impact the surface against bacterial colonisation 
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(O Sullivan et al., 2010; Adams et al., 2009). In this study, 95% biofilm inhibition, 
equivalent to 1 log reduction was achieved for the anticolonising behavior of 12% wt 
AgA surface compared to 68% for the 5% wt AgA (Figure 7.4). SEM analysis 
supported that few bacteria managed to colonise the 12% wt AgA surface compared 
to the other surfaces (Figure 7.5 (c)). The qualitative representation of the agar plates 
for the rolled, neat and diluted samples obtained following the processing of the 
explanted samples further support the reduced number of adherent bacteria of the 
12% wt AgA compared to the other samples (Figure 7.3). It was established in an 
earlier study that the anticolonising activity of AgA was attributed to a synergistic 
effect of the immobilised Ag ion and to a lesser extent the released ion, Chapter 5. It 
was reported that there was 40% and 90% biofilm inhibition was observed for the 
5% wt AgA (day 1 and day 7). At day 1, there was 6% Ag ions released which was 
responsible for a poor bactericidal effect (13% kill) however, the immobilised silver 
ion contributed to 57% kill. The increased Ag ion content of the 12% wt AgA had an 
obvious effect on preventing the bacterial attachment compared to the 5% wt AgA. It 
was reported in Chapter 6 that there was 100% and 90% biofilm inhibition 
determined at day 1 and 14 for 12% wt AgA. Similar concentrations of the Ag ion 
was released for both 5% and 12% surfaces (1 ppm over 30 days) however, 83% of 
Ag still remained on the 12% wt AgA surface following elution at day 30 compared 
to only 10% for the 5% AgA surface. Based on the in vitro results, it can be 
ascertained that a similar mode of action accounts for the bactericidal activity of the 
AgA surfaces in the in vivo trial whereby the immobilised ion plays a dominant role 
and the released Ag ion elicits a minor effect in comparison. 
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Biocompatibility is an important characteristic of biomaterial coatings which 
represents that the implants surface must not evoke an inflammatory response. Such 
a response could jeopardise the successful osteointegration of the implant surface 
with bone tissue. The process of acute inflammation is initiated by cells already 
present in all tissues (macrophages, neutrophils), which at the onset of infection, 
undergo activation and release inflammatory mediators responsible for the clinical 
signs of inflammation (redness, bruising, swelling, pain). These phagocytic cells 
when challenged with specific chemicals such as fMLP and PMA, release ROS 
which is accompanied by the emission of light known as chemiluminescence. 
Therefore, measurement of chemiluminescence is an effective tool in examining 
phagocytic functions (Rohn et al., 1999; Prossnitz and Ye, 1997; Antonini et al., 
1994). The chemiluminescent test was determined to be lower for the 12% wt AgA 
compared to the other surfaces in this study, suggesting that the AgA samples 
induced a lower inflammatory response due to its bactericidal action of the AgA 
coating which was responsible for reducing the number of microbes present.  
 
Systemic infection was not detected for the three test groups, indicating that the 
infection had not spread but was confined to the site of surgery. This is supported by 
previous studies (Kadurugamuwa et al., 2003; Monzón et al., 2001). Systemisation 
of implant induced infections is a serious complication which can lead to septicaemia 
and malfunction of the device (Wu and Grainger, 2006; Kadurugamuwa et al., 
2003). This further illustrates the need for an antimicrobial surface to combat early 
stage infection at the localised site. Cytotoxic effects seem to be dose dependent so 
careful consideration must be given to the formulation of surfaces (Hardes et al., 
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2007). It is well reported that Ag ions have a bactericidal activity at concentrations 
as low as 35 ppb without toxic effects to mammalian cells (Pratten et al., 2004), with 
a Ag ion concentration as high as 10 mg/L required to have toxic effects on 
mammalian cells (Vik et al., 1985). Cytocompatability was also assessed using MG-
63 cells in vitro and revealed that the 5% wt and 12% wt AgA did not compromise 
the osteoblast cell viability compared to the HA surface. No black particles were 
observed around the tissue suggesting that initial qualitative analysis, revealed no 
toxicity however toxicology analysis would be required to verify this. 
 
As previously reported, several models have been reported for the study of 
orthopaedic prosthetic infections. Theoretically in an effort to mimic human 
conditions as closely as possible larger animals such as sheep or dogs should be 
used. However, there are a lot of expense, handling difficulties and housing larger 
animals. Small animals have been extensively used for studying bacterial infections 
at the implant site to investigate antimicrobial surfaces and antibiotic effectiveness 
(Balaban et al., 2004). Common problems associated in vivo models have been the 
variation in infection rates and repeatability which was more than likely due to host 
immune activity, distribution, homogeneity and propagation time of the bacteria cells 
(Balaban et al., 2004, Sheehan et al., 2004). As previously mentioned, the host’s 
defence system can aid in the scavenging of foreign bodies such as microbes. In this 
study, immunosuppressed nude mice were chosen so that the immune system (T 
cells and B cells) would not interfere with the antimicrobial action of the coatings in 
combating the infection. The choice of direct inoculation was chosen due to ease and 
simple means of administration of the inoculum as oppose to the extra steps involved 
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in pre-colonising the implants with bacteria. However, it was noted that infection 
rates were variable from the retrieved samples (CFU data in Figure 7.4). In an 
attempt not to overload each animal with 4 inoculations at each implant site, one 
inoculum was introduced. However, variation in the distribution of bacteria was 
observed. To overcome this constraint, only samples that showed TMTC in the 
rolled sample were enumerated. To address this limitation in future studies, 
precolonised implants could be used to improve the reproducibility of a stable 
infection as seen in other studies (Kadurugamuwa et al., 2003).  
 
In order to prove efficacy in the use of this antimicrobial surface on hard tissue  
implants, further work should involve an osteomyelitis model incorporating an 
intramedullary implant. Vital information about the role of AgA surfaces in a 
prevention strategy as well as the osteointegrative properties of the surface would be 
determined. In addition, the use of AgA in this study proves an attractive alternative 
to the typical antibiotic loaded cements and prophylactic treatment which have poor 
susceptibility to the increasing number of antibiotic resistant bacteria that are 
prevalent. A 6 hour post implantation ‘decisive period’ has been identified during 
which prevention of bacteria adherence is critical to the long term success of the 
implant (Hendrick and Schoenfisch, 2006). Therefore, the AgA surface in this early 
adhesion study has not only demonstrated effectiveness against bacteria colonisation 
but is clinically relevant as the method employed mimics the perioperative infection 
process.  
 
Chapter 7: In Vivo Evaluation of Silver Substituted Apatite Coatings to Combat Infection on Hard 
Tissue Implants 
 
Page | 188  
 
7.5 Conclusions 
The pathogenesis of prosthetic device infections is complex process in which 
bacterial adherence to biomaterials and elaboration of biofilm are critical. The in 
vivo findings here were analogous to those obtained previous in vitro studies detailed 
in Chapter 5 and 6. CoBlast technology was effective in depositing apatitic 
materials on the 3D substrates. A localised infection was delivered to the site of 
implantation which was responsible for the bacterial colonisation of the surfaces. 
Following a two day in vivo evaluation, the 12% wt AgA was observed to 
outperform the lower Ag content surface as confirmed by qualitative analysis of 
biofilm inhibition, SEM images and activated inflammatory response. 
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    Chapter 8 
8.0 General Discussion 
 
The general discussion is structured to address the questions outlined in the 
objectives of this study (Section 1.7): 
 
8.1 Ultimate aim: Added Value and Key Benefits of CoBlast 
Technology 
 CoBlast can produce a high quality surface with the ability to deposit the ‘as 
received’ powders without altering the chemical composition of the starting 
materials as demonstrated in Chapter 3. The utilisation of CoBlast, with its 
advantage of room temperature processing holds considerable potential for 
depositing and delivering therapeutic molecules. The work undertaken in this 
thesis has shown the ability of the CoBlast process to deposit apatite coatings 
on 2D.substrates in Chapters 3-6 and 3D surfaces demonstrated in Chapter 7. 
 A definite tailoring of surface composition and topography can be made 
through the use of the abrasive and dopant selected as highlighted in Chapter 
3.  
 A crystalline HA layer can be deposited onto biomedical metals as 
demonstrated in Chapters 3 and 4. This has the potential to induce the early 
formation of lamellar bone in vivo for long term stability. 
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 In Chapter 5 and 6, the deposition of SrA coatings have shown 
osteoconductive potential and can outperform the gold standard HA as a 
coating on hard tissue implants. 
 AgA surfaces deposited using the CoBlast process offer promising results as an 
anticolonising, cytocompatible surface in addition to possessing 
osteoconductive potential. Furthermore, the AgA surface holds particular 
promise as a preventative surface against perioperative infections.  
 
8.2 Objective 1: Evaluations of HA Coatings Deposited using 
CoBlast Technology in in vitro studies 
The novel deposition process, CoBlast was seen to effectively modify Ti (V) 
substrates with a micron thick HA layer with increased surface roughness (Ra<0.6-
1.8 µm). CoBlast did not alter the chemistry of the crystalline HA powder resulting 
in a highly crystalline HA layer deposited. From an in vitro perspective, the CoBlast 
HA had increased cell proliferation responses supporting a previous in vivo study 
which demonstrated enhanced lamellar bone growth on CoBlast surface compared to 
its microblasted surface (O’Hare et al., 2010). The surface roughness of the resultant 
HA surface produced can be altered depending on the particle size of the abrasive 
used with the potential to enhance the osteointegration process. The implications of 
the preliminary studies undertaken in Chapter 3 demonstrates the ability of CoBlast 
to tailor surface properties that could positively influence the long-term success of 
HA coating implants in the dental and orthopeadic arena. As seen in Chapter 4, the 
industry standard plasma process does alter the chemical composition of crystalline 
HA on deposition producing a thicker (65 µm) and rougher coating (Ra>5 µm) 
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compared to CoBlast. Multi-crystalline phases can result from the thermal 
decomposition of the material when thermally processed using plasma technology. 
This leads to the formation of intermediates (α-TCP, β-TCP and TTCP) which 
lowers the crystallinity of the HA coating which was observed via XRD and FTIR 
analyses of the plasma coating. The formation of these intermediates resulted in a 
faster dissolution process compared to the more crystalline HA coating produced by 
CoBlast. This has a knock-on effect on the biological activity on the different HA 
surfaces with enhanced cell proliferation observed on the stable CoBlast HA 
compared to the more resorbable plasma HA. Plasma HA does exhibit enhanced 
bioactivity in the SBF study in Chapter 4, where the presence of multiple CaP 
phases trigger a rapid formation of CHA, which is the proposed mechanism for the 
chemical bonding of the implant to bone. The bioactivity of the plasma sprayed HA 
surface will promote early osteointegration, however the long term stability will also 
be influenced by the dissolution behavior of the coating as well as the mechanical 
integrity of this layer. Clinical trials have shown that such resorbable characteristics 
of plasma HA can result in delamination and surface cracking leading to aseptic 
loosening (Gross et al., 2004). On the other hand, the more stable CoBlast HA 
surface (lower dissolution rate) induces a slower formation of the CHA layer. A 
different bone bonding mechanism is proposed for the CoBlast surface, which 
involves the modification of the crystalline HA into a less crystalline phase through 
ion-exchange coinciding with a late onset of the carbonate apatite being formed. The 
thin HA coating deposited by CoBlast may incorporate more of the bulk properties 
of the Ti metal leading to enhanced tensile bond strength compared to the thicker 
coating of plasma sprayed HA. The more stable HA surface produced by CoBlast 
which subsequently led to a lower level of surface CHA, also had a positive effect on 
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the mechanical bond strength compared to the plasma surface. The surface chemical 
reactions of HA coatings with SBF is an important consideration for the 
understanding of the surfaces in vivo and this SBF in vitro study further supports 
work performed understanding the performance of these two HA surfaces in vivo. 
The deposition process used is an important consideration as this will influence the 
chemistry and composition of the resultant HA coating which will in-turn affect the 
mechanical interlocking of the implant to bone. As a result, CoBlast is an attractive 
coating technology for depositing HA surfaces that induce lamellar bone growth and 
possess long-term stability and fixation) which may be attributed to key properties 
(crystalline coating, good coating adhesion, stability) when compared to plasma 
spraying approaches. 
 
8.3 Objective 2: Evaluation of Substituted Apatites Containing 
Antimicrobial Metals as an Infection Preventing Strategy in In 
Vitro Studies 
The two major factors limiting the survival of the hard tissue implants are aseptic 
loosening and BAI. The deposition of a high quality HA layer using CoBlast 
technology will reduce the risk of aseptic loosening as already discussed. BAI are the 
result of bacterial adhesion to a biomaterials surface. Upon implantation a 
competition exists whereby microbes and osteoblasts ‘race to the surface’ of the 
implant. For a successful implant, tissue integration occurs prior to bacterial 
adhesion, thereby preventing colonisation However, once bacteria adhere onto an 
implants surface, biofilm can form within 24 hour post implantation (Figure 1.3). A 
6 hr post implantation ‘decisive period’ has been identified during which prevention 
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of bacterial adhesion is crucial for long term success of an implant (Hetrick and 
Schoenfisch, 2006; Poelstra et al., 2002). However, the use of bioceramics with 
bactericidal agents as coatings, in particular AgA, has demonstrated anticolonising 
behaviour against S. aureus and clinical strains MRSA in addition to possessing 
osteoconductive properties with no cytotoxicity effect (Chapters 5 & 6). CoBlast 
was effective in depositing substituted apatites (AgA, SrA, ZnA, AgSrA) onto Ti (V) 
metal with surface roughness of 2.0-3.6 µm. Enhanced osteoblast cell proliferation 
was observed with 5% and 12% wt SrA compared to the other samples investigated 
(HA, AgA, ZnA). Five percent and 12% wt AgA was observed to superior 
antimicrobial properties when compared to the other apatites investigated using S. 
aureus as the antibacterial challenge. The anticolonising behaviour of the 5% wt 
substituted apatites was proposed to be strongly related to the surface action of the 
immobilised antibacterial metal ion with a contributory action from the low levels of 
ions released from the surface. Even with increased surface roughness of the 
substituted apatites, the surface composition (antibacterial metals ion content) played 
a significant role not only in cellular adhesion and proliferation but also in 
preventing attachment of microbes. The colonisation of substituted apatite coatings 
appears to be controlled by the microbe-surface interaction irrespective of the 
surface topography. The anticolonising behaviour of AgA was also linked to the 
amount of the Ag ion present on the surface. However, the behaviour of the 12% wt 
AgA against three clinical isolates (MRSA, MSSA and S. epidermis) exhibited best 
performance against MRSA followed by MSSA only at day 1, with no impact evident 
against S. epidermis. This was more than likely due to the fact that the adhesion of 
the bacterium type S. epidermis is more influenced by surface roughness than MRSA 
and MSSA (Sousa et al., 2009). S. aureus is the most common source of BAI with 
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MRSA being the most prevalent form of methicillin-resistant bacteria found on 
infected hard tissue implants. Good initial kill against these two strains demonstrates 
potential use of the AgA surface as an effective surface to combat infection 
especially in the first 24 h post implantation. Other technologies (plasma and sol-gel) 
have been shown to be capable of depositing Ag loaded apatites, however the same 
drawbacks as outlined in Table 1.3, can be observed. More reliability (lower SD 
obtained with the antimicrobial and anticolonising results) was seen with the higher 
content of AgA present compared to 5% wt. In vitro results demonstrate the potential 
use of AgA as an osteoviable surface with effective anticolonising activity against 
clinical isolates. In addition SrA also demonstrated enhanced osteoconductive 
potential compared to the other substituted apatites analysed but also to the gold 
standard HA coating. 
 
8.4 Objective 3: Evaluation of AgA as an Infection Preventing 
Surface in an In Vivo Model 
CoBlast was effective in depositing AgA onto 3D K-wire substrates with a visible 
increase in surface roughness observed compared to blank Ti. Two Ag containing 
apatitic powders loaded at a concentration of 5% wt and 12% wt were assessed in a 2 
day in vivo infection model using the same strain of S. aureus as in Chapter 7 in 
nude mice. A reduced number of bacterial colonies were evident in the 12% wt AgA 
surface compared to the other coated rods. The results showed that 12% wt surface 
was observed to outperform the 5% wt AgA (% biofilm inhibition, images of agar 
plates and SEM images). A localised infection was contained at the site of 
implantation with lower levels of inflammatory responses activated with the 
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insertion of the Ag loaded implants compared to the HA surfaces. In conjunction 
with these findings, no initial signs of cyctoxicity were observed, suggesting that the 
AgA surface exhibited no toxic effect towards the tissue but was lethal to the 
microbes present but further toxicological studies to confirm this would be required. 
Irrespective of these differences between the in vitro and in vivo studies, good 
correlation was observed in relation to the anticolonising data (% biofilm inhibition). 
It is difficult to ignore the variation in infection rates obtained due to colonisation of 
microbes on the implant surfaces at day 2. Despite this, the in vivo study employed a 
model that replicated the perioperative process and demonstrated effectiveness 
against bacterial colonisation. To overcome this, precolonised implants could be 
used to improve the reproducibility of a stable infection as an alternative to the 
procedure used in this study. More effectively, an infection model that also uses a 
precolonised implant inserted into the intramedullary canal of a rabbit could be used 
to evaluate the infection prevention and osteointegration properties of the surface.   
 
 
8.5 Conclusions 
In summary, the major findings of this thesis are as follows: 
 CoBlast is indeed effective in depositing apatite bioceramics onto biomedical 
metals. A definite tailoring of surface composition and topography can be 
made through the choice of abrasive and dopant selected. A high quality 
crystalline and stable layer of HA can be deposited without any impurities 
present as a direct result of the coating process. The crystalline HA follows a 
different chemical bioactivity mechanism compared to the less pure HA 
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coating deposited using plasma spraying methods. A more mechanically stable 
bond was observed between the CoBlast HA and the underlying Ti metal than 
that of the plasma HA before and after CHA formation.  
 This room temperature process with its ability to retain the chemistry of the 
starting material is an attractive process in areas of tailored surface 
modification, deposition of bioactive materials and offers the potential to 
deliver drugs from coating surfaces. As the plasma process occurs at high 
temperature it limits the co-deposition of therapeutic drugs and biologics 
which may enhance the efficacy of the HA surface. The high temperatures 
employed can destroy the active agents or render them irreversibly inactive. 
Thus, CoBlast offers a versatile route to modify the surfaces of hard tissue 
implants to deliver optimum integration of hard tissue implants 
 The uniform, highly crystalline, defect free, thin film coating associated with 
CoBlast HA is advantageous compared to the thick thermal sprayed HA 
coatings. CoBlast offers as an alternative to the traditional methods of coating 
HA implants. 
 Substituted apatites can be deposited to add functionality to HA coatings. SrA 
was observed to enhance the cell viability of osteoblasts. AgA was observed to 
outperform all other apatites with respect to its anticolonising activity against 
S. aureus and MRSA without cytotoxicity.  
 In vivo results demonstrated that AgA surface can be used to combat infections 
at the localised site thus preventing early stage infection without causing 
inflammatory and initial cytotoxic responses. However further in vivo trials 
would need to be performed to evaluate the osteointegration of AgA surface. A 
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dual in vivo model which investigates the osteointegration process and also the 
anticolonising behaviour would give beneficial results.  
 The use of substituted apatites potentially can be used to produce positive 
patient outcomes and reduce the economic burden of revision surgery due to 
aseptic loosening and BAI.  
 
8.8 Limitations of the Work Performed 
 Some surface techniques proved difficult to analyse CoBlast surfaces, in 
particular, those executed using reflective mode due to surface roughness 
(Zygo white-light interferometer) or thin coatings analysis (reflective and 
transmission mode of XRD). 
 Due to the limit of available samples produced for this study, sample size of 3-
5 were used for analysis. 
 The CoBlast technology was continuously being improved through 
advancements in research and development work, as a result, the nozzle 
arrangement in-addition to the abrasives used was frequently updated as part of 
the standard process set-up.   
 A smaller preliminary study performed prior to the larger animal study which 
mimicked the proposed procedure would have elucidated the potential use of 
precolonised K-wire implants.  
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8.7 Future Work 
Based on the conclusions of this thesis, the following work has been suggested and 
other avenues explored for applications using CoBlast technology: 
  In vivo trials using precolonised implants to assess the anticolonising 
behaviour of AgA. Also, there is a need to investigate the osteointegration of 
AgA using an animal model. 
 Optimisation of materials is key. Increasing Ag loading in order to identify the 
limit to maximise AgA activity, whilst minimising cytotoxicity to human cells. 
It would also be interesting to investigate if enhancing the crystalline 
properties of the substituted apatites would improve the osteoconductive 
potential of these materials. A pre-blend of AgA and SrA powders may 
improve the osteoconductive potential of AgA and the anticolonising 
properties of SrA. 
 Optimisation of process conditions to tailor-make surface properties such as 
pretreating the surface with MCD-425 followed by a CoBlast treatment using 
HA/MCD-106. A surface with increased roughness and HA coating would 
result. 
  A study which investigates the anticolonising behaviour of the substituted 
apatites so as to gain an insight into their mode of action and further 
investigate the hypothesis that metal ions produce a redox reaction on the 
surface which produces ROS capable of killing microbes. Further investigation 
the co-doped AgSrA surface so as to understand why the results obtained were 
not as expected are warranted.  
Chapter 8: General Discussion 
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 CoBlast can deposit onto metals however, nitinol and CoCr are other important 
metals commonly used. Other biomaterials are also used as key components of 
hard tissue implants such as polyethylene which is used as a liner in acetabular 
cups. It would be interesting to investigate if CoBlast can be used to deposit on 
other material substrates.  
 Since CoBlast is a blasting technology which uses materials, could a pre-blend 
of HA and antibiotics be deposited. Also, could proteins such as BMP’s be 
deposited using CoBlast technology. Other therapeutic avenues could be 
explored such as the use of bisphosphonates to prevent osteointegration for 
trauma pins etc. 
 Coat metals with an-allergic materials so that these surfaces could be 
incorporated into individuals who are allergic to the underlying surface, thus 
preventing exposure to the allergen in vivo.  
 Also, recently new infection preventing strategies are emerging such as 
tethering of antibiotics and AmPs so as to have a permanent coating (non-
leaching) of these active agents on the surface.  
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  Appendix I 
Further Analysis on HA surfaces (Chapter 3) 
(a)  
(b)  (c)  
(d)  (e)  
(f)  (g)  
Figure I-1. SEM images ( x2000 magnification): (a) titanium; (b) microblast MCD 
106; (c) CoBlast HA/MCD-106;(d) microblast MCD-180; (e) CoBlast HA/MCD-
180;  (f) microblast MCD-425; (g) CoBlast HA/MCD-425. 
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Appendix II 
Further Analysis on 5% wt Substituted Apatite (Chapter 5) 
Table II-1: Median particle size (d(0.5)) analysis of the powers. Water contact angle 
and ion concentration (% wt using EDX analysis) of the various CoBlast surfaces 
(n=3 samples). 
Coating d(0.5) of the 
powders (µm) 
(±2SD) 
Water contact 
angle (º) of the 
coating (±2SD) 
Ion (%wt) EDX of 
the coatings 
Uncoated Ti  68±9 - 
HA 33±3 18±6 - 
AgA 14±3 0 Ag-3 
SrA 14±3 0 Sr-4 
ZnA 10±1 0 Zn-5 
 
 
Figure II-1: % Ca released from the coating after 30 days incubation in buffer. 
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Figure II-2: XRD analysis of 5% wt substituted apatite powders and coatings. 
 
Figure II-3: Antimicrobial activity expressed as CFU of the immobilised surface ion 
of the various coatings using S. aureus as the bacterial challenge organism (n=3 
samples ±SD). 
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Figure II-4: Antimicrobial activity expressed as CFU of the released ion from the 
coating using S. aureus as the bacterial challenge organism (n=3 samples ±SD). 
 
Figure II-5: Anticolonising activity expressed as CFU of the released ion from the 
coating using S. aureus as the bacterial challenge organism (n=3 samples ±SD). 
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Figure II-6: Antimicrobial activity expressed as CFU of the immobilised surface ion 
of the various coatings at day 0 using Pseudomonas aeruginosa as the bacterial 
challenge organism (n=3 samples ±SD). 
 
Figure II-7: Antimicrobial activity expressed as CFU of the released ion from the 
various coatings using Pseudomonas aeruginosa as the bacterial challenge organism 
(n=3 samples ±SD). 
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Table II-2: Antimicrobial effect (% kill) of the elutions from the various coatings 
using Pseudomona aeruginosa as the bacterium challenge (% kill ±SD) 
Time (Day) 
 
AgA 
 
SrA 
 
ZnA 
 
1 
 25 (±25) 35 (±3) 10 (±2) 
8 
 13 (±62) 0 - 0 - 
16 
 2 (±75) 0 - 0 - 
 
 
Figure II-8:  High resolution XPS spectrum of the AgAP Ag 3d core level 
In order to study the dopants further, curve fitting of the high resolution XPS 3d 
level of the silver sample was carried out, Figure II-. Using the C 1s core level (C-C 
at 285 eV) to charge correct the position of the Ag 3d level, the centroid of the Ag 3d 
5/2 level was determined to be 368.2 eV. This is in good agreement with the 
literature values for elemental Ag (Christ, 1999). If an oxide were present, a decrease 
in the binding energy of 0.6 – 1.0 eV would be expected, which was clearly not the 
case in this study. This indicates that the Ag dopant is carried by the apatite, but is 
not part of the ionic bonding of the crystal structure. 
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(a)  
 
 
 
 
 
 
 
(b)  
 
 
 
 
 
 
 
(c)  
Figure II-9: SEM images: (a) 5% wt AgA (x500 magnification); (b) 5% wt SrA 
(x2000 magnification) and (c) 5% wt ZnA (x500 magnification). 
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        Appendix III 
Further Analysis on 12% wt Substituted Apatites (Chapter 
6) 
Table III-1: Median particle size (d(0.5)) analysis of the powers and various 
analysis on the coatings (coating mass, coating mass after washing treatment, water 
contact angle and % wt ion present ) (n=3 samples). 
Coating d(0.5) 
powders 
(µm) (±2SD) 
Coating mass 
(mg/cm2) 
(±2SD) 
 
Coating 
mass loss 
after IPA 
wash for 15 
minutes 
(±2SD) 
Water contact 
angle (º) of 
the coating 
(±2SD) 
% wt ion 
present in 
the coating 
(EDX) 
Uncoated Ti - - - 8±20 - 
HA - - - 64±12 - 
AgA 7±1 2.2±0.5 0.26±0.57 0 4-Ag 
SrA 6±2 2.5±1.0 0.40±0.5 0 16-Sr 
ZnA 6±2 3.0±0.6 0.65±0.3 0 10-Zn 
AgSrA 8±2 2.5±0.6 0.5±0.2 8±20 5-Ag 
11-Sr 
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Figure III-1: XRD Analysis of 5% wt substituted apatite powders and coatings 
 
(a)  (b)  
(c)  (d)  
Figure III-2. SEM images of 12% wt substituted apatite coatings: (a) AgA (x2000 
magnification); (b) SrA ; (c) ZnA and (d) AgSrA. 
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Figure III-3: Antimicrobial activity expressed as % kill of the immobilised surface 
ion of the various coatings (12% wt substituted apatites) using S. aureus as the 
bacterial challenge organism (n=3 samples ±SD). 
 
Table III-2: Antimicrobial activity of the immobilised ion expressed as CFU of the 
coatings using S. aureus as the challenge organism (ATCC 1448) at day 0 and day 
30 (n=3 samples ±SD). 
  day 0 day 30 
Sample CFU SD CFU SD 
HA 1.1E+06 2.3E+05  3.7E+06 3.0E+05 
AgA 3.6E+05 4.2E+04  8.0E+05 2.0E+05 
SrA 9.0E+05 1.3E+05  4.9E+06 1.1E+06 
AgSrA 7.8E+05 1.3E+05  9.0E+05 1.0E+05 
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Table III-3: Anticolonising activity (CFU) of the coatings using S. aureus as the 
challenge organism (ATCC 1448) at day 1 and day 14 (n=3 samples ±SD)  
  day 1 day 14 
Sample CFU SD CFU SD 
HA 4.1E+05 6.7E+04  4.3E+05 9.4E+04 
AgA 0.0E+00 0.0E+00  4.4E+04 7.4E+04 
SrA 2.3E+05 8.0E+04  3.8E+05 1.0E+05 
AgSrA 1.2E+05 2.3E+04  5.1E+05 7.4E+04 
 
Table III-4: Anticolonising effect of the AgA coating using the clinical strains 
MRSA, MSSA and S.epidermis as the bacteria challenges.  
    day 1 day 14 
  Sample CFU 
log 
Reduction CFU 
log  
Reduction 
MRSA HA 2.2E+06  8.7E+05   
  AgA 2.3E+05 1.0 4.0E+05 0.3 
MSSA HA 1.7E+07   1.6E+07   
  AgA 8.6E+06 0.3 4.6E+06 0.0 
S.epidermis HA 3.7E+06   2.0E+06   
  AgA 1.0E+07 0.0 6.0E+06 0.0 
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Appendix IV 
Preliminary Study Prior to the In Vivo Work (Chapter 7) 
 
Table IV-1: Preliminary work performed to determine the % biofilm using S. aureus 
as the bacterial challenge in an in vitro study 
Coating CFU (±SD) % Biofilm Inhibtion 
day 1 
HA K-wire 2.13x105±1.52x105 - 
5% wt K-wire 2.05x105±1.91x105 0 
12% wt K-wire 2.5x104±7.1x103 88±3 
 
Note: Two nude mice were injected with 1 x 104 CFU of S. aureus (ATCC 1448) 
and survived for two days. The dose was increased to that used in the in vivo trials. 
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Figure IV-1: Scoring of growth plate numbers [1,0] (addition the number of agar 
plates that showed any S. aureus growth on the plates excluding plates that had no 
colonies). 
 
Table IV-2: Scoring of the agar plates following explantation of the K-wires 
Sample 
 
Numbers 
  Roll  
Neat 
 
Dilution 
 
5% wt AgA  
TMTC 13 4 0 
Zeros 14 19 26 
Scoring [1,0] 24 20 11 
12% wt AgA 
TMTC 5 1 0 
Zeros 23 30 32 
Scoring [1,0] 16 10 7 
HA 
TMTC 13 6 1 
Zeros 9 20 23 
Scoring [1,0] 30 19 15 
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Appendix V 
Drug Studies  
Table V-1: Studies Performed  
Studies 
 
Drugs 
 
Outcome 
 
Deposition of HA mixed with 10%  wt/wt 
antibiotics onto Ti using CoBlast 
Technology 
 
Gentamicin, 
Vancomycin, 
Tobraymycin 
 
Burst release and all drugs 
eluted after 15 mins  
 
Deposition of HA loaded antibiotics (drug 
loaded into the HA pores) onto Ti using 
CoBlast Technology 
 
Gentamicin 
 
 
 
 
Burst release and drugs eluted 
after 1-2 hours 
 
 
 
Deposition of HA mixed with HA/PLGA-
drug (HA coating on a PLGA-loaded 
microspheres) onto Ti using CoBlast 
Technology 
Gentamicin 
 
 
 
 
 
Too dilute 
 
 
 
Tethering drugs onto a CoBlast HA 
surface 
 
 
 
Bisphosphonates 
Tetracycline 
 
 
 
Drugs binded to the HA 
surface, elution of tetracycline 
from the surface was over 5 
hours 
 
PLGA films on a CoBlast HA/drug surface 
as a controlled release system 
Gentamicin 
 
Release was over a 24 hour 
period. 
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Appendix VI 
Publications 
 
 
 Coatings 2011, 1, 53-71; doi:10.3390/coatings1010053 
 
coatings 
ISSN 2079-6412 
www.mdpi.com/journal/coatings/ 
Article 
A Modified Surface on Titanium Deposited by a  
Blasting Process 
Caroline O’Sullivan 
1,2,
*, Peter O’Hare 
3
, Greg Byrne 
4
, Liam O’Neill 
5
, Katie B. Ryan 
1
 and  
Abina M. Crean 
1
 
1
 School of Pharmacy, Cavanagh Building, University College Cork, Cork, Ireland;  
E-Mails: katie.ryan@ucc.ie (K.B.R.); a.crean@ucc.ie (A.M.C.) 
2
 Department of Chemical and Process Engineering, Cork Institute of Technology, Bishopstown, 
Cork, Ireland 
3
 The Nanotechnology and Integrated BioEngineering Centre, University of Ulster at Jordanstown,  
Newtownabbey, Co Antrim, BT37 OQB, Northern Ireland; E-Mail: p.ohare@ulster.ac.uk 
4
 School of Electrical, Electronic & Mechanical Engineering, University College Dublin, Belfield, 
Dublin 4, Ireland; E-Mail: gregory.byrne@ucd.ie 
5
 Research & Development, EnBIO, Carrigtohill, Cork, Ireland;  
E-Mail: liam.oneill@enbiomaterials.com 
* Author to whom correspondence should be addressed; E-Mail: caroline.osullivan@cit.ie;  
Tel.: +353-(0)21-490-1667; Fax: +353-(0)21-490-1656.  
Received: 16 July 2011; in revised form: 23 August 2011 / Accepted: 1 September 2011 /  
Published: 13 September 2011 
 
Abstract: Hydroxyapatite (HA) coating of hard tissue implants is widely employed for its 
biocompatible and osteoconductive properties as well as its improved mechanical 
properties. Plasma technology is the principal deposition process for coating HA on 
bioactive metals for this application. However, thermal decomposition of HA can occur 
during the plasma deposition process, resulting in coating variability in terms of purity, 
uniformity and crystallinity, which can lead to implant failure caused by aseptic loosening. 
In this study, CoBlast
TM
, a novel blasting process has been used to successfully modify a 
titanium (V) substrate with a HA treatment using a dopant/abrasive regime. The impact of 
a series of apatitic abrasives under the trade name MCD, was investigated to determine the 
effect of abrasive particle size on the surface properties of both microblast (abrasive only) 
and CoBlast (HA/abrasive) treatments. The resultant HA treated substrates were compared 
OPEN ACCESS 
Coatings 2011, 1              
 
 
54
to substrates treated with abrasive only (microblasted) and an untreated Ti. The HA 
powder, apatitic abrasives and the treated substrates were characterized for chemical 
composition, coating coverage, crystallinity and topography including surface roughness. 
The results show that the surface roughness of the HA blasted modification was affected 
by the particle size of the apatitic abrasives used. The CoBlast process did not alter the 
chemistry of the crystalline HA during deposition. Cell proliferation on the HA surface 
was also assessed, which demonstrated enhanced osteo-viability compared to the 
microblast and blank Ti. This study demonstrates the ability of the CoBlast process to 
deposit HA coatings with a range of surface properties onto Ti substrates. The ability of the 
CoBlast technology to offer diversity in modifying surface topography offers exciting new 
prospects in tailoring the properties of medical devices for applications ranging from dental 
to orthopedic settings.  
Keywords: hydroxyapatite; grit blasting; CoBlast; hard tissue implants 
 
1. Introduction  
Hydroxyapatite (HA), Ca10(PO4)6(OH)2, a proven bioceramic for coating medical device implants is 
widely known, not only for its biocompatible and osteoconductive properties, but also for its increased 
mechanical properties when applied to bio-inert metals for orthopedic use [1-4]. Implant surface 
modifications are often required in order to prescribe a particular surface roughness and increase 
surface area for osteoblast attachment, as well as to enhance the bioactive and osteoconductive 
properties of the underlying substrate. Such surface treatment methods include sand- or grit-blasting 
using abrasives, chemical treatments and deposition of calcium phosphate (CaP) coatings [2-8]. 
Abrasive blasting involves impacting the implant metal surface with abrasive particles under 
pressure to roughen the surface. Roughening orthopedic and dental implants utilizing alumina (Al2O3) 
abrasives is a common practice to enhance implant osteointegration in vivo [5,6]. However, the use of 
apatite abrasives are often preferred as it enhances bone formation [7,18]. It has been shown that this 
technique can be effective in depositing a thin layer of CaP on the surface being roughened [18-20]. A 
number of other HA coating deposition techniques have been employed to confer a bioactive layer 
onto metallic and other inert substrates including plasma spraying, which is one of the most common 
types of coating process for the generation of CaP thin films [3,4,9-14] and alternative deposition 
processes including pulsed laser deposition (PLD) [15], radio frequency (RF) magnetron  
sputtering [16], sol-gel immersion techniques, and electrophoretic deposition [17].  
More recently, a novel approach CoBlast has been shown as an alternative process to deposit HA 
and substituted apatites onto titanium (Ti) substrates [21-23]. The CoBlast technique is based on the 
convergent flow of an abrasive and a dopant stream onto the implant surface which can effectively 
impregnate the metal with the dopant material. The CoBlast approach manipulates the ability of 
abrasive blasting to achieve surface roughening and bioactive layer deposition. The impregnation of 
the dopant material onto the surface results from a combination of the mechanical interlocking and 
tribo-chemical bond formation between the bioceramic material and the underlying metal  
Coatings 2011, 1              
 
 
55
substrate [21]. HA coatings prepared using the CoBlast technique demonstrated enhanced osteoblast 
attachment in vitro and early stage lamellar bone growth in vivo compared to microblasted and 
untreated Ti surfaces [21]. Additionally, a series of substituted apatites (AgA, SrA, ZnA) were 
effectively deposited using the CoBlast technique and these modifications offered the dual benefits of 
osteoconductive properties essential for bone integration with the added potential of microbial 
colonization inhibition without cytotoxic effects [23]. The established research showed that <10 µm 
thick coatings were applied with this technique employing alumina as the abrasive and that there was 
no evidence of alumina being incorporated into the modified surface [21].  
The objective of this study is to demonstrate the use of apatitic abrasives in the treatment of Ti 
substrates using both the CoBlast technique (dopant/abrasive regime) and a control microblast surface 
(abrasive only). The chemical, topological and osteo-viability advantages of treated Ti substrates was 
characterised. The effect of abrasive particle size on the properties and performance of the CoBlast and 
microblast modified surfaces was also investigated. A series of apatitic abrasives (sintered CaP under 
the trade name MCD) with differing mean particle size values were employed for both techniques.  
2. Results and Discussion  
2.1. Chemical Characterization of HA and MCD Abrasive Powders 
The particle size of the HA and MCD abrasives were measured using a laser light technique 
(Mastersizer S), Table 1. The average particle size (d (0.5)) increased in the following order: HA < 
MCD-106 < MCD-180 < MCD-425. The various powders were analyzed for their chemical 
composition using energy dispersive X-ray (EDX) analysis, Table 1.  
Table 1. Mean particle size analysis and energy dispersive X-ray (EDX) analysis of the  
calcium phosphate powders (n = 3). 
Powder 
Mean 
particle 
Size (µm) 
O 
% atm 
Ca 
% atm 
P 
% atm 
 
Ca/P 
 
HA 40 (±4) 71 18 11 1.66 
MCD-106 44 (±2) 72 18 10 1.76 
MCD-180 124 (±6) 73 17 10 1.73 
MCD-425 355 (±6) 77 13 10 1.29 
The calcium phosphate powders (HA and MCD abrasives) were found to be composed of O, P and 
Ca. The Ca/P ratio for stoichiometric HA was found to be similar to the previously reported value of 
1.67 [25]. The increase in Ca/P ratio for MCD-106 and MCD-180, as seen in Table 1, may be 
explained by the presence of impurities such as tricalcium phosphate (TCP) phase as determined by 
powder X-ray diffraction (PXRD) analysis (Figure 1). However, the Ca deficient nature for the more 
amorphous MCD-425 results in a reduced Ca/P ratio (1.29). 
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Relative crystallinity of each powder was investigated using PXRD, (Figure 1). HA was found to be 
highly crystalline with well defined narrow peaks. The main characteristic peaks associated with HA 
can be assigned to the 002, 102, 210, 211, 112, 300 and 202 reflections corresponding to 25.9°, 28.1°, 
28.9°, 31.9°, 32.2°, 33.1° and 34.1°, as previously reported [25]. The resulting PXRD patterns for the 
MCD apatite series indicate a lower crystallinity relative to the HA powder. The small peak present at 
31° and 34.4° was attributed to the TCP phase [26]. Also in the MCD-425 pattern, peaks are poorly 
resolved with low intensity relative to the other apatites, demonstrating the more amorphous nature of 
this material [25,26]. 
Figure 1. Powder X-ray diffraction (PXRD) spectra of the powders (■ denotes HA peaks  
and * represents tricalcium phosphate (TCP)). 
 
The Fourier transform infrared spectrometer (FTIR) spectra of the powders in the range  
1600–450 cm
-1
 are presented in Figure 2. The most intense peaks observed for the crystalline HA 
powder are those attributable to vibrations of the PO4
3-
 groups; the ν1 and ν3 phosphate bands in the 
region of 900–1200 cm
-1
 and ν4 absorption bands in the region of 500–700 cm
-1
, which are used to 
characterize apatite structure. The peak at 962 cm
-1
 is assigned to the ν1 symmetric P-O stretching 
vibration of the PO4
3- 
and the ν3 asymmetric P-O stretching mode are indexed at 1090 and  
1045 cm
-1
 [27]. The bands at 601 and 571 cm
-1
 are assigned to ν4 vibration mode of the phosphate 
group, which occupies two crystal lattice sites (O-P-O bending mode) according to previous  
studies [27]. The HA adsorption bands of the ν1 and ν4 of the PO4
3-
 groups determined here are those of 
stoichiometric HA [16]. The bands at 631 and 474 cm
-1
 correspond to the vibrations of OH
-
 groups in 
the structure [27]. The MCD series showed similar finger-print bonds for calcium phosphate bonds but 
with broader definition, which is representative of the increased amorphous content of these CaP 
materials [28].  
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Figure 2. Fourier transform infrared spectrometer (FTIR) spectra of the various apatite powders. 
 
2.2. Characterization of the Modified Titanium Substrates 
Titanium (V) was used as the base substrate and the untreated Ti surface was determined to contain 
23% O and 77% Ti using EDX analysis. The chemical composition of the microblast surfaces 
(abrasive blast only, no dopant) are presented in Table 2 and were analyzed for O, Ca, P and Ti only.  
Table 2. EDX analysis, coating thickness (PosiTector thickness gauge) and mass of the 
modified surfaces. 
Modification  
O 
% 
atm 
P 
% 
atm 
Ca 
% 
atm 
Ti 
% 
atm 
Ca/P 
Coating 
Thickness 
(µm) (2STD) 
Coating Mass 
(mg/cm
2
) 
(2STD) 
Blank Ti 23 - - 77 - 0 - 
Microblast MCD-106 59 8 12 21 1.56 3 ± 1 - 
 MCD-180 56 6 10 27 1.53 3 ± 1 - 
 MCD-425 55 7 11 27 1.57 3 ± 2 - 
CoBlast 
HA/MCD-
106 
63 13 21 2 1.59 6 ± 3 0.48 ± 0.4 
 
HA/MCD-
180 
67 12 18 3 1.53 6 ± 1 0.44 ± 0.4 
 
HA/MCD-
425 
65 12 20 5 1.61 7 ± 3 0.44 ± 0.3 
The % atm Ti determined reflects the exposure of the underlying substrate and can be used to 
represent the degree of coverage resulting from apatite materials. A high Ti level represents a thin or 
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patchy coating and conversely, a low Ti concentration signifies a thick coating. The EDX results 
reveal that after a wash treatment, the MCD microblasted surfaces show a reduction in Ti 
concentrations to 21–27% atm, compared to 77% atm for the Ti substrate. Also the presence of Ca and 
P which are the main constituents of the MCD abrasive is noted on the surface. This illustrates that a 
thin coating of Ca/P material has been blasted onto the surface and successfully deposited as a stable 
layer onto the Ti surface. The Ca/P values obtained for the microblasted samples treated with the MCD 
series of the abrasives ranged between 1.53 and 1.57 which is consistent with similar grit blasted 
studies [18].  
The chemical composition of the CoBlast surfaces (blasting with both abrasive and dopant) on Ti 
are also presented in Table 2. For CoBlast coatings, the levels of O, P, Ca and Ti obtained were 
determined to be in the range of 63–67%, 12–13%, 18–21% and 2–5% atm, respectively. The reduced 
level of Ti detected in these samples, compared to the Ti substrate and microblasted surfaces, is 
indicative of a high degree of coating coverage across all CoBlast samples. The Ca/P values were 
found to display a ratio of between 1.53 and 1.61, which are relatively close to the value for 
stoichiometric HA [25]. The % atm Ti, determined using EDX analysis, was observed to increase as 
the MCD series particle size order increased, indicating a decrease in the thickness of the deposited 
layer, as outlined in Table 2. This suggests that the smaller the particle size of the MCD abrasive the 
more HA was deposited, although the coating thickness determined using the PosiTector thickness 
gauge, and the coating mass values were found to be similar. The coating thickness of all the CoBlast 
samples was <10 microns which is in agreement with a previous study which used Al2O3 as the 
abrasive [22].  
The scanning electron microscopy (SEM) image of the untreated Ti substrate can be seen in  
Figure 3a which has similar topography to that observed in a previous study [6]. This image reveals a 
very smooth surface and the morphology of a machined metal. The SEM images of the microblast  
MCD-106 surfaces, as well as the corresponding CoBlast HA/MCD-106 surfaces, are presented in 
Figure 3b and c respectively. (More images can be seen as supporting information) 
As expected, the microblast process was observed to roughen the untreated Ti surface. Examination 
of the CoBlast surfaces suggests that the co-introduction of the HA with the abrasive appears to have 
in-filled some of the surface features that are evident on the microblast sample (Figure 3b). The 
CoBlast process results in a roughened, highly regular and uniform surface which is consistent with 
other calcium phosphate coatings produced using simple grit blasting technologies [6,19,20]. It was 
noted that as the particle size (d90) of the MCD abrasive increased from 106 to 425 microns, the 
texture (presence of surface features) and the apparent roughness of the resultant surfaces was also 
observed to increase for both the microblast and CoBlast treatments and this was confirmed by surface 
roughness measurements. 
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Figure 3. Scanning electron microscopy (
(a) titanium; (b) microblast MCD 106;
(a) 
 
(b) 
 
  
       
SEM) images (×1000 magnification) of 
 (c) CoBlast HA/MCD-106. 
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The surface roughness was measured using a stylus method and the results obtained are given in 
Figure 4. The arithmetical mean roughness
tended to increase as the particle size of the
between the surface treated and the untreated Ti. 
(0.4 µm) increased to 0.5, 0.8, 1.4 µm when MCD
employed for microblast treatments. It has been previously reported that an increase in surface 
roughness was observed with the introduction of HA with the Al
technique and the same trend was observed here 
abrasives [21]. Statistically significant differences were noted between the roughness of the microblast 
and CoBlast samples prepared using MCD
was used. A large standard error was observed for the MCD
possibly be a feature of the crude microblast process. As per the microblast samples, the level of 
roughness and irregularity of the Co
particle size, with a significant increase in surface roughness produced by larger abrasive particle 
sizes (p < 0.05). 
Implants with rougher surfaces result in a higher removal torque force and 
osteointegration when compared to those with smoother surfaces [5]. As seen in this study, 
microblasting offers increased roughening of machined Ti substrates as expected and the use of MCD 
abrasives results in the deposition of a thi
roughness of the microblast process can be tuned between 0.5
of the apatite abrasive employed. This is consistent with previously studies [5,6]. Unfortunately, the
coatings deposited using this microblast process have demonstrated poor adhesion to the metal and 
have not been widely employed as final surface treatments for this reason [21].
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Figure 4. Surface roughness (Ra) of the various modifications (* denotes p < 0.05 and ** 
ascribes p < 0.01 determined using student’s t-test). 
 
For the CoBlast samples, the tribo-chemical bonding which results from surface roughening, 
activation and subsequent bonding of the powder to the substrate has been shown to improve the HA 
bonding to the titanium [21,22]. The deposition of HA via the CoBlast process combines the benefits 
of increased roughness and enhanced bioceramic deposition with the added bioactive property of 
improved osteointegration compared to the microblasted surfaces. The surface treatment effect was 
also dependant on the particle size of the abrasive, with the larger particle size producing greater 
surface erosion and a rougher topography resulting in reduced coating thickness.  
In literature, HA coatings, deposited using the standard high temperature plasma spray deposition 
technique, have been reported to contain a variety of crystalline phases and the presence of altered 
chemical functionality [9]. This can lead to the formation of intermediates such as calcium oxide 
(CaO), octa-hydroxyapatite (OHA), α-tricalcium phosphate (α-TCP), β-tricalcium phosphate (β-TCP) 
and tetra-calcium phosphate (TTCP) [10,11]. The presence of these impurities in a HA modified 
surface can decrease the crystallinity and subsequently make it more prone to dissolution. The 
increased solubility of these phases can eventually lead to the poor apposition of bone and compromize 
the mechanical stability of the implant [12, 29]. This can occur when the coating itself de-laminates 
over time due to poor bonding strength of the HA onto the underlying surface or as the coating itself 
resorbs into the surrounding environment [30].  
Figure 5 shows the XRD pattern of the CoBlast HA coated substrates. Due to the thin nature of the 
deposited material and the interference of the background Ti metal, detailed analysis of the XRD 
profiles was not possible. However, for the CoBlast substrates, the peaks detected clearly correspond 
to that of HA powder employed. The additional 2θ peaks observed at 35.3° and 38.5° were assigned to 
the Ti substrate. No evidence of the TCP phase was detected (31° and 34.4°), which suggests that no 
compositional or crystallographic changes occurred to the HA powder during the blasting process, 
with negligible uptake of the abrasive, which is in keeping with previous studies [21,22]. 
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CoBlast demonstrated the ability to deposit a well adhered HA coating with no major evidence of 
contamination with additional calcium phosphate phases. This is in contrast to the variety of crystalline 
phases and the presence of altered chemical functionality produced during the standard high 
temperature plasma spray deposition. The XRD and FTIR analysis does not suggest formation of any 
such impurities within the CoBlast samples indicating that the HA coating on the CoBlast samples has 
retained the same properties as the starting crystalline HA powder employed. Therefore it is 
anticipated that HA modified surfaces prepared using CoBlast should not exhibit the problems 
associated with the presence of impurities observed for HA modified surfaces prepared using standard 
high temperature plasma spray which are outlined above. 
2.3. Cell Culture Analysis 
2.3.1. Cell Proliferation 
Osteoblasts are the key cells that are involved in the osteoconduction process. The success of the 
implantation is strongly influenced by how well the first phase of the attachment and adhesion of these 
cells will occur, which will then lead to the subsequent proliferation and differentiation upon contact 
with the implant surface. CoBlast surfaces have exhibited excellent osteoblast attachment and 
proliferation in vitro compared to their respective controls [21-23]. Biocompatability of the modified 
surfaces was determined via a (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) 
assay and the osteoblast proliferation results are presented in Figure 7. 
Figure 7. (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay 
data for MG-63 cells on modified Ti surfaces over five days in vitro  
(* denotes p < 0.05 and ** ascribes p < 0.01 determined using student’s t-test). 
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Microblast and CoBlast surfaces prepared using the MCD 106 abrasive were selected for 
comparison. There was no significant difference in the cell proliferation between samples analyzed at 
day 1. However, at day 5 there was a significant increase (p < 0.01) in cell proliferation on the CoBlast 
coated substrate compared to the untreated titanium. A significant difference (p < 0.05) was also 
detected between the CoBlast sample and the microblast sample at day 5. The introduction of the 
bioactive HA layer through the CoBlast process was shown to further increase surface roughness and 
this combination of surface topography and bioactive surface chemistry was found to offer notably 
higher levels of cell proliferation after 5 days on the CoBlast surface. No evidence of cytotoxicity was 
observed using MG63 cells on any of the samples evaluated. However, the surface coating thickness 
and surface roughness of the CoBlast coatings was found to be lower compared to plasma HA coating 
in literature (20–300 µm thickness, 3–6 µm Ra)[34] with increased cell proliferation observed on 
plasma HA compared to grit blasted surfaces [1]. 
2.3.2. Cell Morphology 
Surface modification techniques are extremely important for evoking desired cellular responses 
through tailoring the implants surface properties. The osteointegration process is greatly enhanced by 
these modifications, which in turn increases the long term success of the implant. As previously 
mentioned, HA is well known for its osteoconductive properties and its ability to influence cell 
adhesion and interaction at the implant-host interface. It is generally accepted that alongside chemical 
compatibility, the three dimensional surface topography (shape, size and surface texture) of the 
implant also influences early tissue response.  
Figure 8 shows various images of MG63 cells that were cultured on the untreated titanium 
substrates, Figure 8a; microblasted MCD 106 surface, Figure 8b and CoBlast HA/MCD-106, Figure 8c 
after 24 hours.  
Cells attached well to the untreated titanium surfaces and displayed a fibroblastic morphology 
synonymous with that of this osteoblastic cell line. The cells are typically polarized in one direction 
with the average cell length measuring roughly 60–80 µm (Figure 8a). Furthermore, lamellopodia and 
filopodia extensions (cytoskeletal organisation) from the main body of cells onto the surface are 
observed. The presence of these processes suggest good cell-substrate interactions where the cell is 
actively probing for specific topographical features and connects the cell to the substrate (via 
filopodia) from the lamellopida, which is the protrusion of their leading edge indicative of cell 
spreading and migration. However, the presence of numerous spherical cells indicates that not all cells 
are actively involved in spreading and migration. The cells cultured on MCD blasted surface 
(Figure 8b) display morphologies similar to that observed on the untreated titanium surfaces. The cells 
appeared to follow the contours of the MCD blasted surface where they would sit in the defects on the 
surface and align themselves along grooves or dents in a process referred to as ‘contact guidance’ [31]. 
The contact guidance effect has commonly been associated with increased cell proliferation and 
differentiation [31]. The surface roughness was determined to be 0.4, 0.5 and 0.7 µm for the blank Ti, 
microblast MCD-106 and the CoBlast HA/MCD-106 respectively and this obviously influenced the 
proliferation results observed here as mentioned earlier. 
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Figure 8c shows an image of MG
these differed from those of the untreated and microblasted
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spreading. The cells also tended to align to the surface features created by the addition of the bioactive 
layer, which was earlier observed to increase the surface roughness (
lamellopodia and filopodia were present on the CoBlast surface. The addition of a HA coat to the Ti 
surface, resulted in a higher order of 
microblasted surface (Figure 8b).  
Research has proven that the manufacturing process and patterned topography have a significant 
influence on long term adherence and cell proliferation 
surface roughness [32] and early controlled osteoblast alignment was demonstrated on patterned 
substrates [33]. Therefore, due to the patterned nature of the HA surface after CoBlast treatment, a 
more favorable surface resulted for cell spreading w
compared to the microblast and blank Ti surfaces.
using an alumina abrasive have already demonstrated early stage lamellar bone growth [21]. This 
study demonstrates that by employing differing grades of MCD abrasive in the CoBlast process, 
greater control over surface topography can be achieved, which offers the capability to improve 
bone-implant contact in vivo. Further 
studies in stimulated body fluid (SBF) must be investigated to support these capabilities.
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3. Experimental Section 
3.1. Materials 
Titanium (Grade 5, Ti-6Al-4V) coupons (15 mm × 15 mm × 1 mm), were obtained from Lisnabrin 
Engineering Ireland. Hydroxyapatite [Ca10(PO4)6(OH)2] powder was sourced from S.A.I., France. The 
MCD apatite abrasives were all purchased from Himed Inc. (NY, USA). HPLC grade 1M hydrochloric 
acid (HCl), de-ionised water, isopropanol (IPA), ethanol, phosphate buffer solution (PBS), potassium 
bromide (KBr) FT-ir grade, Trypsin EDTA, MTT assay kit, ACS reagent grade dimethyl sulphoxide, 
paraformaldehyde, glutaraldehyde, osmium tetroxide and hexamethyldisilizane were all purchased 
from Sigma-Aldrich UK. MG-63 osteoblast cells were obtained from American Type Culture 
Collection, Rockville, MD, USA. Minimum Essential Medium (MEM), foetal calf serum, penicillin G 
sodium, streptomycin, amphotericin B were purchased from PAA Laboratories GmbH, Austria. 
3.2. Sample Preparation 
Prior to surface modification, the coupons were cleaned ultrasonically in 1M HCl and then in 
isopropanol to remove any contaminants. The CoBlast technique was used to modify the titanium, 
through deposition with a HA layer. The processing utilized twin microblast nozzles for the 
dopant/abrasive system. The HA (dopant) was deposited onto the Ti coupons using compressed air at a 
pressure of 90 psi, speed of 13 mm/sec and a working distance of approximately 20 mm. The MCD 
abrasives (either MCD-106, MCD-180 or MCD-425) were blasted out of the second nozzle at a 
pressure of 75 psi and at a working distance of 8 mm from the surface. The microblast surfaces where 
prepared under the same corresponding conditions as above, however no HA was delivered through 
the dopant nozzle. After the surface treatment step, each sample was ultrasonically washed in  
de-ionized water for 5 mins to remove any loose powder from the surface.  
3.3. Surface Characterisation 
The elemental composition of the powders and the coatings was carried out using a Jeol JSM 5510 
SEM in conjunction with an INCA X-sight EDX spectroscopy detector (Oxford Instruments, 
Buckinghamshire, UK). Images were also taken using the same SEM system. Gravimetric analysis of 
the surface treatments on Ti was used to determine the coating mass using an Ohaus DV314C 
analytical balance by measuring the sample before and after an acid wash (ultrasonic treatment in  
20 mL 1 M HCl for 10 mins). PXRD data was collected on a Siemens GAXRD diffractometer using 
CuKα1 radiation, with an anode current of 30 mA and an accelerating voltage of 40 keV. Data was 
collected in the range of 20 to 60 2θ degrees with a step size of 0.02 and a scan rate of 1 s per step. 
Coating thickness was measured using a PosiTector 6000 N thickness gauge (DeFelsko, NY, USA). 
An average of six readings was used to determine each value. The surface roughness (Ra) was 
determined using a Talsurf 10 surface profilometer (Talyor Hobson, UK). A Perkin Elmer Spectrum 
One FTIR was used to determine the structural fingerprint of the powders and the coatings. The 
coating was scrapped off, gently ground and pressed into a KBR disc (2% wt sample in KBR). 
Powders for FTIR analysis were prepared in a similar manner. FTIR spectra were recorded in the 
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1600–400-cm
-1
 range, with 4 cm
-1
 resolution using 20 scans and background subtraction. The spectra 
gave approximately 70–90% transmittance however the results are presented in an overlay fashion.  
3.4. In Vitro Cell Culture 
Sample modifications including CoBlast HA/MCD-106 and microblast MCD-106 and the blank Ti 
were evaluated for osteoconductivity and cytotoxicity using cell culture tests. Prior to cell culture 
analysis, each sample set was steam autoclaved at 121 °C for 20 minutes. MG-63 cells were used to 
assess cell proliferation. Cells were cultured in the MEM media supplemented with 10% foetal calf 
serum and antibiotic/antimycotic (penicillin G sodium 100 U/mL, streptomycin 100 µg/mL, 
amphotericin B 0.25 µg/mL) in 75 cm
3
 tissue culture flasks. Cells were maintained in a humidified 
atmosphere with 5% CO2 at 37 °C and were sub-cultured when they reached confluence using 0.25% 
Trypsin EDTA solution to provide adequate numbers of cells for the various in vitro culture  
studies undertaken. 
3.4.1. Cell Proliferation 
MG-63 cell attachment to the various treated and untreated Ti substrates was determined after 4 
hours in culture using a commercial MTT assay and employing a modified Mosmann method [24]. 
Cells were seeded onto the samples at a concentration of 1x10
5
 cells/cm
2
and allowed to adhere during 
incubation at 37 °C in 5% CO2 for 4 hrs. The MTT assay reagent was prepared as a 5 mg/mL stock 
solution in PBS, sterilized by filtration, and stored in the dark. An aliquot of the MTT stock solution 
(10% of total volume) was added to each well of a six well plate containing the samples (n = 4 for each 
sample type). After 3 hrs incubation at 37 °C in 5% CO2, 200 µl of dimethyl sulfoxide was added to 
dissolve the formazan crystals. The solution was agitated for 15 min on a shaker to ensure adequate 
dissolution. The optical density of the formazan solutions was read by spectrophotometry using an 
ELISA plate reader (Tecan Sunrise, Tecan Austria) at 570 nm with the background absorbance value 
measured at 650 nm. The absorbance values recorded were determined to be proportional to the 
number of cells attached to the surface in each case. All data reported are expressed as mean ± 
standard deviation.  
3.4.2. Cell Morphology 
MG-63 cells were seeded onto each of the above substrates at a cell density of 5 × 10
5
 cells/cm
2
 in  
6-well plates and were incubated for 24 hours. After cell culture, the samples were gently rinsed with 
PBS to remove any unattached cells and fixed in a modified Karnovsky’s Fixative (2% 
paraformaldehyde/ 2% glutaraldehyde in PBS) for 1 hour. The samples were then rinsed in PBS and 
post-fixed in 1% osmium tetroxide and rinsed three times with PBS. The specimens were dehydrated 
by rinsing in an alcohol series (20, 30, 50, 70, 80, 90 and 95% ethanol), and finally rinsing 3 times in 
100% ethanol. The samples were then were chemically dried in hexamethyldisilizane (HMDS) 
overnight. A 50 nm layer of gold-palladium was deposited onto the substrates using a Polaron E5000 
SEM Sputter Coating Unit. The sputtering conditions used a set voltage of 1.4 kV, with a plasma 
current of 18 mA (argon gas), a deposition time of 2 minutes at a vacuum pressure of 0.05 Torr. The 
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samples were then analyzed using the Jeol JSM 5510 SEM and subsequently using a FEI Quanta 200 
Focused Ion Beam and SEM in backscatter electron mode. 
4. Conclusions  
Detailed surface studies have shown that the combination of an apatite abrasive and a HA dopant in 
the CoBlast process produces surfaces with a combination of optimized apatite chemistry and 
controlled surface structure. The CoBlast process has the ability to retain the chemistry of the starting 
HA material. This offers advantages over conventional high temperature plasma processing which 
alters the HA material from its desired chemical, structural and dissolution requirements for its use as 
an in vivo implant material. The study also shows that employing MCD abrasives offer an alternative 
to alumina for deposition using CoBlast process. In vitro studies clearly show that increased roughness 
of treated surfaces favors enhanced cell proliferation and the CoBlast process offers the ability to tailor 
the surface texture to produce an optimized surface for osteointegration of a HA modified implant. 
Enhanced cell proliferation was observed for CoBlast modified surfaces compared to the microblasted 
surface. The ability of the CoBlast technology to offer diversity in modifying surface topography is 
clearly shown in this and previous studies and represents foundation work, which supported by 
bioactivity studies and in vivo trials, offers exciting new prospects in tailoring the properties of medical 
devices for applications ranging from dental to orthopedic settings.  
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